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ABSTRACT 
Reprogramming Protein Synthesis for Cell Engineering 
Andrew Vito Anzalone 
 
Synthetic biology, which aims to enable the design and assembly of customized 
biological systems, holds great promise for delivering solutions to numerous modern day 
challenges in agriculture, sustainable energy production, and medicine.  However, at its 
current stage, synthetic biology is not yet equipped with the necessary tools and 
understanding to reprogram the immensely complex molecular environment of the cell 
beyond simple proof of concept demonstrations. One current objective within synthetic 
biology is to create robust tools that can be used to manipulate biological systems in a 
predictable and reliable manner. While many transcription-based control devices have 
been reported, little consideration has been given to the eukaryotic protein translation 
apparatus as a target for engineering gene-regulatory tools.  
In this work, we explore the potential for reprogramming the protein synthesis 
machinery for cell engineering. We begin in Chapter 1 by reviewing canonical protein 
synthesis and survey the assortment of translation reprogramming mechanisms that exist 
in nature, focusing on the role of RNA in these processes. We then cover previous efforts 
to engineer the protein synthesis machinery and discuss their methodological approaches. 
Lastly, we examine potential opportunities for engineering protein synthesis that have not 
yet been explored.  
RNA’s prominent role in protein synthesis and its amenability to high-throughput 
in vitro selection approaches raises the possibility that the translation apparatus could be 
engineered through in vitro directed evolution of its RNA components. In Chapter 2, we 
develop an experimental framework for identifying mRNA sequence elements that 
reprogram protein synthesis, focusing on stop codon readthrough. By adapting a 
previously developed in vitro selection technology called mRNA display, we demonstrate 
that molecules of RNA derived from expansive libraries of random sequences can be 
enriched as a result of their translation reprogramming activity. We then analyze these 
stop codon readthrough signals and propose the use of these sequences for enhanced 
unnatural amino acid incorporation technologies. 
In Chapter 3, we apply this very same selection principle for the in vitro directed 
evolution of RNA sequences that stimulate -1 programmed ribosomal frameshifting. 
Then, using previously reported RNA aptamers, we rationally engineer RNA switches 
that regulate translation reading frame in response to small molecule inputs. To further 
optimize switch performance, an in vivo directed evolution platform was established. We 
explore the utility of these RNA switches, particularly their ability to regulate multi-
protein stoichiometry, for performing cellular logic operations and controlling cell fate. 
A major focus of translation engineering has been the incorporation of unnatural 
amino acids for fluorescent labeling of proteins in living cells. The successful 
achievement of this goal will require small molecule fluorophores with desirable 
biological properties, as well as robust synthetic methods for their production. In 
Chapter 4, we present a scalable approach to oxazine and xanthene fluorophores that 
utilizes a general diaryl ether synthetic intermediate. Finally, in Chapter 5, we describe a 
photoactivatable oxazine fluorophore and demonstrate its utility as a live-cell imaging 
reagent with applicability to advanced microscopy techniques. 
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1.0  Chapter outlook 
 The ribosome and its associated translation components are tasked with 
coordinating the biosynthesis of the entire cellular proteome. Despite its immense 
complexity, this ensemble of translation factors collaborates to achieve a strikingly 
simple program for interpreting the genetic code and synthesizing proteins of specifically 
defined sequence. The apparent simplicity and logic in the program makes protein 
translation an extremely attractive and powerful engineering target—merely edit the 
program and you will alter protein expression. However, the complexity of the translation 
apparatus should not be overlooked. Hints of underlying intricacies are revealed by the 
various forms of translation reprogramming found in nature, each of which challenges 
our simplistic view of the protein synthetic apparatus. While perhaps at first 
discouraging, great opportunity resides within this complexity, which may be exploited to 
expand the synthetic and regulatory capabilities of protein synthesis. Here, we briefly 
review the standard translation program and its key components, and introduce a select 
set of translation reprogramming mechanisms that have so far been discovered in nature. 
We then survey the strategies that previous researchers have taken to re-write the 
translational program, focusing primarily on unnatural amino acid incorporation 
technologies. Lastly, we examine emerging opportunities for engineering the translation 





1.1 The standard translation program 
All forms of life (and virus) on earth must use the genetic information stored 
within their nucleic acid genomes to synthesize proteins, the principal executors of 
biological function. According to the central dogma of molecular biology1, the flow of 
information from nucleic acid to protein is unidirectional, and generally requires that 
information first be ‘transcribed’ from a gene’s deoxyribonucleic acid (DNA) sequence 
into ribonucleic acid (RNA). RNA can then be converted into proteins in a process 
termed ‘translation.’ Translation is carried out by the ribosome, a highly evolved 
macromolecular assembly of proteins and RNA composed of a small subunit (30S in 
bacteria; 40S in eukaryotes) and a large subunit (50S in bacteria; 60S in eukaryotes)2. In 
collaboration with a multitude of translation factors and components, the ribosome 
coordinates protein biosynthesis according to a well-defined program. This program 
relies on a set of decoding rules that are applied in succession to non-overlapping triplets 
of nucleotides, termed codons, within messenger RNA (mRNA)3. 
The code operates with 64 distinct codons, which arise from all possible triplet 
combinations of the four standard RNA nucleotide monomers: adenosine (A), uridine 
(U), guanosine (G), and cytidine (C). The program defines each codon to either specify 
the incorporation of a single amino acid residue (sense codons) or the termination of 
protein synthesis (stop or nonsense codons). The AUG codon is also used as a signal to 
initiate protein synthesis. Because proteins are synthesized from 20 standard amino acid 
building blocks, there is an inherent redundancy in the code such that a single amino acid 
is often designated by multiple codons. Three of the 64 codons (ochre UAA; opal UGA; 
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and amber UAG) are typically reserved for programming termination of protein 
synthesis.  
Essentially, the translation program is executed in 3 basic phases: (1) initiation, 
(2) elongation, and (3) termination (Fig. 1-1). Protein synthesis initiates predominantly at 
AUG codons and requires numerous initiation factors that recruit the requisite translation 
machinery to prime the apparatus for elongation. Initiation is a highly regulated step, 
especially in eukaryotes4, as the decision to initiate generally signifies a commitment to 
the synthesis of a full-length protein product.  
 
 
Figure 1-1. Phases of translation. Protein synthesis can be broken down into three basic phases: 
1) Initiation requires the cooperation of multiple distinct initiation factors (IFs), the initiator 
tRNA, and joining of separate 30S and 50S subunits; 2) during elongation, the polypeptide is 
built through successive decoding and peptide bond forming events; and 3) at termination, the 
peptide is released from the translation apparatus at stop codons. 
 
During the elongation phase, individual amino acid monomers are delivered to the 
ribosome in the form of aminoacyl-tRNA, covalently linked through an ester bond to L-
shaped transfer-RNA (tRNA) ‘adaptor’ molecules. In a ternary complex with EF-Tu 
(eEF1a in eukaryotes) and GTP, aminoacyl-tRNAs rapidly bind to the ribosome and 
sample the codon in the ribosomal A-site5. If the ribosome detects proper (cognate) 
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pairing between the codon and tRNA anticodon, selection of the aminoacyl-tRNA and 
accommodation into the A-site are accelerated. Once the aminoacyl-tRNA is properly 
poised in the A-site, peptide bond formation quickly follows (Fig. 1-2)6.  
At this stage of elongation, the entire apparatus must move down the mRNA by 
three nucleotides, or one codon, to allow for the incorporation of the next amino acid 
residue. This process, termed translocation, involves capture of a ratcheted, or hybrid, 
ribosomal state by the GTPase EF-G (EF-2 in eukaryotes)7,8. Hydrolysis of GTP by EF-G 
provides the energetic driving force for translocation of the apparatus, placing the next 
codon in the ribosome’s A-site. The elongation phase continues until the ribosome 
reaches a stop codon. Here, dedicated class I release factors (RF1 and RF2 in bacteria, 
and a cooperative complex9 of eRF1 and eRF3 in eukaryotes) catalyze the hydrolysis of 
the fully synthesized polypeptide from the P-site tRNA, and recycling factors 
disassemble the translation apparatus for reuse10.  
The fidelity of protein synthesis is enforced at multiple stages, beginning with 
aminoacyl-tRNA synthesis by aminoacyl-tRNA synthetase (aaRS) enzymes11. These 
enzymes are responsible for correctly ‘charging’ free amino acids onto their cognate 
carrier tRNA molecules12. Errors in aminoacylation, which could result in mis-
incorporation of an amino acid at an incorrect codon, occur at very low rates (~1 x 10-5) 
owing to kinetic discrimination and editing by aaRSs13–15. Evidence suggests that 
incorrectly charged tRNAs efficiently incorporate amino acids into the elongating 
polypeptide16, suggesting that it is critical that the cellular repertoire of aaRS/tRNA pairs 
operate orthogonally to one another and with high specificity for their amino acid 
substrates. The translational apparatus has also evolved to exquisitely discriminate 
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between codons of similar composition (near-cognate) during the aminoacyl-tRNA 
selection and accommodation stages of elongation6. As a result of kinetic proofreading, 
error rates for this decoding process, which are codon dependent17, are estimated to occur 
between 10-3 to 10-5 per amino acid incorporation18.  
 
 
Figure 1-2. The translation elongation cycle. The ribosome contains 3 sites for tRNAs: (i) an A-
site, where incoming aminoacyl-tRNAs bind; (ii) a P-site, where the peptidyl tRNA resides; and 
(iii) and E-site, where deacylated tRNAs exit from the ribosome. There are three basic steps 
within the elongation cycle. 1) A ternary complex of EF-Tu, aminoacyl-tRNA, and GTP binds to 
the post-translocation complex. The ribosome selects an aminoacyl-tRNA based on codon-
anticodon interactions, then induces EF-Tu to hydrolyze GTP and release tRNA into the 
ribosomal A-site. 2) Peptide bond formation occurs, transferring the peptide to the A-site tRNA. 
3) With the aid of EF-G, the translation apparatus translocates by three nucleotides to allow for a 
subsequent round of elongation. 
 
Maintenance of translational reading frame is also necessary to ensure that the 
proper string of codons is translated19,20. While mis-incorporation of an amino acid at a 
single position in a protein could potentially be problematic, it would often only subtly 
affect protein function. However, a shift in reading frame during elongation changes the 
sequence of the entire downstream peptide and likely results in the synthesis of a 
truncated, junk protein product. Errors in translation reading frame maintenance have 
been estimated at ~ 1 x 10-4 in E. coli21. Maintenance is significantly influenced by the 
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nature of the codons and tRNAs that are present in the P-site22, as well as the 
modification status of the tRNAs23.  
The last phase, termination, must be both efficient and specific for cognate stop 
codons to prevent unintended extension or truncation of the protein sequence. Unlike 
sense codons, stop codons are recognized through RNA-protein interactions as opposed 
to RNA-RNA base-pairing interactions. Similar to sense codon recognition, however, the 
signal for cognate codon detection must be transmitted to the peptidyl tranferase center to 
promote specific chemistry. Interestingly, class I release factors resemble tRNAs in shape 
and size24. This structural mimicry is in agreement with their functional similarities. 
When recognition of a cognate stop codon occurs, the release factor induces an active 
conformation of the ribosome’s peptidyl-transferase center (PTC) and positions a water 
molecule (using a conserved GGQ motif) for nucleophilic attack on the peptidyl-tRNA 
ester bond25. It has long been recognized that the nucleotide context surrounding the stop 
codon in the mRNA plays an important role in the efficiency of release at cognate stop 
codons26,27. Therefore, one mechanism to enhance the fidelity of termination could 
simply be to select for efficient stop codon recognition context28.  
1.2 Translation reprogramming: beyond the standard code 
Faithful translation of the code is necessary for ensuring accurate synthesis of the 
cellular proteome. However, there are surprisingly many instances in which the ribosome 
deviates from its standard mode of translation29. While the classical paradigm of protein 
synthesis likely predominates for the majority of translation events, examples abound of 
non-canonical decoding that result in the expression of alternative protein products. Not 
surprisingly, nature has exploited the inherent complexity and sequence diversity 
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contained within mRNAs and nascent polypeptide chains to re-wire translation and 
expand the coding capacity of individual genes. Examples of such re-wiring include 
programmed stop codon readthrough, programmed ribosomal frameshifting, nascent 
peptide-mediated stalling, ribosomal ‘hopping’, and targeted incorporation of non-
standard amino acids30.  
1.2.1 Programmed stop codon readthrough in eukaryotes 
The amber (UAG), opal (UGA) and ochre (UAA) codons are typically interpreted 
as termination signals by the eukaryotic translation apparatus, stimulating the hydrolytic 
release of polypeptides from the ribosome. However, in special cases, these stop codons 
can be partially reassigned to encode amino acid residues in a context dependent manner. 
This reprogramming event, termed programmed stop codon readthrough (to be 
distinguished from stop codon reassignment), has been well documented in plant and 
animal RNA viruses31. Generally, stop codon readthrough serves to enable the synthesis 
of two distinct proteins from a single mRNA transcript: one, a product of standard 
translation, and the other, a C-terminally extended product that results from readthrough 
of the nonsense codon. In RNA viruses, this mechanism is often used to regulate the 
synthesis of replicase genes32,33.  
Both primary sequences directly adjacent to the stop codon, as well as 
downstream RNA structures, are capable of promoting this reprogramming event. 
Primary sequence signals are exemplified by the well characterized Tobacco Mosaic 
Virus (TMV) readthrough motif33,34, which has a documented consensus sequence CAR-
YYA (R is any purine, and Y is any pyrimidine)—most often CAA-UUA. This 
hexanucleotide motif stimulates stop codon readthrough with an efficiency of 
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approximately 5%35. The TMV sequence can stimulate readthrough at each of the three 
stop codons, however it is generally more efficient at the UAG stop codon27,34. Other 
readthrough signals suggest that even a single cytidine nucleotide directly 3’-adjacent to 
the stop codon is sufficient to induce readthrough36. Another class of stop codon 
readthrough signals comprises a set of downstream structural elements37, typically taking 
the form of RNA stem-loops38 or pseudoknots39,40 (Fig. 1-3). These structures usually 
begin between 8-9 nucleotides downstream of the last nucleotide of the stop codon. In 
structure-based readthrough signals in viruses, the sequence of the intervening linker is 
often conserved and can influence the activity of the readthrough signal41. 
The precise mechanisms by which these reprogramming signals operate are 
currently unknown and may be diverse in nature. However, it is known that readthrough 
generally occurs via the selection of near-cognate tRNAs at nonsense codons29,42. 
Therefore, a reasonable hypothesis concerning the overarching principle behind this 
recoding phenomenon would be that stop codon readthrough signals in some way inhibit 
release factors from functioning efficiently, thus allowing greater opportunity for 
selection of near-cognate aminoacyl-tRNAs at nonsense codons32. It is also formally 
possible that these signals operate by accelerating selection of near-cognate aminoacyl-
tRNAs through interaction with the ribosome’s decoding center.  
 
Figure 1-3. RNA secondary structures 
that induce programmed stop codon 
readthrough. (a) Stem-loop structure 
of the carnation italian ringspot 
tombusvirus. (b) The murine 
leukemia virus (MLV) pseudoknot. 
Figure reproduced from Firth & 
Brierley31 and Napthine et al.38.  
!
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Recent cryo-electron microscopy studies43 of eukaryotic eRF1 bound to the 
ribosome may provide insight into possible mechanisms of programmed stop codon 
readthrough. In the published structure, the eRF1 is found interrogating the stop codon, 
with the two purines at position +2 and +3 stacked (Fig. 1-4). Additionally, the 3’-
adjacent nucleotide (position +4) is observed being drawn into the ribosomal A-site, 
stacking with G626 of 18S RNA. This structure is to be contrasted with the structure of 
bacterial release factor bound to the stop codon, which does not induce this 
conformational change in the mRNA.  
 
Figure 1-4. Stop codon recognition by eRF1. (a) The configuration of the three stop codons 
(UAA, UAG, and UGA) while being recognized by eRF1. The purine nucleotides in the stop 
codon (positions +2 and +3) are seen stacking, and the 3’adjacent nucleotide (+4) is pulled into 
the A-site. (b) eRF1 (AAG) inactive mutant bound to the UGA stop codon. The +4 nucleotide is 





One immediate hypothesis regarding the propensity of a +4 position cytidine 
residue to induce readthrough is apparent from this structure. Base stacking with G626 
would presumably favor purine nucleotides at the +4 position, and would be less 
energetically stabilizing when cytidine occupies the +4 position. Also, the nature of the 
mRNA distortion may require a 3’ region that is malleable to this perturbation. Perhaps, 
the nature of the downstream nucleotides can influence the ability of the mRNA to 
tolerate this movement toward the A-site, and in some cases may be unfavorable if it 
requires the disruption of prev-existing stable interactions. Similarly, structural elements 
at the entryway of the mRNA tunnel may act to encumber movement of the mRNA 
toward the ribosomal A-site.  
1.2.2  Codon redefinition  
 The standard genetic code, which utilizes the same 20 amino acids monomers for 
protein synthesis in all organisms, has long been viewed as universal and unchangeable, 
the result of a ‘frozen accident’44. Indeed, the hypothesis put forth by Francis Crick 
nearly a half-century ago explains many of our observations about the nature of the code 
and its apparent constancy throughout biology. However, over 20 naturally occurring 
alternate genetic codes are now known45, including in mitochondria, refuting this 
proposition of immutability. The most common changes to the code are in the 
redefinition of nonsense codons to sense codons. This can be used to specify either a 
standard amino acid (e.g. UGA coding for tryptophan in mitochondria46) or an atypical 
amino acid such as selenocysteine47,48 or pyrrolysine49.   
 While the former category of codon reclassification (nonsense to standard amino 
acid) typically applies genome-wide, the redefinition of a stop codon to designate a non-
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standard amino acid generally occurs in gene-specific manner. This is especially true for 
selenocysteine (Sec) incorporation at opal (UGA) stop codons (Fig. 1-5), which requires 
the assistance of a cis-acting RNA motif termed the SECIS (selenocysteine insertion 
sequence) element for efficient incorporation50. While a putative PYLIS element has been 
proposed51 to direct pyrrolysine (Pyl) incorporation, the role that this RNA structure 
plays in promoting pyrrolysine incorporation at amber (UAG) codons is not clear and 
likely not necessary52. Thus, the amber stop codon may be ambiguous in organisms that 
utilize pyrrolysine. 
In contrast, selenocysteine, which is encoded by organisms in all kingdoms of 
life53,54, requires several factors for efficienct incorporation at reprogrammed UGA 
codons. In addition to a downstream SECIS element, Sec incorporation also relies on a 
dedicated EF-Tu-like elongation factor called SelB (EF-Sec in eukaryotes). In bacteria, 
this factor is a chimeric protein55 with one domain that binds specifically to Sec-tRNASec 
with high affinity56, and a second domain that binds directly to the mRNA SECIS 
element. In eukaryotes, EF-Sec binds to an adaptor protein called SBP2 that interacts 
with the SECIS element57 to recruit Sec-tRNASec to the ribosome. Interestingly, Sec is not 
directly charged onto its tRNA, but instead synthesized from a serine charged 
intermediate58,59 Ser-tRNASec. While Ser-tRNASec would appear to be a viable substrate 
for translation, the extended acceptor stem of tRNASec precludes it from binding to EF-
Tu60,61, and the lack of an anionic Sec residue diminishes the binding affinity to SelB. 




Figure 1-5. SECIS element directed incorporation of selenocysteine at UGA codons. This figure 
is reproduced from Baranov et al.62 
 
1.2.3 -1 programmed ribosomal frameshifting  
A common translation reprogramming event found in bacteria and eukaryotic 
retroviruses is -1 programmed ribosomal frameshifting (-1 PRF)63. In eukaryotes, this 
reprogramming mechanism was first described in Rous sarcoma virus64,65, where 
synthesis of the Gag-Pol polyprotein was found to require a ribosomal frameshift event to 
access the pol open reading frame. -1 PRF is now appreciated as a general mechanism 
employed by RNA viruses to express reverse transcriptase or RNA-dependent RNA-
polymerase (replicase). In most retroviruses, including HIV66, -1 PRF provides a means 
to strictly control the stoichiometry of Gag and Gag-Pol proteins, which is important for 
viral fitness67. Also, the Gag-Pol fusion enables recruitment of the polymerase into the 
viral particle by physical connection to a structural component of the virion. In other 
positive-strand RNA viruses, -1 PRF is also likely important for setting the correct 
stoichiometry of viral protein synthesis products68. 
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As with programmed stop codon readthrough and selenocysteine recoding, -1 
PRF requires cis-acting signals within the mRNA to site-specifically trigger the 
reprogramming event (Fig. 1-6). In the case of eukaryotic -1 PRF, two features are 
necessary: (1) a heptanucleotide slippery site, which is the site of the frameshift event and 
has the general sequence X-XXY-YYZ (dashes demarcate codons in the original frame; 
X can be any nucleotide; Y can be A or U; and Z can be A, C or U); and (2) a 
downstream RNA stimulatory structure, typically a hairpin or pseudoknot69. While the 
slippery site is restricted to sequences that fit the constraints outlined above, the 
downstream stimulatory elements display a wide range of variability in sequence, size 
and structure. The diversity found in pseudoknot stimulatory elements70 suggests that -1 
PRF relies less on specific interactions, but rather more general engagement of the 
translation apparatus. 
 
Figure 1-6. Scheme of -1 programmed ribosomal frameshifting. The frameshift even occurs 
when tRNAs occupy the heptanucleotide slippery site, and is stimulated by a downstream RNA 
structure (above, an RNA pseudoknot). Figure reproduced from Giedroc & Cornish70. 
 
 Several studies have attempted to unravel the fundamental principles behind 
ribosomal frameshifting in an effort to construct a descriptive mechanistic model for this 
important reprogramming event. It was originally hypothesized71 that the role of the 
stimulatory structure was to provide mechanical tension for the processing ribosome, and 
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evidence suggested that the strength of the RNA structure correlated with frameshift 
activity72,73. However, other evidence suggests that the mechanical stability of the RNA 
structure is not directly correlated to frameshift activity74, indicating that the operative 
mechanism may be more subtle.  
Recent in vitro single molecule fluorescence resonance energy transfer (smFRET) 
experiments75,76 have provided some mechanistic insight into this important translation 
reprogramming event. These studies used the E. coli dnaX -1 PRF signal, which is 
composed of an upstream Shine-Dalgarno sequence in addition to the heptanucleotide 
slippery site and downstream RNA structure found in eukaryotic -1 PRF signals. In these 
studies, frameshift signals produced significant ribosome pausing and impeded EF-G 
catalyzed translocation. Overall, these smFRET experiments suggest that -1 PRF signals 
stimulate the ribosome to enter a non-standard rotated state that eventually leads to frame 
slippage, possibly concurrent with aberrant EF-G-mediated translocation.  
Another recent study77 detailed the use of mass spectrometry (MS) and force 
microscopy to characterize translation products of an mRNA containing the dnaX 
frameshift signal. Translation products characterized by MS were found to contain 
peptides that resulted from not just -1 slippage, but also -4 and +2 slippage (accessing the 
equivalent frame). Additionally, ribosome trajectories corresponding to these positional 
fluctuations were observed using optical tweezers. The results of this study are intriguing, 
suggesting that the ribosome makes large movements along the mRNA when 
encountering a frameshift site, and settles on the -1 frame as a result of acceptable codon-




1.3  Reprogramming translation for synthetic biology  
 The prospect of redefining the intrinsic nature of the genetic code is perhaps one 
of the most appealing and exciting opportunities in synthetic biology. The ensemble of 
components that make up the translation apparatus, including the ribosome, tRNAs, 
mRNAs, aaRS enzymes, and numerous translation factors, is responsible for 
establishment and maintenance of the standard code. Therefore, efforts to modify the 
code would logically focus on engineering these translation components. In addition to 
interpretation of the code, the translation machinery can also control the extent to which 
different proteins are synthesized, presenting opportunities to regulate gene expression 
through targeting translation.   
1.3.1  Unnatural amino acid mutagenesis 
 While the standard genetic code utilizes just 20 basic amino acid building blocks, 
it possesses 64 distinct triplet codons, each of which could theoretically be reserved for a 
unique purpose. Given the abundance of post-translation modifications, as well as the 
addition of new amino acids to some genetic codes, a substantial range of useful 
chemistries are apparently not satisfied by the standard 20 amino acid derivatives. 
Expansion of the genetic code would therefore allow for the addition of new chemical 
functionality to the amino acid repertoire, which could be exploited for various 
applications in basic biology and biotechnology. 
 The most successful strategy for incorporation of non-standard amino acids has 
been amber suppressor tRNA technology. Aminoacylation of amber suppressor tRNAs 
allows for the incorporation of the charged amino acid into proteins in response to the 
amber codon. This was first demonstrated78 with unnatural amino acid substrates in an in 
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vitro translation system, where artificially charged tRNAs were prepared by chemical 
methods (Fig. 1-7). This design remains a viable strategy for producing proteins with 
unnatural side chains, and developments in artificial aminoacylation using evolved 
ribozymes79 have assisted in the generation of these unnaturally charged tRNA reagents.  
 
Figure 1-7. Unnatural amino acid 
incorporation with chemically 
synthesized suppressor tRNAs. 
Truncated suppressor tRNAs are in vitro 
transcribed and ligated to aminoacylated 
dinucleotides. The open reading frame 
of a protein of interest is mutagenized to 
encode an amber nonsense codon, then 
transcribed and translated in vitro in the 
presence of the chemically synthesized 
tRNA. This figure is reproduced from 
Noren et al.78 
 
 
A major transformation occurred when Schultz and coworkers reported80 an 
evolved aaRS enzyme that could recognize an unnatural amino acid substrate and charge 
it onto an amber suppressor tRNA in E. coli. This required that the imported aaRS/tRNA 
pair be orthogonal in the host organism to prevent aminoacylation of the suppressor 
tRNA with natural amino acids. Expression of the evolved orthogonal aaRS/tRNA pair 
expands the genetic code of E. coli, with amber codons partially redefined to specify the 
non-standard amino acid. Since this initial report, numerous evolved aaRS variants have 
been reported for genetic encoding of unnatural amino acids in various organisms81–83.  
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 One valuable application of unnatural amino acid mutagenesis technology is the 
incorporation of biophysical probes84 and chemical handles85 into proteins. Fluorescent 
amino acids86–88 have been successfully incorporated into proteins in vivo, and recent 
developments have extended this technology to applications in human cells89. A more 
modular approach has been devised that relies on post-translational modification of the 
unnatural amino acid using bio-orthogonal click chemistry90,91. Recently, inverse Diels-
Alder click reactions92,93 have been exploited for protein specific labeling with 
fluorescent probes, enabling super-resolution imaging94.  
These and other unnatural amino acid technologies have offered powerful tools 
for manipulating biological systems. However, widespread adoption of the technology 
has been limited due to unreliable and low incorporation yields that are highly substrate 
and protein dependent. Therefore, new approaches are required to enhance the efficiency 
and specificity of unnatural amino acid mutagenesis if it is to become a truly 
transformative tool for basic biology and cell engineering. 
1.3.2  Engineering translation through RNA  
While the protein products of translation are responsible for carrying out most 
cellular functions, the process of protein synthesis itself, which is so central to life, 
conspicuously employs another biopolymer—RNA. From the coding messenger RNA 
template, to the tRNA ‘adaptor’ molecules, to the decoding and peptidyl-transferase 
centers of the ribosome, RNA’s role in protein translation is paramount. RNA is also 
widely used by nature to ‘edit’ the standard translation program and alter the outcome of 
protein synthesis. Thus, any attempt to modify or engineer protein translation would 
wisely consider its RNA components as targets.  
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Many efforts to engineer the RNA components of translation began with 
tRNAs95,96. tRNAs are attractive options for engineering, as they represent relatively 
short stretches of RNA sequence that are well understood in terms of structure and 
function. Engineered quadruplet decoding tRNAs, which suppress frameshift mutations 
as opposed to nonsense codons, have been used for unnatural amino acid incorporation97. 
Orthogonal tRNA/aaRS pairs have been generated by mutation of the tRNA body 
followed by complementary changes in the partner aaRS98,99. Additionally, the anticodon 
stem of a an amber suppressing phosphoseryl-tRNA has been optimized for high 
suppression efficiency by in vivo directed evolution100. While recent efforts to engineer 
tRNAs have taken more ambition approaches, dramatic changes to the tRNA body have 
not been extensively explored. For example, tRNASec, which possesses an extended 
acceptor arm unlike any other natural tRNA101, demonstrates the possibilities for 
engineering non-canonical tRNA variants with specialized function.  
The mRNA also has great potential as a component for translation engineering, 
especially considering the numerous translation reprogramming and recoding events that 
utilize signals contained within the mRNA. However, with the exception of internal 
ribosome entry sites (IRES)102, few of these mechanisms have been adopted for synthetic 
biology. A great deal of research has been devoted to developing unnatural amino acid 
mutagenesis technologies using stop codon suppression. Yet, none of these approaches 
have taken advantage of the natural design of selenocysteine incorporation. Moreover, 
other reprogramming mechanisms such as stop codon readthrough and -1 PRF have 
potential applications for gene regulation through engineering of their RNA components. 
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Adaptation of these and other mRNA-based translation control mechanisms should prove 
fruitful for future cell engineering efforts.  
Without question, the most ambitious RNA target for translation engineering is 
the ribosome. High-resolution structures103 have recently made the rational alteration of 
ribosomal RNA a realistic endeavor. One intriguing example has been the development 
of orthogonal bacterial ribosome-mRNA pairs104, which were created by evolution of the 
Shine-Dalgarno and anti-Shine-Dalgarno sequences in the mRNA and ribosome, 
respectively. These orthogonal ribosomes were further evolved to more efficiently 
decode quadruplet codons by mutation of 16S RNA in the small (30S) ribosomal 
subunit105. Recently, bacterial ribosomes with tethered 30S and 50S subunits were 
reported106,107, enabling mutagenesis of the large ribosomal subunit with genetically 
encoded orthogonal ribosomes. These developments open the opportunity to refashion 
the peptidyl-transferase center to promote new forms of catalysis, introducing perhaps the 
grandest engineering challenge of all—changing the very nature of the chemistry of 
translation.  
1.4 Conclusions 
 The protein synthesis machinery is a complex assembly of RNA and protein 
components that collaborate to translate the genetic code. Nature provides us with several 
examples of ways in which the ribosome can be reprogrammed in a gene-specific manner 
to achieve expanded synthetic and regulatory capabilities. Modification of the standard 
genetic code holds enormous potential for engineering biological systems, and we would 
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A.V. Anzalone, V.W. Cornish, et al. “Identification of Eukaryotic Stop 
Codon Readthrough Signals by In Vitro Selection.” In preparation.  
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2.0  Chapter Outlook 
Translation in eukaryotes can be reprogrammed by cis-acting RNA signals to 
regulate protein expression and expand the coding capacity of individual genes. From 
natural examples, it is apparent that a wide variety of RNA features can promote many 
distinct forms of translation reprogramming. However, this relatively small set of natural 
cases limits comprehensive evaluation of RNA’s translation reprogramming potential, 
and may not be representative of all reprogramming signals in biology. Therefore, 
methods for quickly characterizing large numbers of prospective reprogramming signals 
would advance our understanding of these phenomena, and possibly aid in the 
identification of naturally occurring reprogramming events. In this chapter, we establish 
an experimental framework for in vitro selection of RNA sequences that reprogram 
translation, focusing specifically on stop codon readthrough (RT). We first validated our 
approach, which is based on mRNA display technology, by conducting control and mock 
selection experiments. Then, to enrich RT promoting RNA sequences de novo, we 
applied the selection to a library containing >1014 unique mRNA variants. We performed 
next generation sequencing of the in vitro selection products, then analyzed the data to 
identify and characterize known as well as novel RT motifs. Lastly, we evaluated the 
potential for the in vitro selected RT motifs to enhance stop codon suppression by 
nonsense suppressor tRNAs in vivo. This work establishes that in vitro selections can be 
used to identify RNA sequences with complex biochemical activities, and furthers our 
understanding of translation reprogramming signals. Lastly, this selection strategy serves 
as a platform for the discovery and engineering of new RNA tools for the emerging field 
of synthetic biology (see Chapter 3). 
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2.1  Introduction 
Protein translation, the process by which genetic information is decoded, is 
invariably performed in all living cells by the ribosome and associated translation 
components. Despite being confronted by a vast diversity of messenger RNA templates 
from which a similarly diverse set of polypeptide products is synthesized, the cell’s 
highly evolved protein synthesis machinery is programmed to translate each mRNA 
according to a set of principal decoding rules that relies on successive interpretation of 
non-overlapping triplet nucleotide codons1. While the overwhelming majority of 
translation events conform to this standard program with high fidelity2, there are several 
known instances in which canonical translation is altered in response to cis-acting 
elements within the mRNA or nascent polypeptide3. These events, generally termed 
‘translation reprogramming’ or ‘recoding,’ are exploited by nature for various regulatory 
purposes and serve to expand the synthetic capabilities of the translation apparatus4.  
One example of reprogramming is stop codon readthrough (RT)5, which can be 
stimulated by sequence or structural motifs within the mRNA6. While most cases of 
programmed RT in eukaryotic systems have been discovered in plant and mammalian 
viruses7, this recoding event has also been observed in various endogenous fungal and 
animal genes8–11. Because RT signals can take various forms and often are structural 
elements within 3’ untranslated regions (UTR)12–14, they can be difficult to identify based 
on sequence alone. Moreover, the exact mechanisms by which these reprogramming 
elements operate are not entirely understood, and in some cases, may be influenced by 
auxiliary factors15. As a result, information about the nature, diversity, and overall 
frequency of reprogramming signals remains incomplete. A more comprehensive picture 
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of this phenomenon that better defines RT signals would aid in the identification of 
naturally occurring stimulatory elements as well as provide additional routes of 
investigation for unraveling the mechanisms of programmed RT.  
Previously, genome-wide analysis has been used to identify potential sites of stop 
codon readthrough in natural genes. One survey identified underrepresented stop codon 
contexts in the yeast saccharomyces cerevisiae and verified the readthrough activity of 
these nucleotide sequences16. Additionally, phylogenetic analysis tools have been used to 
predict open reading frames downstream of stop codons on the basis of amino acid 
conservation17. While these analyses provide interesting insight into the prevalence of 
stop codon readthrough in natural contexts, they depend upon the assumption that either 
the readthrough events are rare and thus underrepresented, or that the readthrough signals 
are evolutionarily conserved across organisms. An objective method for evaluating the 
propensity for RNA sequences to promote reprogramming would be useful for 
identifying elements or motifs that are not yet appreciated.    
One potential avenue for broadly characterizing readthrough signals is by 
selection or screen of randomized sequences. De novo screens for eukaryotic RT signals 
have previously been conducted in S. cerevisiae using a short randomized library of six 
nucleotides directly 3’ of the termination codon18. This study concluded that a general 
stop codon readthrough motif exists with the consensus sequence CAR-NBA (where R 
represents A or G, N represents any nucleotide, and B represents any nucleotide except 
C). This study was successful in validating one known readthrough motif, however likely 
did not find additional motifs due to the constrained library size and limitations to the 
number of variants that could be screened.  
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Since many reprogramming elements are composed of RNA structures spanning 
50 or more nucleotides, in vivo libraries offer only a very limited coverage of sequence 
space (~11-13 nucleotides) that would likely be required to construct such structures. For 
example, while yeast serves as a convenient eukaryotic host organism for carrying out 
genetic screens and selections, the current transformation limit constrains the sequence 
space to libraries on the order of ~106 in S. cerevisiae, and screening capabilities often 
fall short of that figure by several orders of magnitude. Moreover, in vivo growth 
selections are often complicated by unknown or uncontrollable factors that influence 
cellular fitness and therefore undermine the selection for the desired trait.  
In contrast, in vitro selections19–23 offer evaluation of library sizes on the order of 
1013-1015 starting unique sequences, which can be subjected to selection under highly 
defined and well-controlled conditions. Since the initial development of SELEX and 
related technologies, many RNA molecules have been discovered that either bind with 
high affinity and specificity to diverse ligands24–26 or catalyze chemical reactions27. 
However, few in vitro selections28 have been reported that identify nucleic acid 
sequences whose function depends on direct interaction with complex cellular machinery 
like the translation apparatus.  
In this work, we leverage the power of in vitro nucleic acid selection to address 
basic questions regarding the nature of programmed stop codon readthrough signals. Our 
approach combines the expansive libraries accessible to classical in vitro selections and 
the molecular complexity of a cell lysate. Using mRNA display22 as a selection tool, we 
link translation reprogramming events to a selectable outcome—namely, a puromycin 
ligation reaction. We show that this system can be used to efficiently select for sequences 
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that promote stop codon readthrough from a library of >1013 variants within as few as 
three cycles of selection. Furthermore, we characterize the selection products with next 
generation sequencing (NGS) and use this data to identify known as well as previously 
unreported stop codon readthrough motifs. Finally, we demonstrate in yeast that 
readthrough signals enhance nonsense suppression by suppressor tRNAs, and thus could 
potentially be used to boost unnatural amino acid incorporation using amber suppression 
technologies29.  
2.2  Results 
2.2.1  Constructing an in vitro selection for translation reprogramming 
 To select for translation reprogramming elements in vitro, we designed a system 
based on mRNA display that labels transcripts that perform the desired reprogramming 
function with selectable peptide tags. mRNA display technology22, which was originally 
developed as a tool for in vitro selections of peptides and proteins, covalently links the 
phenotype contained within a polypeptide to the amplifiable genotype of the mRNA that 
encodes it. In this technology, mRNA templates are prepared with the antibiotic 
puromycin tethered to their 3’ terminus and then translated in a cell-free translation 
system. Puromycin is an aminoacyl-tRNA mimic that can bind to the A-site of the 
ribosome and react with the peptidyl-tRNA, forming a covalent bond to the c-terminal 
amino acid residue of the elongating polypeptide. When the ribosome reaches the 3’ end 
of an mRNA-display template, it stalls at an engineered RNA-DNA junction that 
provides the necessary time and appropriate distance for the tethered puromycin to react 
(Fig. 2-1).  
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While mRNA-display is conventionally employed to select for functional proteins 
and peptides, we repurposed it to select for the translation reprogramming activity of an 
mRNA. Because the puromycin reaction is inefficient at distances greater than 50 
nucleotides or fewer than 19 nucleotides from the RNA-DNA junction30, mRNA-peptide 
fusion is efficient only when the ribosome translates the entirety of the mRNA transcript. 
An obstacle to translation, namely an in frame stop codon, should prevent the ribosome 
from reaching the end of the transcript to form an mRNA-peptide fusion31. However, if 
stop codon readthrough elements exist that promote bypass of the stop codon and 
translation of the remainder of the mRNA template, then an mRNA-peptide fusion should 
form (Fig. 2-1). The peptide, which is designed to contain affinity purification tags, can 
then be used to selectively enrich mRNA sequences that formed mRNA-peptide fusions 
from those that programmed the termination of protein synthesis. These purified mRNAs 
can then be reverse transcribed and PCR amplified for a subsequent round of selection 
and analysis (Fig. 2-2).  
 
Figure 2-1. Principle of selection for stop codon readthrough using mRNA display. The mRNA 
is programmed with an in-frame stop codon. If termination occurs, the peptide is released and no 
mRNA-peptide fusion is formed. If readthrough (RT) occurs, the ribosome can translate the 





Figure 2-2. mRNA-display selection cycle. First, a dsDNA library is transcribed into RNA and 
then ligated to the puromycin adaptor. Then, these mRNA-display transcripts are translated in 
vitro in rabbit reticulocyte lysate to form mRNA-peptide fusions. The resulting translation 
products are affinity purified, reverse transcribed, and PCR amplified for subsequent rounds of 
selection. 
 
As with previously described mRNA display experiments, our DNA constructs 
were designed to contain a T7 promoter for transcription of RNA, a TMV translation 
enhancer element, and both N-terminal and C-terminal affinity purification tags. 
However, unlike typical mRNA display libraries, our construct also contains a 
programmed in-frame stop codon that ordinarily triggers translation termination. Thus, 
the vast majority of mRNA-display templates will be incapable of forming mRNA-
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peptide fusions since they likely do not contain RT motifs. N-terminal purification tags 
serve to exclude sequences that initiate internally at methionine residues downstream of 
the stop codon. C-terminal purification tags are used to remove sequences that subvert the 
selection by means of a frameshift mutation, or by premature puromycin fusion reaction. 
First, in order to establish that the mRNA-display selection can discriminate 
against mRNAs that contain stop codons, we generated a control library (1014) that 
contained no programmed stop codon and a stretch of 75 randomized nucleotides in the 
open reading frame (Control Selection A). Previously, it was shown that mRNA display 
templates can be pre-selected for open reading frames devoid of stop codons31, thus 
purifying transcripts that encode only amino acid residues from those which program 
termination. The probability that the 75-nucleotide randomized region contains one or 
more stop codons is ~70%. Thus, after selection, the anticipated result is that the 30% of 
the sequences within the starting library that lack stop codons in the open reading frame 
would become enriched. Indeed, after a single round of selection, all 12 sequences 
sampled were devoid of stop codons in the randomized region (Table 2-1), versus 2 of 10 
prior to selection (data not shown).  
To ascertain the fate of transcripts containing a programmed stop codon but no 
readthrough motif, we constructed a template containing an in frame UAG stop codon 
followed by a single randomly generated 66-nucleotide sequence encoding 22 amino 
acids (Control Selection B). When subjecting this construct to a single round of selection, 
we unexpectedly found that 5 out of 10 sequences isolated contained mutations to the 
programmed stop codon and an additional sequence contained a frameshift deletion 
mutation upstream of the stop codon that placed the UAG out of frame (Table 2-2). Only 
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4 out of 10 sequences were identical to the original construct. Presumably, these 
mutations arose during in vitro transcription of the RNA where the most significant error-
prone amplification occurred (vs. plasmid replication). Given that polymerase errors 
occur with relatively low frequency (T7 RNA polymerase error rate has been estimated at 
~5x10-5)32, this result demonstrates that the selection is capable of strongly enriching rare 
active sequences in a single round of selection. For future rounds of selection, these 
mutations can be corrected by primer encoded stop codons. 
 
Table 2-1. Control Selection A results. Purifying out nonsense-encoding sequences. 
Sample Sequence Result 
1 P Q D G N S V A W V V G S H A C D W S R E H V G C No STOP 
2 S N F K A I P L C L T L R T R V P D L E R D R V I No STOP 
3 H T A E V T Q W G E S R C R G A L R T F G R C K L No STOP 
4 R F I S R A D Q A S M R S I R I C G A L L G S K Q No STOP 
5 S R C V F G I H R I C G Q G C F R Q L I L V T R V No STOP 
6 A T W Q M I V S W R S I S C R A I Y G R L Q I R G No STOP 
7 S L T G S N S E R I S R G Y R T K A H S G G R I L No STOP 
8 D S S A H F P N I C S G F V L V R I L G V A G T C No STOP 
9 T Y V L F G K R G P M G A Q K N W R V Q G W S E S No STOP 
10 G N V R W F P G D L R R H V T L R V M S Q S N K C No STOP 
11 P R I R C Y A R K V Q I R E L A P R G R H L G C S No STOP 





Finally, to demonstrate that reprogramming signals adjacent to stop codons can be 
enriched from a background of inactive sequences, we performed mock selections 
(Control Selection C). For the active recoding sequence, we chose the Murine Leukemia 
Virus (MLV) stimulatory element12,13,33, a pseudoknot structure that promotes stop codon 
readthrough at a reported level of 4-5%. Selections were conducted by varying input 
ratios of the active MLV construct to the inactive control construct. The results, shown in 
Table 2-3, reveal that the active MLV sequence is significantly enriched at an estimated 
level of ~30-fold after a single round of selection. Therefore, the in vitro translation 
system is capable of responding to reprogramming elements within the mRNA, and the 
mRNA display selection strategy is capable of enriching active reprogramming elements 
from a pool composed largely of inactive sequences.  
 
Table 2-2. Control Selection B results. A single sequence containing a stop codon.  
Sample Sequence Description 
1 No mutations 
2 No mutations 
3 No mutations 
4 *TAG(Stop) → TGG(Trp) 
5 *TAG(Stop) → TAT(Tyr) 
6 *ΔA35→Frameshift mutation, no stops 
7 *TAG(Stop) → TGG(Trp) 
8 No mutations 
9 *TAG(Stop) → TGG(Trp) 




Table 2-3. Control Selection C results. Mock selection with MLV readthrough signal. 
Dilution  







1 : 1 5 / 6 1 / 6 5 
1 : 10 9 / 12  3 / 12 30 
1 : 100 3 / 11 8 / 11 37.5 
1 : 1,000 0 / 13 13 / 13 -- 
    
Combined 1:10 and 1:100   33.6 
 
2.2.2  De novo enrichment of 3’ stop codon readthrough motifs 
Based on the control and mock selection results described above, we designed a 
random library aiming to identify readthrough stimulating motifs 3’ to the programmed 
stop codon. Because readthrough stimulating elements can exist in the nucleotides 
directly adjacent to the stop codon as well as several nucleotides downstream as hairpin 
or pseudoknot structures, we chose to encode a 75 nucleotide randomized library 
immediately 3’ of a UAG nonsense codon. While this vast theoretical library size (1045) 
will have exceedingly low coverage from only 1014 input molecules, any set of 21 
nucleotides from the 75 randomized positions will have >95% coverage. Since many 
reprogramming stimulatory structures have redundant base-pair possibilities and loops 
with flexible lengths and compositions, a number of active structural motifs should be 
accessible without coverage of every nucleotide within that structure.  
After a single round of selection on this library, sequences containing mutations 
to the stop codon were enriched, as was observed in the earlier control selections (Control 
Selection B). To ensure that these mutant sequences would not take over the library due 
to their extremely efficient enrichment, primers used for PCR amplification after reverse 
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transcription were designed to contain the entire 5’ segment of the selection construct 
leading up to and including the TAG stop codon. Therefore, any sequences with stop 
codon or frameshift mutations either failed to amplify entirely or were corrected, thus 
preventing false enrichment in subsequent rounds of selection. Additionally, sequences 
that form aptamers that bind to the anti-FLAG agarose gel and are eluted with FLAG 
peptide were eliminated by reverse transcription of the RNA (to disrupt RNA structure) 
and a secondary FLAG purification34.  
After three rounds of selection, sequencing of sampled library members revealed 
enrichment of a hexanucleotide motif directly adjacent to the UAG stop codon with the 
consensus sequence CAA-YYA (data not shown). Significantly, this is the same naturally 
occurring readthrough stimulating sequence used by Tobacco Mosaic Virus (TMV) and 
generally conforms to the previously identified CAR-NBA motif found in yeast18. 
Enrichment of this sequence motif was highly suggestive that sequences promoting stop 
codon readthrough were being efficiently selected. Additionally, a small population of 
sequences were found to contain FLAG peptide epitopes encoded in the library region, 
suggesting that internal initiation downstream of the stop codon followed by synthesis of 
a library encoded FLAG epitope is a selectable feature.  
To assess the activity of the library members, we developed a fluorescent protein 
based reporter in the yeast saccharomyces cerevisiae that enables a streamlined cloning 
and assay workflow. Since many eukaryotic reprogramming elements are functional in 
yeast, sequences enriched from the in vitro selection in rabbit reticulocyte lysate are also 
likely to be active in this assay. The reporter construct contains an N-terminal GFP 
followed by the stop codon, the library insert and a C-terminal mCherry (Fig. 2-3). By 
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comparison to control constructs that produce only GFP or only GFP-mCherry fusion 
proteins, reprogramming efficiencies can be determined based on the ratio of the signals 
from the two fluorescent proteins. Indeed, when selecting samples of yeast colonies, each 
containing a single library element from the in vitro selection, various degrees of stop 
codon readthrough were observed, with the highest levels reaching 20% (Fig. 2-3). 
 
Figure 2-3. Dual-FP reporter assay of RT in S. cerevisiae. Selection products were cloned into 
the dual-FP reporter plasmid and colonies were assayed for readthrough activity by quantification 
of the fluorescence outputs and comparison to an authentic fusion protein control (FS mut, set to 
100%). The CAA-YYA motif is clearly observed in the top sequences, however, given the 
difference in readthrough efficiencies of these sequences, other factors beyond the CAA-YYA 
motif apparently contribute to the reprogramming activity of these sequences.  
 
2.2.3  High-throughput sequencing and analysis of RT selection products 
 To better characterize the landscape of readthrough motifs, we submitted our in 
vitro selection products to high-throughput next generation sequencing (NGS). This 
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provided ~100 million initial raw sequencing reads. Unique sequences were retrieved 
from this pool and the total number of reads associated to each sequence was tallied. The 
sequence list was then filtered to remove members that encoded library FLAG epitopes 
or internal stop codons, reducing the set to ~11 million unique sequences. Additionally, 
because the remaining sequences were significantly composed of variants that were 
simple nucleotide substitutions or frameshift mutations away from a parent sequence, all 
duplicates with a hamming distance of < 10 were removed from the top-ranked 1 million 
unique sequences. This reduced the pool of sequences to a final set containing ~42,000 
truly unique members, which were used for the analysis. These sequences account for 
~43 million of the initial ~100 million sequencing reads. Within this group, 50% of the 
read mass (21.5 million) is contained within the top ~10,000 sequences (Fig. 2-4).  
 
Figure 2-4. Distribution of NGS sequence mass. Composition of the library mass (reads) 
contributed by the top N sequences is plotted (blue). 50% of the total reads are contributed by the 




 We first analyzed the prevalence of each of the four nucleotides in the position 
directly adjacent to the amber stop codon (hereafter referred to as position +1). Within 
the 500 top-ranked unique sequences (ranked by read count), almost every member 
contained a C at the +1 position (497 out of 500), and nearly 99% of the read mass 
contained within this group was contributed by these sequences. This is consistent with 
previous reports that a cytidine nucleotide adjacent to the stop codon establishes an 
inefficient termination context35. In the total set of ~42,000 sequences, 76% contain a C 
at the +1 position, accounting for 85.5% of the sequencing read mass.  The next most 
prevalent nucleotide at the +1 position was G, which represents 12% of total sequences 
and 8% of the read mass for the entire sequence pool (Table 2-4). 
Table 2-4. Prevalence of nucleotides 3’ adjacent to stop codon (+1).  
Nucleotide 
Top 500 sequences Top 42,000 sequences 
Number of 
sequences % of read mass 
% of total 
sequences 
% of total 
read mass 
C 497 98.8 76.0 85.5 
G 2 1.0 12.0 8.0 
A 0 0 6.9 4.0 
U 1 0.1 5.1 2.5 
 
 Next, we evaluated the prevalence of the three nucleotides adjacent to the stop 
codon, occupying positions +1 to +3 (Table 2-5). For this triplet of nucleotides, there is a 
strong enrichment for the CAA codon, particularly in the top 500 sequences where it is 
found 442 times and accounts for roughly 91% of this group’s read mass. Three other 





Table 2-5. Prevalence of first (+1 to +3) and second (+4 to +6) codons. 
Position Sequence 
Top 500 sequences Total library 
Number of 
sequences 
% of read 
mass 
% of total 
sequences 
% of total 
read mass 
Codon 1 
(+1 to +3) 
CAA 442 90.8 41.1 52.6 
CAG 22 3.4 11.4 11.8 
CCA 29 4.2 6.1 6.8 
CTA 1 0.1 5.0 4.4 
Codon 2 
(+4 to +6) 
TTA 159 36.0 17.1 20.2 
TCA 145 28.3 12.2 16.3 
CTA 78 15.8 8.3 10.6 
CCA 52 8.6 5.7 7.3 
CGA 47 7.7 5.5 6.9 
 
 Likewise, the next downstream codon (positions +4 to +6) was enriched for 
specific triplets. Significantly, the five most abundant codons at this position conform to 
a consensus YBA motif (where Y is either T or C, B is not A; and, the TGA stop codon is 
excluded), with TTA being the most abundant (Table 2-5). Overall, the enrichment 
profile of these first two codons is suggestive of a broader CAR-YBA motif. To 
determine whether a true association exists between these codon pairs, we performed chi-
squared and Fisher’s exact statistical tests. Both of these methods were used to evaluate 
the 2x2 contingency table containing the observed frequencies of the codons under 
consideration pairing with one another or any other codon. The outputs of the tests are 
various statistics that reflect the significance of the association (χ2 and p-value) and 





The statistics for a select group of sequence pairs are summarized in Table 2-6. 
All combinations of CAA with YBA codons showed large positive φ coefficients and χ2 
values (strongest for TTA and TCA), suggesting the presence of a consensus CAA-YBA 
motif. All together, the CAA-YBA motif is observed at the beginning of 34% of the total 
sequences in the analysis pool. Of note, CAG in the first codon position was less strongly 
associated with YBA codons (consider φ coefficients, Table 2-6), suggesting that CAG 
may be part of distinct motifs outside of an overall CAR-YBA motif (where R is A or G). 
However, with the exception of CAG-TCA, positive association of CAG with YBA 
codons was still observed at a statistically significant level. Additionally, we observed 
large test statistics for association between CCA at codon 1 and CBA triplet at codon 2, 
with little correlation observed between CCA and TTA.  
Interestingly, when codon 1 was CTA, we observed large negative test statistics 
for all YBA codons. In fact, the CTA-TTA pair represented one of the largest negative 
associations for all codon pairs. Instead, the CTA codon was highly associated with G at 
the +4 position (Table 2-6), with an additional slight preference for G at the +5 position 
(not shown). Notably, recent studies have revealed the CTAG motif in four human genes 
that display stop codon readthrough8. Additionally, a previously described stop codon 
readthrough signal from Sindbis virus also possess the CTAG motif adjacent to the stop 









Table 2-6. Chi-squared and Fisher’s exact test results for statistical association between 
select sequence pairs.  
 
Codon 1 
(+1 to +3) 
Codon 2 
(+4 to +6) φ  χ





TTA 0.312 3891 42.8 5.7 < 0.0001 
TCA 0.276 3042 39.0 6.1 < 0.0001 
CTA 0.127 646 18.4 2.5 < 0.0001 
CCA 0.084 284 12.4 2.0 < 0.0001 
CGA 0.073 214 10.8 1.9 < 0.0001 
CAG 
TTA 0.033 43 5.6 1.3 < 0.0001 
TCA -0.051 106 -9 0.6 < 0.0001 
CTA 0.045 79 8.0 1.5 < 0.0001 
CCA 0.053 114 9.8 1.8 < 0.0001 
CGA 0.040 64 7.4 1.6 < 0.0001 
CCA 
TTA -0.014 7.6 -2.4 0.9 0.005 
TCA 0.034 47 6.2 1.5 < 0.0001 
CTA 0.128 651 23.7 3.5 < 0.0001 
CCA 0.071 206 13.5 2.5 < 0.0001 
CGA 0.103 423 19.4 3.3 < 0.0001 
CTA 
TTA -0.103 424 -18.2 0.03 < 0.0001 
TCA -0.078 240 -14.1 0.1 < 0.0001 
CTA -0.067 182 -12.6 0.05 < 0.0001 
CCA -0.051 106 -9.8 0.1 < 0.0001 
CGA -0.067 182 -12.6 0.05 < 0.0001 
Codon 1 
(+1 to +3) 
Position 
+4 φ  χ





G 0.233 2180 40.9 6.9 < 0.0001 
A 0.011 4.4 2.0 1.15 0.03 
T -0.115 526 40.9 6.9 < 0.0001 
C -0.08 295 -14.2 0.3 < 0.0001 
aThis is the non-adjusted p-value output of the Fisher’s exact test. Negative correlations 
are shaded gray.  
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In the third codon position, CAG was the most common triplet sequence, nearly 
twice as prevalent as the next most abundant triplet. CAG at codon 3 was also positively 
associated with the CAA-YBA motif (φ = 0.096, χ2 = 366). Overall, the sequence CAA-
TTA-CAG is observed 532 times, and accounts for almost 3 times as many reads as the 
next best codons following CAA-TTA (Fig. 2-5). Significantly, the CAA-TTA-CAG is 
precisely the wild-type TMV readthrough sequence. While the third codon is not 
commonly cited for its contribution to readthrough efficiency, initial characterization of 
the TMV sequence demonstrated a noticeable decrease in readthrough when this codon 
was omitted36. By comparison, the triplet GGA is highly underrepresented following 
CAA-TTA, especially when compared to its abundance in other library regions. We 
evaluated this effect using the dual-FP reporter in yeast. Mutating a selection product 
from a sequence beginning CAA-TTA-CAG to CAA-TTA-GGA resulted in a 2-fold 
decrease in readthrough efficiency (9.1% down to 4.4%), providing strong evidence that 
the codon following CAA-TTA also plays a role in reprogramming. 
Previously unreported motifs were uncovered by contingency analysis, which was 
particularly revealing when the statistical tests were performed beyond the arbitrary 
codon framework. One especially strong association was found between CGC and CAG 
triplets spanning position +1 to +6 (φ = 0.231, χ2 = 2135). This association can be further 
extended to a CGC-CAG-R consensus motif if the +7 nucleotide is considered in the 
analysis (φ = 0.051, χ2 = 111). A substantially longer motif was identified when analysis 
of the CAG-ACT codon pair (φ = 0.060, χ2 = 147) was extended to downstream 
nucleotide quartets (+7 to +10), revealing a motif spanning +1 to +10 with the consensus 




Figure 2-5. Codons adjacent to CAATTA. Cumulative reads for all codons directly 3’-adjacent to 
CAA-TTA (blue) or significantly downstream (codons 10, 11 and 12) of the stop codon (red). 
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2.2.4  Enhanced amber suppression with 3’ RT sequences 
 Unnatural amino acid mutagenesis has tremendous potential as a tool for basic 
science and biotechnology29. While numerous analogs of unnatural amino acids have 
been successfully incorporated in vivo by genetic encoding with evolved aaRS 
enzymes37, the low yield of incorporation remains a major barrier to widespread adoption 
of the technology in eukaryotes. One of the primary competing processes for unnatural 
amino acid incorporation at stop codons is peptide hydrolysis by release factors. Release 
factor knockouts in E. coli were shown to enhance stop codon suppression38, however 
this also dramatically increased the off-target incorporation of UAAs at natural stop 
codons in other cellular mRNAs. Additionally, because eukaryotes have just a single 
dedicated release factor for recognition of all stop codons, knockout in this setting is not 
viable. Therefore, we envisioned applying the in vitro discovered readthrough signals to 
improve incorporation efficiency in a way that is specific to the target mRNA. 
We sought to determine if the library readthrough signals could enhance 
suppression efficiency in yeast using an orthogonal E. coli tyrosine amber suppressor 
tRNA/aaRS pair. This assay was performed using the dual fluorescent protein reporter 
containing the library reprogramming signals. The results, shown in Figure 2-6, 
demonstrate significant enhancement of suppression that is correlated to, but not a direct 
function of, readthrough in the absence of suppressor tRNA. In the case of low basal 
readthrough, tRNA-mediated suppression was observed at levels that ranged between 5% 
and 15%. Impressively, when examining the reprogramming signals that promote higher 
levels of readthrough, we found that readthrough levels in the presence of suppressor 
tRNA reached as high as > 60%. This strongly supports the hypothesis that amber 
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suppression competes with RF hydrolysis, and that inhibition of release enhances 
suppression efficiency by suppressor tRNAs. 
 
 
Figure 2-6. Enhanced amber suppression with 3’ RT motifs. Readthrough efficiency of sampled 
reprogramming elements in the absence (green) and presence (red) of tyrosine amber suppressor 
tRNA.  
 
2.3  Discussion 
 RNA plays a central role in reprogramming the protein synthetic machinery. 
While naturally occurring signals have provided examples of RNA motifs and structures 
that can promote reprogramming, the diversity of these features makes exhaustive 
analysis of potential reprogramming sequences a major difficulty. To address these 
challenges, we developed a strategy to in vitro select for RNA elements that reprogram 
the translation machinery using mRNA display, enabling the search of vast libraries of 
randomized RNA sequence in excess of 1013 starting members. Significantly, this in vitro 
RNA selection differs from previous SELEX-type experiments in that it selects for an 
RNA function that requires direct collaboration with complex cellular machinery. 
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Because the selection is conducted in a cell lysate, the large library sizes that are 
accessible to typical RNA selections are maintained, while gaining molecular complexity 
on par with an in vivo system.  
The control experiments performed here validate the hypothesis that full 
translation of an mRNA transcript can be used as a general selectable outcome with 
mRNA display. The principle behind this selection is analogous to the use of downstream 
reporter genes in an in vivo setting. Importantly, control experiments also demonstrated 
that mRNA display could be used to select for authentic translation reprogramming 
elements and significantly enrich these sequences from a background of predominantly 
inactive sequences. Overall, these results establish mRNA display as an effective tool for 
the in vitro selection of translation reprogramming elements.  
We then applied the mRNA display selection to search a large library of RNA 
sequences (1014 variants) for stop codon readthrough signals. Significantly, after just 
three rounds of in vitro selection, this yielded highly active readthrough elements as 
determined by an in vivo dual-FP assay in S. cerevisiae. The products of the selection 
were submitted to high-throughput sequencing in order to identify and characterize 
various stop codon readthrough signals. An overwhelming prevalence of a 
hexanucleotide motif with the consensus sequence CAA-YBA was observed. 
Importantly, this is a well-established readthrough signal, typified by the TMV 
readthrough sequence CAA-TTA. By analyzing the group of sequences containing the 
CAATTA motif, we also discovered that the codon directly 3’ to this sequence also 
influences readthrough efficiency. Aside from this well-established motif, we also found 
significant enrichment for a CTAG motif directly adjacent to the stop codon, which has 
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recently been found to stimulate stop codon readthrough in four human genes and several 
fungal genes. Lastly, analysis of the NGS data was used to identify previously unreported 
motifs, namely CGC-CAG-R and CAG-ACT-YMMG. Further analysis of this sequence 
pool could identify structural elements, though these are likely to be far more diverse at 
the sequence level. 
Beyond characterization of readthrough elements, this selection potentially 
provides useful parts for emerging biotechnologies. We demonstrated that stop codon 
readthrough signals discovered from in vitro selection are capable of significantly 
enhancing nonsense suppression with amber suppressor tRNAs. This has potential 
applications to the field of unnatural amino acid mutagenesis, which utilizes suppressor 
tRNAs to direct the incorporation of non-standard amino acids into proteins. Overall, this 
selection strategy provides a framework for engineering new devices for synthetic 
biology (see Chapter 3).  
 
2.4  Experimental Methods 
 General materials and methods. Standard methods for molecular biology in 
Saccharomyces cerevisiae and Escherichia coli were used39. Oligonucleotides used in 
this study are listed in Table 2-7 (chapter 2.5). DNA sequences of the selection 
constructs are outlined in Table 2-8 (chapter 2.5). Unless otherwise specified, PCR 
reactions were carried out with Vent Polymerase (NEB) in 1X Thermopol buffer. All 
steps involving RNA were performed with RNase-free materials and RNase-free ddH2O 




PCR assembly of selection constructs. Control constructs and libraries were 
assembled by PCR from chemically synthesized oligonucleotides. All dsDNA constructs 
contain a 5’ T7 promoter, a TMV translation enhancer sequence, ATG start codon, N-
terminal FLAG peptide, reprogramming segment, and C-terminal hexahistidine tag. The 
library for Control Selection A was constructed by PCR amplification of the CT-Lib 
oligonucleotide with CT-For and CT-Rev in a 1-mL reaction. The Inactive-RT construct 
used in Control Selections B and C was assembled by polymerase extension of NegRT-
Inner-for with NegRT-Inner-rev, followed by PCR amplification with NegRT-For and 
NegRT-Rev. The Murine Leukemia Virus (MLV) readthrough construct used in Control 
Selection C was prepared by PCR fusion of two dsDNA segments: one derived from 
polymerase extension of MLV-PK-1 with MLV-PK-2, and another derived from 
polymerase extension of AVA110-MLV-PK with MLV-PK-4. The fused product was 
amplified with MLV-PK-1 and MLV-PK-4. The 75-nucleotide randomized readthrough 
library was constructed by PCR amplification of the library oligonucleotide RT-Lib with 
RT-For and RT-Rev in a 1-mL reaction.  
In vitro transcription of RNA templates. RNA was in vitro transcribed from 
dsDNA templates (250 nM) using T7 RNA polymerase. Transcription reactions were 
performed with T7 RNA polymerase (NEB, 6uL/100uL reaction) in T7 buffer (50 mM 
Tris, pH 8, 20 mM MgCl2, 10 mM DTT, 2 mM spermidine, 0.01% Triton-X100) 
supplemented with NTPs (5 mM final of each NTP) at 37 ˚C. After 2-3 hours, if the 
transcription reaction produced a white precipitate, supplemental MgCl2 (5 mM) was 
added to the reaction. Total reaction times ranged between 4 and 5 hours. Transcription 
reactions were terminated by the addition of 0.1 volumes of 0.5 M EDTA, pH 8. For the 
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first round transcription of the CT and RT libraries, reactions were performed at the 1-mL 
scale to provide adequate library coverage and sufficient quantities of RNA. RNA was 
purified by denaturing polyacrylamide gel electrophoresis, typically 7.5% Urea-PAGE. 
Following electrophoretic separation (250V, 50 minutes, 1X TBE), RNA bands were 
visualized by UV-shadowing and excised from the gel. The RNA was eluted from the gel 
slab by electro-elution (15 minutes, 225V, 1X TAE) in dialysis tubing (10,000 MWC). 
The eluted RNA was buffer exchanged into 0.3 M NaOAc (pH 5.2) by spin filtration 
(Amicon 10,000 MWC), then precipitated by the addition of 2.3 volumes of 100% 
ethanol and storage overnight at -80 ˚C. The precipitated RNA was pelleted by 
centrifugation (4 ˚C, 14,000 rpm) and air-dried. The pellet was then resuspended in an 
appropriate volume of RNase-free ddH2O (to roughly 100 uM final) and the 
concentration measured by UV-absorbance. If necessary, RNA solutions were further 
diluted to the desired concentration.  
Preparation of mRNA-display templates. mRNA-display templates were 
prepared by splint ligation of the in vitro transcribed RNA to the puromycin adaptor 
(phospho-dA27-CC-puromycin) using T4 RNA ligase (NEB, 2,000,000 U/mL). The RNA 
(10 uM final), phospho-dA27-dCdC-puromycin (10 uM final), splint oligonucleotide 
AVA95 (15 uM final), splint oligonucleotide AVA96 (5 uM final), and RNase-free 
ddH2O were combined and heated to 95 ˚C for 5 minutes. The mixture was then treated 
with the appropriate volume of 10X T4 ligase buffer (1X final) and quickly transferred 
directly to ice and cooled for 5 minutes. The reaction was then allowed to warm to room 
temperature for 5 minutes and treated with T4 DNA ligase (40,000 U/mL final). The 
reaction was left at room temperature for 2 hours, then treated with 0.5 M EDTA, pH 8 to 
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a final concentration of 10 mM. The ligation reactions were separated using 7.5% Urea-
PAGE gels and the slower migrating ligation product (upper band) was excised. RNA-
puromycin products were isolated similarly to the RNA transcripts from the previous step 
by elution from the PAGE gel and precipitation.  
In vitro translation and mRNA-peptide fusion purification. General 
considerations: Translations are conducted in 40% rabbit reticulocyte lysate (nuclease 
treated, Promega) with mRNA-display template concentrations ranging from 200 to 800 
nM. Rabbit reticulocyte lysate should be thawed just prior to use and distributed in 
aliquots after the first thawing to avoid multiple freeze-thaw cycles. Rabbit reticulocyte 
lysate should not be centrifuged. Rabbit reticulocyte lysate should always be the last 
component added to the reaction mixture. The first round translation reaction for the 
readthrough library was performed at a 1-mL scale. The following translation and 
purification protocol serves as a representative selection round performed at the 100-uL 
scale. FLAG purifications34 and Ni-NTA purifications30 were performed essentially as 
described. 
In vitro translation. Components are combined at 4 ˚C in the order as listed: 
mRNA-display template (10 mM, 2 uL), amino acid mix (50X, 2 uL), KCl (2.5 M, 4 uL), 
Mg(OAc)2 (25 mM, 2 uL), RNase-free ddH2O (50 uL), and freshly thawed rabbit 
reticulocyte lysate (2.5X, 40 uL). The reaction is mixed well and incubated at 30 ºC for 1 
hour. After incubation, 38 uL of puromycin salt mix (31.2 uL of 2.5M KCl + 6.8 uL 1M 




FLAG purification #1. The translation reaction is then diluted 10-fold by adding 9 
volumes (1.24 mL) of 1X FLAG binding buffer, then incubated at 4 ºC with rotation for 
1.5 hours with 30 uL of M2-anti-FLAG resin (prewashed 2x with 0.75 mL FLAG clean 
buffer and 3x with 0.75 mL 1X FLAG binding buffer). The resin is then gently pelleted 
(1,000 g) and the supernatant removed. The resin is washed with 0.75 mL FLAG binding 
buffer, gently pelleted, and the supernatant removed. This is repeated with 5 additional 
FLAG binding buffer washes. mRNA-peptide fusions are then eluted 2x by incubating 
the resin at 4 ºC with rotation for 20 minutes with 100 uL of FLAG peptide in FLAG 
binding buffer (200 ug/mL FLAG peptide).  
Ni-NTA purification. The FLAG elutions are combined and mixed with 1 volume 
of 2X Ni-NTA binding buffer, then incubated at 4 ˚C with rotation for 1 hour with 100 
uL of Ni-NTA resin (prewashed 3x with RNase-free ddH2O). The resin was then gently 
pelleted (1,000 g) and the supernatant removed. The resin is then washed with the 
following solutions, each 0.75 mL: (i) Ni-NTA Wash Buffer-1 (2x); (ii) a 4:1 mix of Ni-
NTA Wash Buffer-1 to Ni-NTA Wash Buffer-2; (iii) a 3:2 mix of Ni-NTA Wash Buffer-
1 to Ni-NTA Wash Buffer-2; (iv) a 2:3 mix of Ni-NTA Wash Buffer-1 to Ni-NTA Wash 
Buffer-2; (v) a 1:4 mix of Ni-NTA Wash Buffer-1 to Ni-NTA Wash Buffer-2; (vi) Ni-
NTA Wash Buffer-2; and (vii) a 19:1 mix of Ni-NTA Wash Buffer 2 to Ni-NTA Elution 
Buffer. mRNA-peptide fusion are then eluted from the resin 2x with 100 uL portions of 
Elution buffer by incubation at 4 ˚C  with rotation for 30 minutes. The combined elutions 
are spin-concentrated to a volume of ~30 mL (0.5-mL 30,000 MWC amicon) and 1 uL of 
the concentrated elution is saved for the non-reverse transcribed PCR control reaction.  
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Reverse transcription of cDNA from purified mRNA-peptide fusions. The reverse 
transcription reaction is prepared by adding the following components in the order listed: 
concentrated Ni-NTA elution (30 uL), reverse transcription primer AVA95 (100 uM, 3 
uL), dNTP mix (10 mM, 15 uL), RNase-free ddH2O (160 uL). These components are 
mixed and incubated for 5 minutes at room temperature, then treated with: 5X first-strand 
buffer (5X, 60 uL), DTT (0.1 M, 30 uL), RNasin (1 uL), and Superscript II Reverse 
Transcriptase (1 uL). The reaction is mixed well and incubated at 42 ºC for 50 minutes.  
FLAG purification #2. An optional second FLAG purification can be performed 
to remove undesired RNA aptamers from the selection pool. After incubation, the reverse 
transcription reaction is spin concentrated and buffer exchanged (0.5-mL 30,000 MWC 
amicon) into 0.5 mL FLAG binding buffer. The FLAG purification is performed 
essentially as described for FLAG purification #1. The combined elutions are spin 
concentrated to ~30 uL for PCR. 
 PCR amplification of cDNA. Analytical PCR reactions are prepared for controls 
with no RT reaction (ddH2O as template) and pre-reverse transcription mRNA-peptide 
fusions (concentrated FLAG elution), in addition to the post-reverse transcription 
product. The following components are combined in the order listed for a 50-uL scale 
reaction: PCR template (0.5 uL), forward primer (100 uM, 0.5 uL), reverse primer (100 
uM, 0.5 uL), dNTP mix (10 mM, 1 uL), 5X GoTaq Buffer (5X, 10 uL), ddH2O (37 uL), 
GoTaq Polymerase (0.5 uL). If analytical reactions produce the desired results, no PCR 
product for ddH2O as template or pre-reverse transcription mRNA-peptide fusions as 
template, a PCR is performed at a 0.5 mL scale with the post-reverse transcription 
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product as a template. This PCR product serves as the dsDNA input for the subsequent 
round of selection, and as template for cloning into reporters or sequencing vectors.  
Dual-fluorescent protein reporter for determining RT activity in S. 
cerevisiae. The reporter plasmid was constructed by inserting the yEGFP open reading 
frame (amplified with primer pair AVA111·AVA112) between the GPD promoter and 
the open reading frame of a yeast-optimized mCherry40 flanked by a GPD terminator in a 
pRS425 backbone (high copy, LEU2 marker). NheI and AatII restriction sites were 
encoded between the GFP and mCherry open reading frames for replacement of the 
intervening sequence with a RT insert. To assay library readthrough activity, dsDNA 
products from the in vitro selection were PCR amplified in two steps (primer pairs 
AVA136·AVA118 and AVA119·AVA118) to add homology to the NheI/AatII digested 
dual-FP reporter plasmid. The library was cloned by in vivo gap repair into yeast strain 
Fy251 using high efficiency transformation as previously described41 and plated on 
selective medium (synthetic complete agar with leucine dropout containing 2% dextrose; 
SC-Agar-(Gluc) L-). Individual colonies were isolated and grown in liquid SC-(Gluc) L- 
media to mid-log phase and the readthrough efficiency was determined by comparing 
quantified GFP and mCherry fluorescence signals to a fusion protein control (calibrated 
to 100% readthrough). 
Next-generation sequencing. NGS was performed using the Illumina HiSeq 
platform (Columbia Genome Center). DNA was prepared for sequencing by PCR in three 
separate batches containing either 0, 1, or 2 variable nucleotides at the start site of the 
HiSeq read to avoid identical base calls during the initialization phase of sequencing. The 
third round in vitro selection products were PCR amplified with primer pair 
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AVA314·AVA320, AVA315·AVA320 or AVA316·AVA320. All three PCR products 
were then mixed and amplified with primer pair AVA319·AVA321 to add full HiSeq 
adaptor sequences. After sequencing, the raw fastq file was filtered to remove FLAG-
epitope containing sequences or sequences that encode an in-frame stop codon. The copy 
number of each remaining unique sequence was computed. From this set of sequences, 
the 1 million top-ranked (by abundance) members were evaluated for their true 
uniqueness (defining truly unique as representing an original starting library member 
derived from chemical synthesis). Sequences that were single nucleotide substitutions, or 
frameshift mutations, away from a higher ranked parent sequence were removed by 
setting a hamming distance threshold. This reduced the set of sequences to ~42,000, and 
these sequences were used for the subsequent analysis.  
 Analysis of NGS sequencing data. NGS sequencing results were evaluated using 
simple counting algorithms, Fisher’s exact tests, and chi-squared tests implemented in 
customized python code. For calculating the association between two variables, for 
instance the identity of codon 1 having the sequence CAA and the identity of codon 2 
having the sequence TTA, a 2 x 2 contingency table was constructed containing the 
following elements: the occurrence (number of unique sequences) of CAA and TTA; the 
occurrence of CAA and notTTA; the occurrence of notCAA and TTA; and, the 
occurrence of notCAA and notTTA. Expected frequencies that would result for null 
association were then calculated based on this contingency table. Fisher’s exact and chi-
squared tests were used to determine the statistical significance of the association (χ2 and 
p-value) and degree of correlation (φ and odds ratio). For any pair of sequence segments 
(for instance +1 to +3 analyzed for association with +4 to +6), the aforementioned 
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statistical tests were performed over the set of all pairs of sequences contained within the 
data set.  
  
2.5 DNA sequences 
Table 2-7. Sequences of oligonucleotides used in this study.  
Name Sequence (5’ to 3’) 
CT-Lib G ACT ACA AGG ACG ACG ACG ACA AGT ACN NNN NNN NNN 
NNN NNN NNN NNN NNN NNN NNN NNN NNN NNN NNN NNN 
NNN NNN NNN NNN NNN NNN NNN NNN NNN NNG GCA GCG 
GCC ATC ATC ACC ATC 
CT-For TCT AAT ACG ACT CAC TAT AGG GAC AAT TAC TAT TTA CAA 
TTA CAA TGG ACT ACA AGG ACG ACG ACG ACA AGT AC 
CT-Rev ATA GCC AGA TCC AGA CAT TCC CAT AGA ACC GCC GTG 
GTG ATG GTG ATG ATG GCC GCT GCC 
NegRT-
Inner-for 
CGA CGA CAA GAC CCT AGA TGA CTA GCA CCG AGA ACC 
CGG CGC CAC GCA 
NegRT-
Inner-rev 
GAT GGT GAT GAT GGC CGC TGC CAT ACG TTC CCT TTA ATT 
GCC TGC CGG 
NegRT-
For 
CAC CGA GAA CCC GGC GCC ACG CAA TGG AAC GTC CTT 
AAC TCC GGC AGG CAA TTA AAG GGA ACG TAT 
NegRT-
Rev 
ATA CGT TCC CTT TAA TTG CCT GCC GGA GTT AAG GAC GTT 
CCA TTG CGT GGC GCC GGG TTC TCG GTG 
MLV-PK-
1 
TCT AAT ACG ACT CAC TAT AGG GAC AAT TAC TAT TTA CAA 
TTA CAA TGG ACT ACA AGG ACG ACG ACG ACA AGA CCC 
TAG ATG ACT AG 
MLV-PK-
2 
CTG GGT TCA GGG GGG GGC TCC TGA CCC TGA CCT CCC TAG 
TCA TCT AGG GTC TTG TCG TCG 
AVA110-
MLV-PK 
GGA GCC CCC CCC TGA ACC CAG GAT AAC CCT CAA AGT 
CGG GGG GCA ACC CGT CGG CAG CGG CCA TCA TCA CCA TC 
MLV-PK-
4 
ATA GCC AGA TCC AGA CAT TCC CAT AGA ACC GCC GTG 
GTG ATG GTG ATG ATG GCC GCT GCC 
RT-Lib G ACT ACA AGG ACG ACG ACG ACA AGT AGN NNN NNN NNN 
NNN NNN NNN NNN NNN NNN NNN NNN NNN NNN NNN NNN 
NNN NNN NNN NNN NNN NNN NNN NNN NNN NNG GCA GCG 
GCC ATC ATC ACC ATC 
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RT-For TCT AAT ACG ACT CAC TAT AGG GAC AAT TAC TAT TTA CAA 
TTA CAA TGG ACT ACA AGG ACG ACG ACG ACA AGT AG 
RT-Rev ATA GCC AGA TCC AGA CAT TCC CAT AGA ACC GCC GTG 
GTG ATG GTG ATG ATG GCC GCT GCC 
AVA95 TTT TTT TTT TTT ATA GCC AGA TCC 
AVA96 TTT TTT TTT TTT NAT AGC CAG ATC C 
AVA111 ATA AAC ACA CAT AAA CAA ACA AAG AAT TCA TGT CTA 
AAG GTG AAG AAT TAT TCA CTG GTG 
AVA112 GCT AGC TTT GTA CAA TTC ATC CAT ACC ATG GGT AAT ACC 
AVA118 CAT ATT ATC TTC TTC ACC TTT TGA AAC CAT GAC GTC TCC 
AGA CAT TCC CAT AGA ACC GCC 
AVA119 ATT ACC CAT GGT ATG GAT GAA TTG TAC AAA GCT AGC GGC 
AGC GGC GAC TAC 
AVA136 AGC TAG CGG CAG CGG CGA CTA CAA GGA CGA CGA CGA 
CAA GTA G 
AVA314 TTC CCT ACA CGA CGC TCT TCC GAT CTT ACA AGG ACG ACG 
ACG ACA AGT AG 
AVA315 TTC CCT ACA CGA CGC TCT TCC GAT CTN TAC AAG GAC GAC 
GAC GAC AAG TAG 
AVA316 TTC CCT ACA CGA CGC TCT TCC GAT CTN NTA CAA GGA CGA 
CGA CGA CAA GTA G 
AVA319 AAT GAT ACG GCG ACC ACC GAG ATC TAC ACT CTT TCC CTA 
CAC GAC GCT CTT CCG ATC 
AVA320 GTG ACT GGA GTT CAG ACG TGT GCT CTT CCG ATC ATG GTG 
ATG ATG GCC GCT GCC 
AVA321 CAA GCA GAA GAC GGC ATA CGA GAT CGT GAT GTG ACT 










Table 2-8. Sequences of readthrough and control selection constructs.  
Construct Sequence 
CT-Lib 
TCT AAT ACG ACT CAC TAT AGG GAC AAT TAC TAT TTA CAA 
TTA CAA TGG ACT ACA AGG ACG ACG ACG ACA AGT ACN NNN 
NNN NNN NNN NNN NNN NNN NNN NNN NNN NNN NNN NNN 
NNN NNN NNN NNN NNN NNN NNN NNN NNN NNN NNN NNG 
GCA GCG GCC ATC ATC ACC ATC ACC ACG GCG GTT CTA TGG 
GAA TGT CTG GAT CTG GCT AT 
Inactive-
RT 
TCT AAT ACG ACT CAC TAT AGG GAC AAT TAC TAT TTA CAA 
TTA CAA TGG ACT ACA AGG ACG ACG ACG ACA AGA CCC TAG 
ATG ACT AGC ACC GAG AAC CCG GCG CCA CGC AAT GGA 
ACG TCC TTA ACT CCG GCA GGC AAT TAA AGG GAA CGT ATG 
GCA GCG GCC ATC ATC ACC ATC ACC ACG GCG GTT CTA TGG 
GAA TGT CTG GAT CTG GCT AT 
MLV 
TCT AAT ACG ACT CAC TAT AGG GAC AAT TAC TAT TTA CAA 
TTA CAA TGG ACT ACA AGG ACG ACG ACG ACA AGA CCC TAG 
ATG ACT AGG GAG GTC AGG GTC AGG AGC CCC CCC CTG 
AAC CCA GGA TAA CCC TCA AAG TCG GGG GGC AAC CCG 
TCG GCA GCG GCC ATC ATC ACC ATC ACC ACG GCG GTT CTA 
TGG GAA TGT CTG GAT CTG GCT AT 
RT-Lib 
TCT AAT ACG ACT CAC TAT AGG GAC AAT TAC TAT TTA CAA 
TTA CAA TGG ACT ACA AGG ACG ACG ACG ACA AGT AGN NNN 
NNN NNN NNN NNN NNN NNN NNN NNN NNN NNN NNN NNN 
NNN NNN NNN NNN NNN NNN NNN NNN NNN NNN NNN NNG 
GCA GCG GCC ATC ATC ACC ATC ACC ACG GCG GTT CTA TGG 
GAA TGT CTG GAT CTG GCT AT 
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3.0  Chapter Outlook 
 Protein translation in eukaryotes is reprogrammed through diverse molecular 
mechanisms to expand the coding capacity of individual genes. One such mechanism 
termed -1 programmed ribosomal frameshifting (-1 PRF) utilizes cis-acting signals within 
the mRNA to redirect ribosomes into a new translation reading frame that gives rise to an 
alternative protein product. In this chapter, we establish -1 PRF as a powerful framework 
for engineering small molecule responsive RNA switches that control protein synthesis in 
eukaryotes. First, we implemented our in vitro selection for translation reprogramming 
developed in Chapter 2 to identify efficient -1 PRF stimulatory elements and 
characterized the selection products by high-throughput sequencing. Then, we 
demonstrate the construction of ligand responsive -1 PRF switches by coupling -1 PRF 
stimulatory elements to RNA aptamers using rational design and in vivo directed 
evolution. Our -1 PRF switches can control the relative stoichiometry of two distinct 
protein outputs from a single mRNA and demonstrate consistent ligand response across 
whole populations of cells. We further applied -1 PRF switches to build condensed logic 
gates and an apoptosis module in yeast. Together, these results showcase the potential for 
engineering RNA to reprogram translation, opening new opportunities for scalable and 





3.1  Introduction 
The ribosome coordinates the biosynthesis of proteins from mRNA templates 
according to a standard translational program. While this process typically proceeds with 
high fidelity1, in some cases, the translational program is momentarily altered in order to 
change the protein output of a gene2,3. This ‘reprogramming’ endows the translation 
apparatus with expanded synthetic capabilities, enabling the expression of proteins 
containing non-canonical amino acids (such as selenocysteine or pyrrolysine) or the 
regulated expression of multiple distinct protein products from a single mRNA 
transcript4. Some forms of translation reprogramming have been directly adopted for 
biotechnology, including internal ribosome entry sites (IRES)5 and co-translational 
cleaving 2A peptides6. Moreover, substantial effort has been directed toward engineering 
translation components for the redefinition of stop codons to specify unnatural amino 
acids in living cells7. While significant progress has been made in these areas, other 
modes of translation reprogramming remain largely unexplored despite their potential 
applications for synthetic biology.  
Several reprogramming mechanisms utilize cis-acting RNA elements to signal the 
recoding event at a specific location along the mRNA, offering attractive opportunities to 
engineer RNA devices that regulate protein synthesis. Encouragingly, other RNA-based 
gene-regulatory frameworks have recently emerged as powerful tools for engineering 
biological systems8. Over two decades of SELEX and related in vitro selection 
technologies9–11 have yielded synthetic RNA molecules that bind to diverse ligands12,13 
and catalyze chemical reactions. Engineered RNA devices, particularly allosteric 
ribozymes14–18, have been applied to synthetic biology for cellular computation19, gene 
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regulation20, and controlling cell phenotype21,22. Much of this success may be attributed 
to the modularity of RNA device construction, which could be broadly applicable beyond 
previously explored classes of RNA devices.  
We identified -1 Programmed Ribosomal Frameshifting (-1 PRF) as a potentially 
modular RNA mechanism for developing new gene-regulatory tools. Eukaryotic -1 PRF 
signals are composed of two general features: (i) a heptanucleotide slippery site where 
the frameshift event occurs, with the general sequence X-XXY-YYZ (dashes demarcate 
codons in the original frame; X can be any nucleotide; Y can be A or U; and Z can be A, 
C or U); and (ii) a downstream stimulatory RNA structure, typically a hairpin or 
pseudoknot23. When encountering a -1 PRF signal in an mRNA, a fraction of translating 
ribosomes slip back by a single nucleotide, placing the translation apparatus in the -1 
reading frame. This, in turn, alters the amino acid composition of the polypeptide that is 
synthesized downstream of the frameshift site. 
-1 PRF is especially common in retroviruses, including HIV, where it serves to 
establish a precise stoichiometry of Gag and Gag-Pol proteins24. Regardless of variation 
in mRNA transcript levels or translational activity, the stoichiometry of frameshift to 
non-frameshift protein products remains constant for a given -1 PRF signal. Thus, -1 PRF 
is an attractive mechanism to set the relative abundance of multiple proteins by co-
encoding them on a single transcript. While viral -1 PRF signals have fixed activities, we 
were inspired by the natural polyamine sensing antizyme +1 frameshift signal25 to 
engineer ligand responsive -1 PRF devices (Fig. 3-1a). It was previously demonstrated in 
vitro and in living cells that certain prokaryotic transcriptional riboswitches can serve as 
frameshift stimulatory elements and trigger -1 PRF in response to their cognate 
!
! 74 
ligands26,27. However, a general strategy for constructing synthetic -1 PRF devices that 
can be controlled by orthogonal ligands has not yet been developed.  
 
 
Figure 3-1. Building ligand responsive -1 PRF switches. (a) Gene control concept. The protein 
output of an mRNA is dictated by the translation reading frame. -1 PRF switch devices direct the 
ribosome’s translation reading frame depending on the presence or absence of a ligand. (b) 
Methodological approach towards building -1 PRF switches. Active frameshift stimulatory 
elements are discovered from large RNA libraries using a functional in vitro selection. Frameshift 
stimulatory elements are then coupled to RNA aptamer modules by rational design to create 
ligand responsive -1 PRF switches. Lastly, devices can be optimized by in vivo directed evolution 
in yeast using a -1 PRF regulated transcriptional activator as a selectable output. 
 
Here, we establish a platform for engineering ligand-responsive -1 PRF switch 
devices from synthetic components and apply them for in vivo regulation of protein 
synthesis. We describe a functional in vitro selection for -1 PRF stimulatory element 
discovery, combining the combinatorial complexity of a classical in vitro selection with 
the biochemical complexity of a cell lysate. We further leverage rational design and in 
vivo directed evolution to construct robust ligand-responsive -1 PRF switches (Fig. 3-1b). 
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Our devices display robust behavior by balancing protein output stoichiometry, enabling 
the assembly of logic gates and a phenotypic control switch that responds with precision 
at the individual cell level. 
3.2  Results 
3.2.1  An in vitro selection for -1 programmed ribosomal frameshifting 
 To establish a -1 PRF toolkit for synthetic biology, we set out to compile a 
collection of robust RNA frameshift stimulatory elements that are suitable for 
downstream applications. Ideally, these elements are short in length, have well-defined 
structures, trigger high efficiency -1 PRF, and are readily exchanged with other 
frameshift elements of similar size and composition. However, natural -1 PRF 
stimulatory elements are diverse in both size and sequence, and in some cases, require 
>3000 nucleotides for frameshift activity. Moreover, natural -1 PRF signals stimulate 
frameshifting at levels that are tuned for optimal viral replication (typically 5-10%), not 
maximal efficiency3. The above limitations place constraints on the scope of available 
parts, the modularity for engineering, and the achievable dynamic range of ligand-
responsive devices. Therefore, we developed a selection strategy to discover novel -1 
PRF stimulatory elements from large libraries of sequence variants derived from a 
uniformly compact scaffold.  
The directed evolution approach that we designed exploits mRNA display, a well-
established in vitro selection technology28. During in vitro translation of mRNA-display 
templates, the amplifiable genotype of the mRNA is connected to the phenotype of the 
polypeptide through a critical puromycin ligation reaction. While mRNA-display is 
conventionally employed to select for functional proteins and peptides, we repurposed it 
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to select for the translation reprogramming activity of an mRNA (Fig. 3-2). Due to the 
strong distance dependence of the puromycin reaction29, mRNA-peptide fusion occurs 
only if the ribosome translates the entire mRNA transcript. As a result, upstream stop 
codons that terminate translation prevent mRNA-peptide fusion from occurring30. We 
exploited this specificity of puromycin reactivity to differentiate frameshift stimulating 
sequences from inactive sequences.  
 
 
Figure 3-2. Translation reprogramming selection principle. mRNA-display templates form 
mRNA-peptide fusions if the ribosome translates the entire transcript. Ribosomes that terminate 
translation upstream of the designated fusion point will fail to produce mRNA-peptide fusions 
(upper). Frameshifting enables bypass of encoded stop codons to produce mRNA-peptide fusions 
(lower). 
 
An mRNA library was designed such that only active -1 PRF signals promote 
mRNA-peptide fusion formation. Starting from a prokaryotic riboswitch scaffold26, 14 
nucleotides were randomized to generate 2.7x108 sequence variants (see Appendix A.1). 
Notably, a library of this size is easily accommodated by the mRNA-display technology, 
which allows for upwards of 1014 input sequences29. To enrich active -1 PRF stimulatory 
elements, the library was encoded downstream of the heptanucleotide slippery site U-
UUA-AAC and an in-frame UAG termination codon (Fig. 4-3). After three cycles of in 
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vitro selection, assaying of selection products in a dual-fluorescent protein (dual-FP) 
reporter in S. cerevisiae revealed enrichment for active frameshift stimulating elements 
(Fig. 3-4 and Fig. 3-5).   
 
Figure 3-3. In vitro selection for -1 PRF stimulatory elements. (a) The mRNA display selection. 
The display construct encodes an N-terminal FLAG tag, a heptanucleotide slippery site, an in-
frame stop codon, the stimulatory element library, and a C-terminal hexahistidine tag encoded in 
the -1 frame. The selection cycle comprises four stages: (i) DNA is in vitro transcribed and 
ligated to the puromycin adaptor; (ii) mRNA display templates are translated in vitro in rabbit 
reticulocyte lysate; (iii) mRNA-peptide fusions are isolated from non-fused RNA by affinity 
purification of the peptide tags; (iv) enriched sequences are reverse transcribed and PCR 
amplified for subsequent rounds of selection. 
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Flow cytometry of the pooled selection products within dual-FP reporter plasmids 
showed significant enrichment of active frameshift stimulators, displaying in vivo 
efficiencies of up to 30% (Fig. 3-5). Moreover, flow cytometry of individual clones 
revealed that the ratio of fluorescent proteins remained constant for a given population of 
cells harboring the same -1 PRF signal, irrespective of total protein synthesis (Fig. 3-4). 
As a result, two populations of yeast with frameshifting efficiencies that differ by only 3- 
to 4-fold are highly resolvable, despite overall expression levels that span several orders 
of magnitude.  
 
Figure 3-4. Dual-FP reporter assay of -1 PRF efficiency in S. cerevisiae. The frameshift variant is 
cloned between green fluorescent protein (GFP) and the red fluorescent protein mCherry. The 
ratio of fluorescence signals reflects bulk -1 PRF efficiency. Flow cytometry of individual clones 






Figure 3-5. Characterization of in vitro selection products by flow cytometry. (a) Dot plot and 
(b) histogram of bulk in vitro selection products cloned into the dual-FP reporter. 
 
The in vitro selection products were submitted for next-generation sequencing 
(NGS) to characterize the landscape of frameshift stimulatory elements. A computational 
pipeline was implemented to identify promising sequence motifs for downstream 
engineering applications. Sequences were grouped on the basis of compatibility with 
different geometries of H-type pseudoknots, and also clustered on their primary sequence 
identity (see Appendix A.1). PK enrichment was assessed by explicitly computing the 
initial probability distribution over the space of PK structures, and comparing with the 
empirical distribution observed post-selection (Fig. 3-6). Following motif grouping, 
comparative analysis and secondary structure prediction algorithms (pKiss31) were used 
to further support secondary structure assignment. Additionally, the differential 
abundance of variants within a motif was used to identify nucleotide preferences at 





Figure 3-6. NGS analysis of in vitro selected -1 PRF stimulators. Sequences were analyzed for 
their compatibility with various H-type pseudoknot base-pairing geometries, then clustered based 
on primary sequence identity. Comparative analysis was applied to support base pair predictions, 
and mutational analysis identified sequences constraints on the motif. See Appendix A.1 for 
further details.  
 
 
Figure 3-7. Frameshift stimulatory motifs. (a) H-type pseudoknot and (b) hairpin motifs 
identified by NGS (purple circles indicate nucleotide positions that were randomized in the 
starting library).  
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3.2.2  Rational design and in vivo optimization of ligand responsive -1 PRF switches 
To engineer ligand responsive devices, we rationally coupled our -1 PRF 
stimulatory elements to small molecule binding RNA aptamers. For our stimulatory 
element, we chose sequence NL-2 from the in vitro selection because it displayed high -1 
PRF efficiency in yeast (30%), was the second most abundant sequence in the NGS, and 
has a confidently predicted pseudoknot fold (Fig. 3-7). As aptamer domains, we chose 
the theophylline12 and neomycin32 binding aptamers based on their previous success for 
in vivo applications.  
 
Figure 3-8. Rational design of frameshift switches. (a) OFF-switch design. In the absence of 
ligand, the stimulatory pseudoknot (purple) is energetically dominant, producing high frameshift 
levels. Ligand binding induces aptamer (gold) folding, which disrupts the pseudoknot structure 
leading to lowered frameshift levels. (b) ON-switch design. A switching hairpin (gray) is 
installed to disrupt the pseudoknot and lower basal frameshifting. In the presence of ligand, the 
aptamer folds and destabilizes the switching hairpin, allowing the pseudoknot to re-fold and 
restore frameshift activity. 
 
In OFF-switches (Fig. 3-8a), the RNA aptamer and NL-2 pseudoknot sequences 
overlap creating competition for folding. In the absence of ligand, the active pseudoknot 
predominates and stimulates high -1 PRF activity. However, in the presence of ligand, the 
folded aptamer is stabilized by ligand binding energy and disrupts the NL-2 pseudoknot, 




Figure 3-9. Design and characterization of OFF switch devices. (a) General scheme depicting the 
intended structural rearrangements. A representative theophylline responsive OFF switch 
sequence is shown. (b) Optimization of a theophylline responsive OFF-switch. Increasing the 
length of the theophylline aptamer stem leads to increasing disruption of the stimulatory 
pseudoknot. Frameshift levels, both in the absence and presence of ligand, are inversely 
correlated with aptamer thermodynamic stability. (c) Efforts to optimize a neomycin responsive 
OFF-switch. As with the theophylline responsive switches, in general, frameshift levels are 
inversely correlated to the thermodynamic stability of the aptamer. However, this relationship is 
not as direct, and this method was unable to provide a switch that possessed ideal -1 PRF levels 
and ligand responsiveness. Instead, the neomycin OFF-switch was optimized by in vivo directed 
evolution (see Fig. 3-13). 
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length and composition of the aptamer stems. As a general trend, we found that 
increasing the thermodynamic stability of the aptamer lowered frameshift activity (Fig. 3-
9). This simple approach led to the discovery of a high-performing theophylline OFF 
switch that displays a 7-fold reduction in -1 PRF in the presence of ligand.  
Unfortunately, rational optimization of aptamer stability did not result in adequate 
neomycin OFF-switch activity. Therefore, we devised an in vivo directed evolution 
platform for optimizing switch performance that exploits the unique output of -1 PRF 
(Fig. 3-10). Briefly, -1 PRF devices were inserted between the open reading frames of a 
Gal4 minimal DNA binding domain (BD) and a Gal4 minimal activation domain (AD)33. 
Overall, expression of Gal4 responsive genes in a yeast two-hybrid strain34 is a function 
of the Gal4(BD) / Gal4(BD-AD) ratio, which in turn is dictated by -1 PRF efficiency 
(Fig. 3-10). Additionally, we also demonstrated that functional expression of selectable 
markers in the yeast two-hybrid strain is dependent of frameshift efficiency. In growth 
assays (Fig. 3-11), fixed -1 PRF stimulators of varying efficiency were cloned between 
the Gal4(BD) and Gal4(AD), then evaluated for growth in the positive selection 
conditions and counterselection conditions. We found that higher efficiency -1 PRF 
stimulators grew better in positive selection conditions, but were very sensitive to 5-FOA under 
counterselection conditions.  
We designed a library of neomycin OFF-switches by varying nucleotides in the 
aptamer’s terminal stem region. After one round of positive selection in the absence of 
ligand and counter-selection in the presence of neomycin, we identified multiple switches 
with improved performance (Fig. 3-12), the best of which demonstrated 5.5-fold change 
in -1 PRF in response to neomycin. Aside from directed evolution applications, this Gal4 





Figure 3-10. Directed evolution of -1 PRF switches in S. cerevisiae. (a) -1 PRF switches are 
encoded between a Gal4 minimal DNA binding domain (Gal4-BD) and a Gal4 minimal 
activation domain (Gal4-AD). Failure to frameshift at the switch results in translation termination 
to product a free Gal4-BD. Frameshifting allows for translation of the full minimal Gal4 
transcription factor. Activation of Gal4 responsive genes is a function of Gal4-BD/Gal4-TF ratio 
and -1 PRF efficiency (see Fig. 3-11 and 3-11). (b). Selection scheme. A library of -1 PRF 
devices is cloned into the Gal4 selection vector by gap repair directly into the yeast 2-hybrid 
selection strain MAV203. The transformants are subjected to positive selection in media lacking 
histidine supplemented with the his3 inhibitor 3-aminotriazole (3-AT). For the selection of ON 
switches, media is also supplemented with the small molecule inducer. Counterselection is 
performed in minimal media containing 5-fluoroorotic acid (5-FOA) and the small molecule 
ligand in the case of OFF switch selections. After rounds of selection, DNA can be extracted from 
the culture and cloned into the dual-FP reporter for characterization, or mutagenized and 
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Figure 3-11. Assaying Gal4 activity with a GFP reporter.  
 
 
Figure 3-12. Growth assays of -1 PRF devices in the Gal4 selection construct. -1 PRF stimulators 
of varying efficiency were cloned into the Gal4 selection plasmid and assayed for growth in (a) 
positive selection conditions in His- minimal media containing varying amounts of 3-AT or (b) 
counterselection conditions media containing varying concentrations of 5-FOA. Higher efficiency 
-1 PRF stimulators grow better in positive selection, while lower efficiency -1 PRF stimulators 
grow better in the counterselection conditions. (c) A theophylline responsive ON-switch in the 
Gal4 selection. The construct shows theophylline-assisted growth in the positive selection 
conditions and growth inhibition by theophylline in the counterselection conditions. 
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For our ON-switches, a “switching hairpin” was introduced to compete with the 
NL-2 pseudoknot to reduce basal -1 PRF levels. By design, structural rearrangements 
stimulated by ligand binding serve to destabilize the switching hairpin, leading to 
coincident refolding of the pseudoknot and restoration of -1 PRF activity (Fig. 3-8b). 
Several constructs were designed with varying lengths and compositions of the aptamer 
stems and switching hairpins to tune the relative stabilities of the ON and OFF states. 
These constructs were assessed using RNA secondary structure prediction (NUPACK35) 
and tested experimentally in the dual-FP assay to correlate hairpin and aptamer stability 
to switch activity (Fig. 3-14 and Fig. 3-15). With minimal optimization, this approach led 
to efficient ON-switches that respond to theophylline (5.9-fold) or neomycin (4.2-fold) 
(Fig. 3-16a).  
When evaluating the theophylline responsive ON-switch Theo-ON-11 by flow 
cytometry, populations of cells exposed to theophylline can be distinguished from 
untreated cells with >99% accuracy (Fig. 3-16b). This highlights that the stoichiometric 
precision of -1 PRF is retained even in the context of a ligand responsive switch. Overall, 
these results demonstrate that rational design of RNA structural rearrangements 
controlled by small molecule ligands can be used to modulate -1 PRF and gene 
expression, and that devices can be quickly optimized by a Gal4-based in vivo directed 











Figure 3-13. Optimization of a neomycin responsive OFF-switch by in vivo directed evolution. 
(a) Scheme of the neomycin OFF switch library targeting the aptamer stem. Two libraries, each 
containing 5 randomized nucleotides in the aptamer, were, cloned into the Gal4 selection vector 
and transformed into the yeast two-hybrid selection strain. (b) After one round of 
counterselection in the presence of neomycin and one round of positive selection in the absence 
of neomycin, selection products were cloned into the dual-FP reporter. Randomly sampled 
colonies were assayed for ligand responsiveness. One variant (aptamer structure depicted on the 



























Figure 3-14. Design and characterization of theophylline responsive ON switches. (a) General 
scheme depicting the intended structural rearrangements induced by ligand binding. A 
representative theophylline responsive ON switch sequence is shown. (b) First, basal 
frameshifting levels were tuned down by inserting a switching hairpin to compete with 
pseudoknot folding. Basal frameshifting and ligand induced frameshifting is inversely correlated 
with switching hairpin length and thermodynamic stability. (c) Activation was optimized by 
adjusting the length of the aptamer stem. Frameshifting activity, in general, correlated with the 
stem length and thermodynamic stability of the aptamer. Incorporation of other thermodynamic 






Figure 3-15. Design and characterization of neomycin responsive ON switches. (a) General 
scheme depicting the intended structural rearrangements induced by ligand binding. A 
representative neomycin responsive ON switch sequence is shown. (b) Frameshift levels were 
tuned by adjusting the length and loop composition of the switching hairpin. In general, basal 
frameshifting and ligand induced frameshifting is inversely correlated with switching hairpin 
thermodynamic stability. In this case, by comparison to the theophylline ON switches, hairpin 





Figure 3-16. Summary of optimized switches. (a) The ligand responsiveness of four switch 
devices as assayed in the dual-FP reporter. Theophylline was used at a concentration of 40 mM; 
neomycin was used at a concentration of 500 mg/mL. (b) Flow cytometry of the Theo-ON-11 
switch in the presence and absence of theophylline (40 mM) as visualized by the histogram of the 
ratio of GFP to mCherry signals (on log scale). 
 
3.2.3  Constructing logic gates and phenotypic controllers with -1 PRF switches 
 We envisioned exploiting multiple translational reading frames by layering our -1 
PRF devices within individual mRNAs to create logic gates and phenotypic controllers. 
Logic gates are important genetic devices for executing cellular computation and 
programming biological systems. While diverse logic gate architectures have been 
reported19,36,37, most require the expression of multiple components to transduce small-
molecule inputs into gene expression output. We recognized the opportunity to construct 
highly condensed logic gates from a single mRNA transcript using -1 PRF switches. To 
this end, we constructed both a NOR gate (Fig. 3-17a) and an AND gate (Fig. 3-17b). 
Logic gate outputs predicted by individual switch activities are in good agreement with 
the experimentally obtained results, demonstrating that the frameshift switch devices 
function independent of one another and their context. Moreover, ON/OFF states are well 
distinguished by flow cytometry, particularly for the NOR gate. Though not 
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demonstrated here, it is conceivable that other more complex logic gates could be 
constructed by layering -1 PRF switches in alternative configurations within mRNAs. 
 
 
Figure 3-17. Construction of logic gates with layered -1 PRF switch devices. (a) The NOR gate 
is composed the Theo-OFF-3 switch and the Neo-OFF-DE switch layered within a single mRNA. 
(b) The AND gate is composed of the Theo-ON-5 switch and the Neo-ON-4 switch layered 
within a single mRNA. Translation in the absence of a ligand follows the black path; theophylline 
directs translation down the red path; neomycin directs translation down the blue path. Activity 
of the gate was assessed within the dual-FP reporter by flow cytometry. For both gates, 
mCherry is encoded in the -2 frame with respect to GFP. Theophylline was used at a 
concentration of 40 mM; neomycin was used at a concentration of 500 mg/mL. 
 
Next, to demonstrate the utility of -1 PRF for controlling cell phenotype and 
studying interacting proteins in vivo, we designed an apoptosis module in yeast using 
mammalian Bcl-2 family proteins38. Though naturally absent from S. cerevisiae, 
heterologously expressed Bcl-2 family members retain their basic functions in yeast39. 
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Bax expression in S. cerevisiae has been shown to induce cell death through 
mitochondrial membrane permeabilization40. Moreover, co-expression of the pro-survival 
protein Bcl-xL protects yeast from Bax mediated lethality39, consistent with its function 
in mammalian systems.  
A third subset of factors termed the BH3-only proteins are proposed to inhibit the 
pro-survival family members by direct interaction, and perhaps additionally interact with 
Bax to activate its killing function. Thus, a model has been proposed in which cell fate is 
dictated by the relative expression of BH3-only and pro-survival proteins in a background 
of Bax expression38. While previous studies in yeast have demonstrated that the BH3-
only protein Puma enhances Bax mediated lethality, co-expression of pro-survival Bcl-xL 
mitigated all lethal effects41. Thus, it is unclear to what extent Bcl-xL expression is 
required to rescue cells from Bax induced cell death and how the relative production of 
Puma and Bcl-xL influence cell viability. 
Our -1 PRF expression system could offer insight into the underlying mechanism 
of this process by precise ligand-dependent alteration of protein stoichiometry. We 
designed an expression construct that allows for the simultaneous control of the BH3-
only protein Puma by a theophylline responsive ON-switch and the pro-survival protein 
Bcl-xL by a neomycin responsive OFF-switch (Fig. 3-18a). Both proteins are encoded 
within the same mRNA and are synthesized according to the frameshift activity of their 
corresponding switch. Importantly, the Puma open reading frame and theophylline 
responsive ON switch required recoding to remove stop codons from the 0-frame, 
allowing for non-frameshifting ribosomes to bypass Puma out of frame and access the 
downstream Neo-OFF switch and Bcl-xL. Using the small molecule ligands, we titrated 
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the relative levels of Puma and Bcl-xL in a background of Bax expression and observed 
the effects on cell viability (Fig. 3-18b).  
 
 
Figure 5. Constructing a cell death module in yeast. (a) The apoptosis module construct and 
biological principle. A single mRNA construct encodes Puma under the control of a theophylline 
responsive ON-switch and Bcl-xL under the control of a neomycin responsive OFF-switch. 2A 
peptides encoded N-terminal to the Puma and Bcl-xL open reading frames cleave the functional 
proteins from the nonsense translation products of the switch devices and alternative reading 
frames. The latter products are targeted for degradation by an N-degron signal at the N-terminus 
of the polypeptide. Translation in the absence of a ligand follows the black path, theophylline 
directs translation down the red path, and neomycin directs translation down the blue path. 
Relative production of Puma and Bcl-xL controls the ability of Bax to induce cell death. (b) 
Evaluating cell death as a function of relative Puma and Bcl-xL expression. Cells expressing Bax 
and the Puma/Bcl-xL apoptosis module were grown in various concentrations of neomycin (0 
µg/mL, 40 µg/mL, 150 µg/mL, 650 µg/mL) and theophylline (0 mM, 1 mM, 5 mM, 20 mM) and 
assessed for viability by plating efficiency. 
 
In the absence of ligands, cells were protected from Bax mediated killing through 
expression of Bcl-xL. Turning down Bcl-xL with neomycin had little effect on cell 
viability, producing a 4-fold decrease in viability at maximal concentrations. Treatment 
with theophylline alone to increase Puma production while maintaining high Bcl-xL had 
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no influence on Bax-mediated killing, consistent with previous reports41. However, when 
cells were treated with both ligands, we observed a cooperative effect building up to a 
>300-fold decrease in cell viability at maximal concentrations of theophylline and 
neomycin (Fig. 3-18b). These results support the hypothesis that apoptosis is regulated 
by the relative balance between BH3-only proteins and pro-survival proteins42, and 
establish this system as an efficient kill switch in S. cerevisiae. Moreover, this represents 
a functional AND gate with a phenotypically meaningful output.  
3.3  Discussion  
Our results demonstrate that translation reprogramming can be co-opted and 
engineered to regulate gene expression in living cells. Because reprogramming occurs 
through RNA mediated mechanisms, it is amenable to various directed evolution 
strategies and rational engineering of devices using modular RNA components. Notably, 
our method applies a combination of these approaches to construct -1 PRF switches. 
Furthermore, this approach may be applicable to designing -1 PRF switches for higher 
eukaryote systems, such as mammalian cells, where -1 PRF is commonly observed. 
We employed an in vitro directed evolution approach that selects for a complex 
functional phenotype in the setting of a cell lysate. Notably, previous attempts to improve 
allosteric ribozymes by in vitro directed evolution resulted in devices that were non-
functional in living cells18. This was attributed to potential differences between the in 
vitro and cellular environments. However, our in vitro selections were conducted in a cell 
lysate and enriched for a function that requires direct interaction with the cell’s complex 
biochemical machinery. This, perhaps, improved the likelihood that selection products 
would retain activity in vivo. Analogous to previously reported allosteric selections17, this 
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in vitro directed evolution platform could also be adapted for the selection of ligand 
responsive frameshift devices and the discovery of novel aptamers. Moreover, it could be 
readily redesigned to select for other forms of translation reprogramming such as +1 
frameshifting or stop codon readthrough. 
Constitutively active -1 PRF elements are directly applicable for fixed protein 
expression, and are easily exchanged with individual variants or libraries of variants. The 
diversity of selection products provides a 150-fold range in frameshifting efficiencies. -1 
PRF is also compatible with use in combination with transcription-based expression 
control tools. The characterization of our selection products by NGS supports future 
efforts to engineer -1 PRF elements by providing structural information and sequence-
activity relationships. Moreover, further analysis of the NGS data could advance our 
understanding of -1 PRF and support experimental elucidation of the reprogramming 
mechanism. 
Ligand responsive -1 PRF switches provide distinct advantages over other gene-
control strategies. Since -1 PRF switches are based on modular RNA parts, it is feasible 
to scale the number of devices using other aptamer and frameshift components. Whereas 
engineering proteins that respond functionally to the binding of a ligand remains a 
challenge, there are better prospects for discovering new RNA aptamers for small 
molecule recognition. The platform that we established here should be applicable to the 
construction of other -1 PRF switch devices based on alternative RNA aptamer and 
frameshift modules to engineer biosensors for molecules of interest.  
-1 PRF devices also provide a unique output: stoichiometrically defined products 
of alternative translation reading frames. This stoichiometric control offers precision and 
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consistency that can be exploited for various purposes, but especially those that depend 
on the balance of two functionally interacting proteins. Interestingly, natural biological 
mechanisms may utilize a similar principle, albeit through transcriptional networks43. As 
demonstrated by our apoptosis module, this form of regulation can be used for achieving 
robust phenotypic performance in genetically modified organisms.  
Importantly, outputs of -1 PRF signals need not be a protein product directly, but 
may instead be an input frame for another -1 PRF switch device. As a result, -1 PRF 
signals are very conducive to layering within individual mRNAs. With some creativity 
and ingenuity, it should be possible to conceive and construct various configurations of -1 
PRF signals that can be used to perform complex logic operations and other regulatory 
functions in the cell. We believe that the tools and methodology developed here will 
empower our efforts to develop sophisticated genetic programs and advance our 
capabilities to study and engineer biological systems. 
3.4  Experimental Methods 
Nucleotide sequences used in this study are detailed in section 3.5.  
Frameshift stimulator library design. The starting library was synthesized as an 
oligonucleotide (IDT) encoding a modified PreQ1-class I riboswitch26 with 14 positions 
randomized in the region surrounding the ligand cavity. This library has a theoretical 
diversity of 2.68 x 108 unique sequences. The selection construct was assembled from 4 
oligonucleotides (AVA105, AVA106, AVA107 and AVA108) by PCR with Vent 
Polymerase (NEB) in a 1-mL reaction. Full-length starting library construct: 5’-TCT 
AAT ACG ACT CAC TAT AGG GAC AAT TAC TAT TTA CAA TTA CAA TGG 
ACT ACA AGG ACG ACG ACG ACA AGA CTT TAA ACT AGT TGA CGC GNN 
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NCT ANN NNN NNN CGC GTT AAA CNN NCT AGA AGG CGG TTC TAT GGG 
AAT GTC TGG ATT AAG CCA TCA TCA CCA TCA CCA CGG CAG CGG CTA T-
3’.  
In vitro selection for -1 programmed ribosomal frameshifting. The mRNA 
display selection protocol described in Chapter 2 was generally followed. Briefly, the 
DNA library was in vitro transcribed with T7 RNA polymerase (100 uL reaction) and 
purified by 8.5% Urea-PAGE gel. The resulting RNA was ligated to phospho-A27CC-
puromycin (TriLink Biotechnologies) by splint ligation using primers AVA95 and 
AVA96 as splint oligonucleotides. The puromycin conjugated mRNA templates were 
purified from non-ligated RNA by 8.5% Urea-PAGE gel. 20 pmoles (1.2 x 1013 
molecules) of mRNA display templates were translated at 30˚ C for 1 hour in 100 mL of 
40% rabbit reticulocyte lysate (nuclease treated, Promega) supplemented with amino 
acids, Mg(OAc)2 to 0.5 mM final, and KCl to 100 mM final. After incubation at 30˚ C, 
the translation reaction was treated with 38 mL of puromycin salt mix and incubated at 
room temperature for 15 minutes, then placed on ice. The translation reaction was diluted 
10-fold with 1.24 mL of chilled FLAG binding buffer. 30 mL of anti-FLAG M2 Affinity 
Gel (Sigma) was pre-washed twice with FLAG clean buffer and three times with FLAG 
binding buffer. The diluted translation reaction was incubated with the anti-FLAG 
affinity gel for 1.5 hrs at 4˚ C with rotation. After incubation, the anti-FLAG gel was 
separated from the supernatant and washed six times with 0.75-mL portions of chilled 
FLAG binding buffer. mRNA-peptide fusions were isolated in two elutions by incubating 
the anti-FLAG gel with 100-mL portions of 200 mg/mL FLAG peptide (Sigma) in FLAG 
binding buffer for 20 minutes at 4˚ C with rotation. 100 mL of Ni-NTA resin (Qiagen) 
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was pre-washed three times with ddH20. The combined FLAG elution fractions were 
diluted with 200 mL of 2x Ni-NTA binding buffer and incubated with Ni-NTA resin at 4˚ 
C with rotation for 1 hour. After a series of washes (Supplementary Table XX), mRNA-
peptide fusions were eluted with Ni-NTA elution buffer and buffer exchanged into 
reverse transcription buffer using 30,000-MW cutoff spin concentrators (Amicon). 
mRNA was reverse transcribed with Superscript II (Invitrogen) for 50 minutes at 42˚ C 
(Ni-NTA elution, 30 mL; 100 mM RT primer AVA95, 3 mL; 10 mM dNTP mix, 15 mL; 
RNAse-free ddH20, 160 mL; 5X First-strand buffer, 60 mL; 0.1M DTT, 30 mL; RNasin, 
1 mL, Superscript II Reverse Transcriptase, 1 mL). The reverse transcription reaction was 
spin-concentrated then amplified with GoTaq polymerase (Promega) using primers 
AVA108 and AVA109 in a 0.5 mL reaction to generate the DNA for subsequent rounds 
of selection. Of note, primer AVA109 includes the entire 5’ segment of the construct 
leading up to the first in frame TAG stop codon in order to correct frameshift insertion 
mutations enriched in the previous round of selection.  
Dual-fluorescent protein reporter assay for -1 PRF activity in yeast. The 
reporter plasmid was constructed by inserting the yEGFP open reading frame (amplified 
with primer pair AVA111·AVA112) between the GPD promoter and the open reading 
frame of a yeast-optimized mCherry44 flanked by a GPD terminator in a pRS425 
backbone (high copy, LEU2 marker). NheI and AatII restriction sites were encoded 
between the GFP and mCherry open reading frames for replacement of the intervening 
sequence with a -1 PRF insert. To assay library -1 PRF activity, dsDNA products from 
the in vitro selection were PCR amplified in two steps (primer pairs AVA117·AVA118 
and AVA119·AVA118) to add homology to the NheI/AatII digested dual-FP reporter 
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plasmid. The library was cloned by in vivo gap repair into yeast strain Fy251 using high 
efficiency transformation as previously described45 and plated on selective medium 
(synthetic complete agar with leucine dropout containing 2% dextrose; SC-Agar-(Gluc) 
L-). Individual colonies were isolated and grown in liquid SC-(Gluc) L- media to mid-log 
phase and the -1 PRF efficiency was determined by comparing quantified GFP and 
mCherry fluorescence signals to a fusion protein control (calibrated to 100% frameshift). 
For analysis of the pooled selection products, the rescued transformation was grown in 
liquid SC-(Gluc) L- selection media for 3 days to enrich for transformants, then analyzed 
directly by flow cytometry (LSRII).  
NGS of in vitro selection products. NGS was performed using the Illumina 
HiSeq platform (Columbia Genome Center). DNA was prepared for sequencing by PCR 
in two separate batches containing either 5 or 9 variable positions at the start site of the 
HiSeq read to avoid identical base calls during the initialization phase of sequencing. The 
in vitro selection products were PCR amplified with primer pair AVA317·AVA322 or 
AVA318·AVA322. Both PCR products were then mixed and amplified with primer pair 
AVA319·AVA321 to add full HiSeq adaptor sequences. After sequencing, the raw fastq 
file was trimmed to the scaffold of interest and the copy number of each unique sequence 
was computed (step 1 of sequence analysis pipeline, see Appendix A1).  
Analysis of NGS for motif classification. The scaffold and its 14 variable 
positions define a restricted region of sequence space (2.68 x 108). We constructed a 
pseudoknot (PK) feature space based on a combination of the nucleotide constraints and 
our user-defined segment constraints, generating a set of 2,068 individual PK features 
(Appendix A1 Fig. A1-2). We enumerated the full set of unique sequences theoretically 
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present in the initial library and calculated their compatibilities with the 2,068 PK 
features. The feature with the greatest amount of base pairing (including G·U) was 
associated to each sequence. PK compatibilities were similarly calculated for the 
sequences observed in the in vitro selection products. Highly enriched PK features could 
then be measured by comparing the two distributions. Of the top 10% of PK features by 
enrichment, those with the highest absolute representation in the selection library defined 
the broad motif categories. Within a set of PK-compatible sequences, a greedy clustering 
algorithm was used to divide the set of sequences into the final motifs. The modes of the 
different motif sets were further characterized in terms of the abundances and entropies 
of their immediate neighborhood in sequence space. In particular, the modes from the 
highest abundance motifs were assessed for single- and pairwise- nucleotide variant 
sensitivity, to reveal potential base pair position and tertiary interactions within a given 
PK geometry. See Appendex A-1 for further details 
Rational design of -1 PRF switches. Switch constructs were evaluated using 
RNA secondary structure predictions and thermodynamic calculations (NUPACK and 
pKiss) as described in Appendix A2 and Figure A2-1. Constructs were assembled from 
synthesized oligonucleotides (IDT). Switches were cloned into the dual-FP reporter by in 
vivo gap repair of NheI/SalI digested dual-FP reporter plasmid using the -1 PRF switch 
fragment and an mCherry PCR product containing homology to the switch. Colonies 
were grown overnight in SC-(Gluc) L- media, then used to seed SC-(Gluc) L- cultures 
(starting OD600 ~ 0.02) with or without the small molecule ligand. Cultures were grown 
to mid-log phase and measured for -1 PRF activity by quantification of GPF and mCherry 
fluorescence signals.  
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Gal4 selection system for in vivo directed evolution of -1 PRF switches. The 
Gal4 selection plasmid was constructed by inserting a minimal Gal4 transcriptional 
activator between the ADH1 promoter and ADH1 terminator in a pRS425 vector 
backbone. Gal4 was PCR amplified from yeast genomic DNA in two pieces with primer 
pairs MS049·AVA155 (Gal4 minimal DNA biding domain, amino acids 1-147) and 
AVA158·MS050 (Gal4 minimal activation domain, amino acids 768-881). Between the 
Gal4 binding and activation domains, BamHI and HindIII restriction sites were encoded 
for replacement of the intervening sequence with a -1 PRF insert. The yeast two-hybrid 
background strain MaV203 (Invitrogen) was used for all growth assays and growth 
selections. Control -1 PRF sequences were cloned into the Gal4 selection vector by in 
vivo gap repair of the BamHI/HindIII digested plasmid -1 PRF inserts (two step PCR, 
first with AVA156·AVA162, then AVA161·AVA162). The Neo-OFF libraries were 
constructed by PCR assembly of oligonucleotides (Library 1: AVA345·AVA347, then 
AVA156·AVA346, then AVA161·AVA276; Library 2: AVA345·AVA348, then 
AVA156·AVA346, then AVA161·AVA276). This generated 2,048 combined theoretical 
variants. The library was cloned by in vivo gap repair into the Gal4 selection plasmid, and 
the rescued transformation culture was grown in SC-(Gluc) L- at 30 ˚C to enrich for 
transformants. Positive selection media (SC-(Gluc) HL-, 80 mM 3-AT, 10 mL) was 
inoculated with the library to a starting OD600 = 0.01 and grown for 60 hours at 30 ˚C to 
OD600 = 1.2. SC-(Gluc) L- containing 500 µg/mg neomycin was inoculated with positive 
selection products and grown from OD600 = 0.1 to OD600 = 1.5 to allow for protein 
turnover. This culture was then used to inoculate counterselection media (SC-(Gluc) L-, 
500 µg/mg neomycin, 0.05% 5-fluoroorotic acid) to a starting OD600 = 0.02 and grown 
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for 84 hours at 30 ˚C to a final OD600 ~ 1.3. DNA was isolated from the counterselection 
culture and used as PCR template for amplification of the -1 PRF switches and cloning 
into the dual-FP reporter for assaying frameshift activity (AVA117·AVA357, then 
AVA119·AVA367, gap repaired with mCherry AVA358·AVA208 PCR product). 
Logic gate construction and evaluation. The NOR gate was assembled by 
fusion PCR of the Theo-OFF-3 switch fragment (AVA119·AVA406) and the Neo-OFF-
DE switch fragment (AVA246·AVA247). The AND gate was assembled by fusion PCR 
of the Theo-ON-5 switch fragment (AVA119·AVA245) and the Neo-ON-4 switch 
fragment (AVA246·AVA247). Gate inserts were cloned by gap repair of the NheI/SalI 
digested dual-FP reporter plasmid using the gate PCR fragment and an mCherry PCR 
product (AVA248·AVA208). Colonies were grown overnight in SC-(Gluc) L- media, 
then used to seed SC-(Gluc) L- cultures (starting OD600 ~ 0.02) with or without the small 
molecule ligand. Cultures were grown to mid-log phase and analyzed by flow cytometry. 
Apoptosis module and cell viability assay. pBM272-339646 encoding wild-type 
mouse Bax under the control of the Gal10 promoter (CEN plasmid, Ura) was obtained 
from Addgene. The human Puma open reading frame (BBC3, Gene ID: 27113) 
nucleotide sequence lacking the ATG start codon was codon optimized for yeast 
expression, manually recoded to remove stop codons from its +1 frame, and ordered 
synthesized (IDT). The nucleotide sequence for human Bcl-xL (BCL2L1, Gene ID: 598) 
was codon optimized for yeast expression and ordered synthesized (IDT). The N-degron 
signal (Ubiquitin-Arg-LacI(1-37)) was amplified from an existing plasmid with primer 
pair AVA462·AVA364. The full construct (Table 3-3) was assembled by conventional 
molecular biology techniques and chromosomally integrated at the LEU2 locus in an 
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Fy251 background strain giving AA01 (leu2Δ::LEU2-pTDH3-[Apoptosis Module]). This 
strain was then transformed with pBM272-3396, giving strain AA02. For control 
viability assays, cultures of AA02 were grown for 72 hours at 30 ˚C without Bax 
induction in synthetic complete media with uracil dropout containing 2% raffinose (SC-
(Raf) U-) and either no ligand, theophylline (20 mM), neomycin (650 µg/mL), or both 
theophylline (20 mM) and neomycin (650 µg/mL). For assessing viability with Bax 
expression, cultures of AA02 were grown in synthetic complete media with uracil 
dropout containing 2% raffinose and 2% galactose (SC-(Gal) U-) with varying 
concentrations of theophylline (0 mM, 1 mM, 5 mM, or 20 mM) and neomycin (0 
µg/mL, 40 µg/mL, 150 µg/mL, or 650 µg/mL) for 72 hours at 30 ˚C. After this time, the 
OD of each culture was measured, diluted to a standard cell density, and then plated at 
the appropriate dilution in triplicate on SC-Agar-(Gluc) U- plates. Colonies from each 













3.5  DNA sequences and apoptosis viability 
Table 3-1. Sequences of -1 PRF OFF-switches. 
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Sequences begin with the slippery site and end with the insulating sequence. The 











































































Sequences begin with the slippery site and end with the insulating sequence. The 
pseudoknot sequence is underlined, the switching hairpin is italicized, and the aptamer 







Table 3-3. Sequences of logic gates and the apoptosis module. 
 

































































Table 3-4. Sequences of oligonucleotides used in this work.  
 
Name Sequence (5’ to 3’) 
AVA-95 TTT TTT TTT TTT ATA GCC GCT GCC 
AVA105 TCT AAT ACG ACT CAC TAT AGG GAC AAT TAC TAT TTA CAA 
TTA CAA TGG ACT ACA AGG ACG 
AVA106 CGC GTC AAC TAG TTT AAA GTC TTG TCG TCG TCG TCC TTG 
TAG TCC ATT GTA ATT GTA AAT 
AVA107 GAC AAG ACT TTA AAC TAG TTG ACG CGN NNC TAN NNN 
NNN NCG CGT TAA ACN NNC TAG AAG GCG GTT CTA TGG 
GAA TGT C 
AVA108 ATA GCC GCT GCC GTG GTG ATG GTG ATG ATG GCT TAA TCC 
AGA CAT TCC CAT AGA ACC GCC 
AVA109 TCT AAT ACG ACT CAC TAT AGG GAC AAT TAC TAT TTA CAA 
TTA CAA TGG ACT ACA AGG ACG ACG ACG ACA AGA CTT 
TAA ACT AG 
AVA111 ATA AAC ACA CAT AAA CAA ACA AAG AAT TCA TGT CTA 
AAG GTG AAG AAT TAT TCA CTG GTG 
AVA112 GCT AGC TTT GTA CAA TTC ATC CAT ACC ATG GGT AAT ACC 
AVA117 AGC TAG CGG CAG CGG CGA CTA CAA GGA CGA CGA CGA 
CAA GAC 
AVA118 CAT ATT ATC TTC TTC ACC TTT TGA AAC CAT GAC GTC TCC 
AGA CAT TCC CAT AGA ACC GCC 
AVA119 ATT ACC CAT GGT ATG GAT GAA TTG TAC AAA GCT AGC 
GGC AGC GGC GAC TAC 
AVA155 GTA GTG CGC CAG AAC CAC TGC CGG ATC CCG ATA CAG 
TCA ACT GTC TTT GAC 
AVA156 CGG CAG TGG TTC TGG CGC ACT ACA AGG ACG ACG ACA 
CAA GAC TTT AAA CTA 
AVA158 TAT GGG AAT GTC TGG AAA GCT TGC CAA TTT TAA TCA AAG 
TGG GAA TAT TGC 
AVA161 TAA CAA AGG TCA AAG ACA GTT GAC TGT ATC GGG ATC 
CGG CAG TGG TTC TGG CGC ACT AC 
AVA162 AGC AAT ATT CCC ACT TTG ATT AAA ATT GGC AAG CTT TCC 
AGA CAT TCC CAT AGA ACC GCC 
AVA208 CAC ACA GGA AAC AGC TAT GAC CAT G 
AVA245 AGT CTT TGA TTG TTC ACC TGA ACC CAT TTT AAT TTT ATT 
ATT TAT TTT TGG TGC TGC C 
AVA246 ATG GGT TCA GGT GAA CAA TCA AAG ACT TTA AAC TAG 
TTG ACG CGG TTC 
AVA247 ATA GCC ATA TTA TCT TCT TCA CCT TTT GAA ACC 
AVA248 ATG GTT TCA AAA GGT GAA GAA GAT AAT ATG GC 
AVA276 AGC AAT ATT CCC ACT TTG ATT AAA ATT GGC AAG CTT AGC 
CAT ATT ATC TTC TTC AC 
AVA317 TTC CCT ACA CGA CGC TCT TCC GAT CTN NNN NGA CAA GAC 
TTT AAA CTA GTT GAC GCG 
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AVA318 TCC CTA CAC GAC GCT CTT CCG ATC TNN NNN NNN NGA 
CAA GAC TTT AAA CTA GTT GAC GCG 
AVA319 AAT GAT ACG GCG ACC ACC GAG ATC TAC ACT CTT TCC CTA 
CAC GAC GCT CTT CCG ATC 
AVA321 CAA GCA GAA GAC GGC ATA CGA GAT CGT GAT GTG ACT 
GGA GTT CAG ACG TGT GCT C 
AVA322 GAC TGG AGT TCA GAC GTG TGC TCT TCC GAT CAC ATT CCC 
ATA GAA CCG CCT TCT AG 
AVA345 GAC ACA AGA CTT TAA ACT AGT TGA CGC GGT TCT ATC TAG 
TTA CGC GTT AAA CCA ACT AG 
AVA346 CAA GCT TAG CCA TAT TAT CTT CTT CAC CTT TTG AAA CCA 
TTT TAA TTT TAT TAT TTA TGT 
AVA347 CCT TTT GAA ACC ATT TTA ATT TTA TTA TTT ATG TTT NCT 
AGN NGG ACC ATT AAA GGA CAA GCN NCT AGT TGG TTT 
AAC GCG TAA CTA GAT 
AVA348 CAC CTT TTG AAA CCA TTT TAA TTT TAT TAT TTA TGT NNN 
CTA GNG GAC CAT TAA AGG ACA TCN CTA GTT GGT TTA 
ACG CGT AAC TAG AT 
AVA357 CTT AGC CAT ATT ATC TTC TTC ACC TTT TGA AAC C 
AVA358 GGT TTC AAA AGG TGA AGA AGA TAA TAT GGC 
AVA364 CCT TGT AGT CGC CCT GCA GGC TGC CCT GCA TTA ATG AAT 
C 
AVA367 TTA AAA ATG TCG ACG GTT CTG GTC AAT TGC TTA ACT TCG 
ATT TAC TTA AAT TGG 
AVA406 GTC TTT GAT TGT TCA CCT GAA CCC ATT TTA ATT TTA TTA 
TTT ATT TTT CTA GAG CTG CC 
AVA462 CAA AAT GCA GAT TTT CGT CAA GAC TTT GAC CGG 
MS049 GAT ATC GAC GTC ATG AAG CTA CTG TCT TCT ATC GAA C 






















Table 3-5. Colony countsa for viability assay of apoptosis module.  
!
Conditionsb Plate 1 Plate 2 Plate 3 Average Stand. Err. 
T-0 N-0 64 70 62 65.3 2.4 
T-1 N-0 77 52 68 65.7 7.3 
T-2 N-0 90 78 67 78.3 6.6 
T-3 N-0 102 114 100 105.3 4.4 
T-0 N-1 82 78 72 77.3 2.9 
T-1 N-1 63 51 55 56.3 4.3 
T-2 N-1 24 34 31 29.7 3.6 
T-3 N-1 10 7 7 8.0 1.0 
T-0 N-2c 62.7 65 61.5 63.1 1.0 
T-1 N-2c 24.5 26.2 29.5 26.7 1.8 
T-2 N-2c 2.5 4.1 3.8 3.5 0.5 
T-3 N-2c 1.3 1.2 0.6 1.0 0.2 
T-0 N-3c 21.8 18.3 16.8 19.0 1.5 
T-1 N-3c 3.3 3.5 4.4 3.7 0.3 
T-2 N-3c 0.3 0.8 0.3 0.5 0.2 
T-3 N-3c 0.3 0.1 0.1 0.2 0.1 
      
T-0 N-0d 75 72 80 75.7 2.3 
T-3 N-0d 99 101 94 98 2.1 
T-0 N-3d 90 103 110 101 5.9 
T-3 N-3d 127 129 139 131.7 3.7 
 
aCultures were diluted to a standard cell density based on OD600 and so that 
approximately 103 cells were plated on SC(gluc) L- selection. Colony counts are reported 
as number of colonies per 103 cells plated. 
bLigand concentrations. T-0: No theophylline; T-1: 1 mM theophylline; T-2: 5 mM 
theophylline; T-3: 20 mM theophylline. N-0: No neomycin; N-1: 40 µg/mL neomycin; 
N-2: 150 µg/mL neomycin; N-3: 650 µg/mL neomycin. 
cCultures were diluted 10-fold less in this case so that 104 cells were plated.  
dCultures in which Bax expression was not induced with galactose, grown with raffinose 
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4.0  Chapter Outlook 
 Fluorescence based methods for visualizing the localization of molecules within 
cells are critical for studying basic biological processes. In many ways, the fluorescent 
proteins (FPs) have revolutionized cell biology, offering user-friendly fluorescent tags 
that achieve exquisite labeling specificity through genetic encoding. While FPs play an 
important role in basic biological imaging, they are currently limited to labeling protein 
molecules that can tolerate an FP fusion. Moreover, recently developed imaging 
modalities, especially those that rely on single molecule detection as in super-resolution 
imaging, benefit from fluorescent tags with higher photon outputs and photostability. As 
a result, synthetic small molecule fluorophores, which often have superior photophysical 
qualities, have become increasingly important reagents for these more demanding 
imaging technologies. Nonetheless, methodologies for synthesizing fluorophores are 
often troubled by poor yields, numerous byproducts, and challenging product isolation. 
This makes further functionalization of the core scaffolds challenging and hinders the 
development of new fluorescent probes. In this chapter, we address these synthetic 
difficulties and present a general approach for the preparation of oxazine and xanthene 
fluorophores via a common diaryl ether intermediate. First, we identified a suitable 
copper(I) based catalyst system for the efficient preparation of electron rich diaryl ethers. 
Second, we developed a scheme for efficiently converting diaryl ethers into oxazine 
fluorophores by a two-step process that results in high yields and nearly no side products. 
Lastly, we developed a scheme to convert diaryl ethers to rosamine fluorophores by a 
tandem Friedel-Crafts acylation and cyclization process.  Notably, an example from each 
class was performed on the gram-scale. 
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4.1  Introduction 
Recent advances in fluorescence spectroscopy have driven the demand for small 
molecule dyes with improved photophysical and fluorescence properties1–3. In addition to 
their development as live-cell protein labeling reagents4,5, engineered fluorescent dyes 
have also been developed as environmental sensors that can provide readouts of local 
viscosity, pH, solute concentration, and electrical potential6–10. Current and future 
developments in this field, especially those relevant to single-molecule and cellular 
imaging, depend on the synthesis of customized fluorescent dyes that emit in the red 
region of the visible spectrum, have high extinction coefficients and quantum yields, and 
display high photostability11,12.  
Amongst our best dyes for these purposes are those from the oxazine and 
xanthene classes, exemplified by commercial compounds ATTO-655 and Alexa Fluor-
594, respectively11,13,14. Derivitization of these parent scaffolds by chemical modification 
of commercially available dyes is often limited, either due to cumbersome 
functionalization of the parent compounds or prohibitive costs in obtaining sufficient 
quantities of dye for carrying out the necessary synthetic steps. Thus, the de novo 
synthesis of fluorescent dyes from basic organic building blocks is an essential aspect of 
technology development. Despite the obvious importance of these molecules and the 
evident need for improved synthetic methodologies, oxazines and xanthenes are still 
largely synthesized using methods reported decades or more ago that do not take 
advantage of the efficiencies of modern chemical transformations15–17.  
Aiming to develop improved technologies for in vivo super resolution imaging, 
we sought to prepare derivatives of the commonly utilized oxazine ATTO-65514. Due to 
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the expense associated with obtaining large quantities of this dye and the lack of 
commercial availability of other desirable analogs, we set out to synthesize the oxazines 
following previously described methods16,17. These prior works rely on coupling a pair of 
aminophenol derivatives, one of which is substituted with an electrophilic nitroso or 




Figure 4-1. Retrosynthetic analysis for oxazine and xanthene fluorophores. Prior works utilized 
multicomponent couplings, whereas our approach pre-assembles the diaryl scaffold for facile and 
versatile conversion to various fluorophores. LG = leaving group. X = H or RCO2–. 
 
Though the aminophenol intermediates are readily prepared, the final coupling 
and cyclization reactions frequently result in low yields (~15%) and necessitate the use of 
preparative scale reverse phase high performance liquid chromatography (prep-HPLC) in 
order to obtain material of satisfactory purity. In our hands, the quantities obtained by this 
method proved insufficient to reasonably carry out the remaining steps in the synthesis of 















































Prior Works Our Work
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quantities was impractical. As a result, we concluded that the existing approach was not a 
viable synthetic route and chose to pursue alternative synthetic strategies. 
Within the oxazine core structure, we identified a previously unexplored diaryl-
ether disconnection, which is exploited in the retrosynthetic analysis shown in Figure 4-
1. We envisioned that a step-wise coupling and cyclization process would proceed in 
higher overall yield when compared to the classical coupling strategy and, more 
importantly, would yield fewer byproducts in the final step. Thus, isolation and 
purification could be carried out using standard flash chromatography techniques 
amenable to gram-scale operations. In pursuit of this synthetic strategy, it was necessary 
to examine methods for synthesizing the diaryl ether in a versatile and robust fashion.  
Here, we report a novel and scalable synthetic approach to the assembly of the 
widely used oxazine and xanthene fluorophores via a diaryl-ether intermediate (Fig. 4-1). 
Taking advantage of recent developments in transition metal catalysis, we constructed 
electronically activated diaryl ethers to serve as tethered nucleophiles, reacting with a 
range of substrates to undergo cyclization to cationic fluorescent compounds (Fig. 4-1, 
our work). Final products were provided in good overall yields, were amenable to 
purification using standard silica-based normal phase flash chromatography, and, 
significantly, could be prepared on the gram scale. 
4.2  Results 
4.2.1  Assembly of diaryl ethers by Cu(I)-mediated coupling chemistry  
In addition to the more traditional dihydroquinoline and tetrahydroquinoline 
derivatives, we also chose to explore an indoline-based scaffold to study this synthetic 
sequence. The precursor indoles provide a large number of building blocks from which to 
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start, and we were also interested in the photophysical properties of the resulting oxazine 
products, which are not well described for the indoline class. Preparation of the indoline 
coupling partners proved to be straightforward by Gribble reduction and alkylation of the 
commercially available indole starting materials (Fig. 4-2)18. 
 
 
Figure 4-2. Preparation of hydroxyindolines and iodoindolines for coupling reactions. 
Conditions: (a) NaI, CuI (5-10 mol %), N,N’-dimethylethylenediamine (10-20 mol %), 1,4-
dioxane, 110 oC, 22 hrs. (b) NaBH3CN, AcOH, RT. (c) NaBH4, AcOH, RT. (d) Alkyl halide, 
base, heat (see 4-2d and 4-2e). 
 
The Ullmann ether synthesis poses a potential route to the diaryl ether structural 
motif by copper(I) promoted reaction between phenols and aryl halides19. Although 
attractive in theory, the classical reaction conditions typically employ strong base, 
stoichiometric quantities of copper, and heating at temperatures in excess of 200 ˚C. 
Additionally, the reaction is known to be highly substrate dependent and, when 
successful, commonly results in only modest yields. To overcome these limitations and 
eliminate the harsh reaction conditions, we chose to explore a more contemporary 




























its corresponding triflate 4-S8 unexpectedly proceeded predominantly in a Heck-type 
manner from reaction at C-5 of the indoline, producing the biaryl phenol derivative 4-S9 
as the major product (Fig. 4-3). Thus, the palladium catalyzed coupling reaction does not 
appear to be a useful method for synthesizing diaryl ethers when electron rich carbon 
nucleophiles, such as those that exist in our system, are present. 
 
 
Figure 4-3. Palladium catalyzed coupling of electron rich phenols and aryl triflates. Conditions: 
1.2 eq. phenol, 2 mol% Pd(OAc)2, 3 mol% 2-(di-tert-butylphosphino)biphenyl, 2 eq. K3PO4, 
toluene, 110 ˚C.  
 
We next turned to recent developments in ligand-assisted copper catalyzed 
coupling reactions21. Based on work reported by Buchwald and coworkers, we found that 
the coupling between phenol 4-1b and 3-iodoaniline (4-2a) provided the diaryl ether 4-3b 
in 82% yield when carried out in the presence of catalytic copper iodide (10 mol %) and 
2-picolinic acid (20 mol %) at 85 ˚C in DMSO (Table 4-1, entry 2). This catalytic system 
offers the advantage of orthogonality with the aniline functional group. As opposed to 
aryl iodides, aryl bromides were found to be very poor substrates in our system, with 
nearly no product formation observed even at elevated temperatures (180 ˚C) and 
increased catalyst loadings (50 mol %). Nonetheless, aryl iodides were readily prepared 
from the corresponding commercially available aryl bromides by employing a copper 














Table 4-1. Diaryl ethers by copper(I) catalyzed couplings of phenols and aryl iodides.[a] 
 












































[a] Conditions: 1.2 eq. phenol, 10 mol % copper(I) iodide, 20 mol % 2-picolinic acid, 2.0 





































Couplings carried out according to the aforementioned conditions provided a 
range of substituted diaryl ethers in good yields (Table 4-1). Following these coupling 
reactions, anilines 4-3a and 4-3b were transformed to their dihydroquinoline derivatives 




Figure 4-4. Modified Skraup reactions to prepare dihydroquinolines. Conditions: (a) 0.25 eq. 
TsOH, acetone, RT, 48 hrs. (b) 0.5 eq. TsoH, 2,2-dimethoxypropane, RT, 5 days.  
 
4.2.2  Synthesis of oxazine fluorophores 
Having established a reliable means of synthesizing the critical diaryl ether 
intermediates, we next explored conditions for converting these compounds to their 
corresponding oxazine dyes. This transformation was readily accomplished by reaction 
of diaryl ether 4-3d with one equivalent of 4-nitrobenzene diazonium tetrafluoroborate, 
followed by heating the corresponding diazene 4-4d with p-toluenesulfonic acid (TsOH) 
to 65 ˚C in ethanol (Fig. 4-5). The latter process proceeded with near-quantitative 
conversion and following trivial silica based flash chromatography to remove the 
























Figure 4-5. Reaction sequence for preparing oxazines from diaryl ethers.   
 
Through implementing this strategy, several substituted oxazine dyes with various 
spectroscopic properties were synthesized in good to excellent yields from the 
corresponding diazene compounds (Table 4-2). Of note, over one gram of oxazine 4-6f 
was prepared by this method in 94% yield, demonstrating the scalability of our approach 
(Table 4-2, entry 6). Additionally, 4-6g, the sulfonated analog of 4-6c resembling 
commercially available ATTO-655 was synthesized in good yield by this method. 
Table 4-2. Synthesis of substituted oxazine dyes.[a] 
 














































































































[a] Conditions: 3.0 eq TsOH, EtOH, 65 ˚C, 4-8 hrs. [b] Ar = p-NO2Ph. [c] Diazenes were 
obtained and used as regioisomeric mixtures, which cyclize to a single oxazine product. [d] 
Reaction conducted on the gram-scale. 
4.2.3  Synthesis of rosamine fluorophores by tandem Friedel-Crafts 
acylation/cyclization  
 To further expand the scope of this methodology, we examined other popular 
fluorescent dyes for similar diaryl ether disconnections and identified xanthene dyes, 
















































method for synthesizing these aminoxanthenes calls for heating two equivalents of an 
aminophenol with one equivalent of a carboxylic acid anhydride or aldehyde under acidic 
conditions (ZnCl2 or H2SO4) often at high temperatures (Fig. 4-1, prior works)15. When 
this strategy is employed with derivatized analogs, the reactions typically result in modest 
to poor yields and make isolation of the product difficult by conventional purification 
methods23. We sought to prepare these fluorescent dyes from our diaryl ethers in an 
analogous manner to the synthesis of the oxazine dyes. After screening several Lewis 
acid catalysts and reaction conditions, we found that Ga(OTf)3 catalyzed the tandem 
Friedel-Crafts acylation-cyclization reaction between the aforementioned diaryl ethers 
and aromatic acid chlorides to provide the corresponding xanthene dyes in modest to 
good yields with substantial recoverable starting material (Table 4-3)24–26. 
Supplementing the reaction with additional Ga(OTf)3 did not lead to further 
product formation, suggesting that a byproduct formed in the course of the reaction was 
inhibiting forward progression. Possibly, this was due to substrate inactivation by HCl, 
which is generated in the course of the Friedel-Crafts acylation and by hydrolysis of the 
acid chloride with water generated in the cyclization step. Interestingly, in the case of the 
p-Me2N derivative (Table 4-3, entry 3), nearly full consumption of starting material was 
observed, suggesting that the dimethylamino group may be capable of buffering the 
reaction to allow for increased conversion. Higher conversions of starting material could 
be obtained by re-subjecting the crude product mixture (following workup) to the initial 







Table 4-3. Tandem catalytic Friedel-Crafts acylation/cylization reaction for the synthesis 






























































[a] Conditions: 8 eq acid chloride, 15 mol % Ga(OTf)3, MeNO2, 60˚C, 4Å mol sieves, 16 hrs. [b] 
B.R.S.M = % yield based on recovered starting material. [c] No Lewis acid catalyst required, 2.2 
eq of TFAA in DCM at RT for 12 hrs. [d] 5 eq of the acid chloride was used. [e] Reaction 








MeNO2, 60 ˚C, 















































Of note, this synthetic strategy allows for the synthesis of asymmetrically 
functionalized xanthene dyes, which are not accessible by the classical coupling strategy. 
Additionally, several dyes were prepared in significantly higher yields when compared to 
traditional syntheses. For example, compound 4-7b, an asymmetric xanthene, was 
synthesized in 83% yield simply by reaction of the diaryl ether with 2.2 equivalents of 
trifluoroacetic anhydride at room temperature without a Lewis acid catalyst. By 
comparison, rhodamine 700, a similar dye possessing the trifluoromethyl substituent at 
the meso carbon, is reported to be prepared in only 5% yield from aminophenols27. 
Although this current work is limited to the synthesis of rosamines with fully substituted 
anilines, it may be possible to synthesize mono- or non-alkylated analogs by minor 
modification of this synthetic approach. 
 
4.2.4  Photophysical characterization of oxazine and rosamine fluorophores  
Figure 4-6 shows the absorption and fluorescence spectra for several of the 
oxazine and xanthene dyes synthesized. Notably, the increased conjugation of oxazines 
4-6a and 4-6b results in significant red-shifts in the absorption and fluorescence spectra. 
Similarly, xanthenes 4-7b, 4-7e and 4-7f possessing electron withdrawing side chains 
also display red-shifted spectra. The dimethylamino-substituted rosamine 4-7c displays 
pH dependent fluorescence, with a near 30-fold increase in fluorescence intensity in 
acidic conditions (data not shown). Spectral properties of the dyes in aqueous solution are 






Figure 4-6. Spectral characterization of synthesized fluorophores. (a) Absorbance and (b) 
fluorescence spectra of various oxazine and xanthene derivatives. Spectra were obtained in H2O, 
with the exception of 4-7c, which was obtained in aqueous 50 mM HCl. 
 
Table 4-4. Spectral properties of fluorescent dyes in H2O.[a] 
Dye lmax abs (nm) emax (M-1cm-1) lfluor (nm) Fwhm[b] (nm) Ff 
4-6a 703 50,000 717 42 0.08 
4-6b 682 69,000 696 44 0.09 
4-6c 664 67,000 681 45 0.24 
4-6d 648 66,000 661 43 0.11 
4-6g 663 97,000 677 43 0.20 
4-7a 553 58,000 576 49 0.19 
4-7b 616 61,000 643 90 0.08 
4-7c 559 79,000 585 53 0.14 
4-7d 555 60,000 575 47 0.21 
4-7e 579 68,000 602 44 0.27 
4-7f 581 57,000 600 42 0.24 
[a] Measurements were made in H2O, with the exception of 4-7c, which was measured in aqueous 





4.3  Discussion  
In summary, we have established a high-yielding, scalable synthetic route for the 
preparation of the widely used oxazine and xanthene based fluorescent dyes using diaryl 
ether intermediates. Compared to previously existing synthetic methodologies, our work 
provides a versatile means for preparing these fluorescent dyes and eliminates the need 
for tedious and expensive purifications. Following this synthetic approach, a number of 
oxazine and xanthene fluorophores were synthesized and characterized. With proper 
synthetic planning, we believe this to be a general and widely applicable approach to the 
synthesis of derivatives of oxazine and xanthene dyes, and may facilitate the 
development of novel fluorophores and probes with unique properties. 
 
4.4  Experimental Methods 
General Experimental Methods 
All reactions were carried out under an argon atmosphere. Anhydrous 1,4-dioxane, 
dimethylsulfoxide, tetrahydrofuran, acetonitrile and dichloromethane were purchased as 
Sure Seal™ bottles from Sigma-Aldridge. Potassium phosphate tribasic was purchased 
from Sigma-Aldrich and ground to a fine powder just prior to use. Sodium iodide powder 
was purchased from Alfa Aesar and ground to a fine powder just prior to use. Copper(I) 
iodide (99.999%) powder was purchased from Sigma-Aldrich. 6-hydroxyindole and 6-
bromoindole were purchased from Chem-Impex International. Gallium(III) 
trifluoromethanesulfonate was obtained from Acros. All other reagents were 
commercially available and used without further purification. Flash chromatography was 
performed using a Teledyne ISCO CombiFlash Rf system. NMR spectra were recorded 
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on Bruker DRX-300 and DRX-400 instruments. The following abbreviations were used 
to describe multiplicities: s = singlet; d = doublet; t = triplet; q = quartet; m = multiplet; 
br = broad. High-resolution mass spectrometry (HRMS) was performed by the Columbia 
University Mass Spectroscopy Core Facility with a JOEL HX110 mass spectrometer by 
means of fast atom bombardment (FAB). Absorbance measurements and spectra were 
obtained with a Tecan Infinite 200 and fluorescence measurements and spectra were 
obtained with a Horiba Scientific Fluorolog-3 spectrofluorometer. Measurements were 
performed in quartz cuvettes with a 1-cm path length using solutions with absorbance 
under 0.1 to prevent inner filter and other non-linear effects. 
 
General procedure for the Copper(I) promoted coupling of phenols and aryl iodides.  
According to the published protocol by Maiti and Buchwald21, an oven dried, sealable 
glass vessel was charged with a magnetic stirbar, the phenol (2.40 mmol), potassium 
phosphate (4.00 mmol, 849 mg), copper(I) iodide (0.20 mmol, 38 mg), 2-picolinic acid 
(0.40 mmol, 49 mg), and the aryl iodide, if a solid (2.00 mmol). The vessel was then 
fitted with a rubber septum, evacuated under vacuum and backfilled with argon. This 
process was repeated 3 times. The vessel was then charged with DMSO (4.0 mL), or if 
the aryl iodide is a liquid, the vessel was charged with the aryl iodide as a solution in 
DMSO. The rubber septum was removed and the reaction vessel was immediately sealed 
tightly with a Teflon screw cap. The reaction was then heated to 85 ˚C for 16-24 hours. 
After cooling to room temperature, the reaction was diluted with 10 mL of water and 
extracted with ethyl acetate (25 mL, 4x). The combined organic layers were washed with 
brine and dried over Na2SO4, then concentrated in vacuo to a crude residue. Purification 
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by flash chromatography (hexanes/ethyl acetate) afforded the diaryl ethers as colorless 
oils, which were stored at -20 ˚C under inert atmosphere (these compounds become 
colored upon prolonged exposure to air at room temperature or storage as a solution in a 
halogenated solvent, such as chloroform). 
General procedure for the reaction of diarly ethers with p-nitrobenzenediazonium 
tetrafluoroborate.  
The diarly ether (1.00 mmol) was dissolved in methanol or ethanol (2 mL), cooled to 0 ˚C 
in an ice bath, then treated with aqueous 2N HCl (5 mL). After sufficient time to cool, the 
reaction was treated with p-nitrobenzenediazonium tetrafluoroborate (1.00 mmol) in 5 
mg portions over 5 minutes, then stirred at 0 ˚C for 1 hour. The reaction was then diluted 
with dichloromethane (10 mL), quenched by the slow addition of saturated aq. NaHCO3 
and extracted with dichloromethane (3 x 20 mL). The combined organic layers were 
dried over Na2SO4 and concentrated in vacuo to a deep red-purple residue. Flash 
chromatography (10-30% ethyl acetate/hexanes) provided the diazene as a mixture of 
regioisomers in the case of asymmetrical diaryl ether starting materials (both of which 
transform to the same oxazine product upon cyclization). Full characterization of diazene 
4-4d is provided.  
 
General procedure for cyclization of diazene-diaryl ethers to oxazines 
The diazene diaryl ether (0.2 mmol) was dissolved in anhydrous ethanol (20 mL) and 
treated with p-toluenesulfonic acid monohydrate (0.6 mmol). The deep red reaction 
mixture was heated to 65 ˚C – 70 ˚C, becoming deep blue after a short period of heating. 
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The reaction was monitored by TLC (8% MeOH/DCM) and continued until complete 
conversion of starting material to the product (typically ~4-8 hrs). After cooling to room 
temperature, the reaction was treated with 4% NaHCO3 and extracted with 
dichloromethane (3 x 25 mL). The combined organics were dried over anhydrous 
Na2SO4, and then concentrated to a crude blue-red residue. Products were purified by 
flash chromatography (silica gel) using a gradient of 0-10% MeOH/DCM.  
 
General procedure for the Ga(OTf)3 catalyzed tandem Friedel-Crafts 
acylation/cyclization.  
A small roundbottom flask or sealable vial was purged with argon and charged with a 
magnetic stirbar, activated 4 Å molecular sieves, the diaryl ether (0.50 mmol), anhydrous 
nitromethane (0.80 mL), the acid chloride (4.0 mmol for 4-7a, 4-7d, 4-7e; 2.5 mmol for 
4-7c, 4-7f), and gallium triflate (0.075 mmol). The reaction was heated to 60 ˚C for 16 
hours. After cooling to RT, the reaction was diluted with dichloromethane (25 mL) and 
4% aq. NaHCO3 (30 mL) and extracted with dichloromethane (3 x 25 mL). The 
combined organic layers were dried over anhydrous Na2SO4 and then concentrated to 
crude darkly colored residues. Products were purified by flash chromatography (silica 
gel) using a gradient of 0-10% MeOH/DCM. 
 
Dye Characterization:  
All dyes were HPLC purified (C18 semi-prep, MeCN/H2O) prior to characterization. 
Measurements were performed in DI water with the exception of 4-7c, which required 50 
mM HCl for fluorescence. Molar extinction coefficients were determined using the Beer-
!
! 134 
Lambert law by measuring the absorbance of known concentrations of dye solution. 
Fluorescence quantum yields were determined using the comparative method28,29. In 
brief, fluorescence emission was compared to that of a quantum yield reference solution 
under the same excitation and collection conditions.  
 
 
1,2,3,4-tetrahydroquinolin-7-ol (4-S1). 7-hydroxy-3,4-dihydroquinolin-2(1H)-one (4.90 g, 30.0 
mmol) in a slurry of THF (125 mL) was cooled in an ice bath and treated with lithium aluminum 
hydride (1.82 g, 1.60 mmol). After complete addition, the reaction was heated to reflux overnight. 
Upon cooling to room temperature, the reaction was quenched by the addition of aqueous 
saturated ammonium chloride (50 mL) and extracted with ethyl acetate (3 x 40 mL). The 
combined organic layers were washed with brine and dried over anhydrous Na2SO4, then 
concentrated to provide 4-S1 in 4.34 g as an orange solid (98%). This compound has been 
previously characterized17. 1H NMR (400 MHz, CDCl3) δ 6.81 (d, J = 8.1 Hz, 1H), 6.12 (dd, J = 
8.1, 2.5 Hz, 1H), 6.01 (d, J = 2.4 Hz, 1H), 3.46 (s, 1H), 3.29 (t, J = 5.7, 2H), 2.70 (t, J = 6.4 Hz, 
2H), 1.93 (td, J = 11.4, 6.3 Hz, 2H). 
 
1-ethyl-1,2,3,4-tetrahydroquinolin-7-ol (4-1b). A solution of 4-S1 (1.00 g, 6.70 mmol) in 
glacial acetic acid (25 mL) was treated with sodium borohydride (1.01 g, 26.8 mmol). After 
stirring at room temperature for 2 hours, a TLC of the reaction indicated approximately 50% 
consumption of starting material. At this time, acetaldehyde was added in small portions (reaction 
TLC’d after each addition) until consumption of starting material was achieved. The reaction was 
then concentrated under reduced pressure to a thick residue, which was diluted with 60 mL of 
saturated aqueous NaHCO3 and neutralized with solid NaHCO3. The resulting solution was 
extracted with ethyl acetate (3 x 35 mL). The combined organic layers were washed with brine 
(30 mL) and dried over anhydrous Na2SO4, then concentrated to a crude orange oil. Purification 






orange crystalline solid. 1H NMR (400 MHz, CDCl3) δ 6.82 (d, J = 8.0 Hz, 1H), 6.24 (s, 1H), 
6.12 (d, J = 8.0 Hz, 1H), 3.33 (q, J = 7.1 Hz, 2H), 3.28 (t, J = 5.7 Hz, 2H), 2.70 (t, J = 6.4 Hz, 
2H), 2.02 – 1.91 (m, 2H), 1.18 (t, J = 7.1 Hz, 3H). 13C NMR (300 MHz, CDCl3) δ 155.41, 146.33, 
130.27, 115.73, 103.21, 98.89, 48.64, 45.92, 27.80, 22.84, 10.94.  HRMS (FAB) Calcd for 
C11H15NO+ [M]+: 177.1154; found 177.1162. 
 
1-ethylindolin-6-ol (4-1c). 6-hydroxyindole (2.66 g, 20.0 mmol) was dissolved in glacial acetic 
acid (65 mL) and treated with sodium borohydride (3.78 g, 100 mmol) in small portions at room 
temperature. After 4 hours, the reaction was concentrated in vacuo to a thick residue, which was 
then diluted with 60 mL of saturated aqueous NaHCO3 and neutralized with solid NaHCO3. The 
resulting solution was extracted with ethyl acetate (35 mL, 3x). The combined organic layers 
were washed with brine (30 mL) and dried over anhydrous Na2SO4, then concentrated in vacuo 
and dried under high vacuum to provide an orange crude solid. Purification by flash 
chromatography (5-20% ethyl acetate/hexanes) provided 2.09 g (64%) of 4-1c as a tan solid. 1H 
NMR (400 MHz, CDCl3) δ 6.90 (d, J = 7.8 Hz, 1H), 6.10 (dd, J = 7.8, 2.1 Hz, 1H), 6.02 (d, J = 
2.1 Hz, 1H), 4.87 (br s, 1H), 3.37 (t, J = 8.2 Hz, 2H), 3.12 (q, J = 7.2 Hz, 2H), 2.90 (t, J = 8.2 Hz, 
2H), 1.20 (t, J = 7.2 Hz, 3H). 13C NMR (75 MHz, CDCl3) δ 156.28, 153.81, 125.12, 122.92, 
104.95, 96.93, 53.32, 43.78, 28.14, 11.98. HRMS Calcd. for C10H13NO+ [M+]: 163.0997; found 
163.1007. 
 
6-iodoindole (4-S2). According to the published protocol by Klapars and Buchwald22, an oven 
dried, sealable glass tube was charged with a magnetic stirbar, 6-bromoindole (4.94 g, 25.2 
mmol), freshly ground sodium iodide (7.55 g, 50.4 mmol), and copper(I) iodide (480 mg, 2.52 
mmol). The vessel was then fitted with a rubber septum, evacuated under vacuum and backfilled 
with argon. This process was repeated three times. The vessel was then charged with 1,4-dioxane 
(25 mL) followed by N,N’-dimethylethylenediamine (0.58 mL, 5.40 mmol) via syringe. The 
rubber septum was removed and the reaction vessel immediately sealed tightly with a Teflon 







diluted with saturated aqueous NH4Cl (30 mL) and extracted with dichloromethane (4 x 25 mL). 
The combined organic layers were washed with brine (30 mL) and dried over Na2SO4, then 
concentrated to a brown residue. The residue was triturated in hexanes and concentrated to 
provide 4-S2 (5.87 g, 99%) as a brown crystalline solid. This compound has been previously 
characterized30. 1H NMR (400 MHz, CDCl3) δ 8.18 (br s, 1H), 7.80 (s, 1H), 7.43 (s, 2H), 7.21 – 
7.13 (t, J = 2.8 Hz, 2H), 6.56 (t, J = 2.2 Hz, 1H). 
 
 
6-iodoindoline (4-2b). 4-S2 (5.86 g, 24.1 mmol) was dissolved in glacial acetic acid (100 mL) 
and cooled in an ice bath just until the solution began to become partially frozen. At this point, 
the solution was treated portion-wise with sodium cyanoborohydride (4.52 g, 72.3 mmol), then 
allowed to warm to room temperature and stir for 3 hours. The reaction mixture was concentrated 
to a thick residue, then diluted with 50 mL of saturated aqueous NaHCO3. The resulting solution 
was extracted with ethyl acetate (3 x 40 mL). The combined organic layers were washed with 
saturated aqueous NaHCO3 (30 mL) and brine (30 mL), then dried over anhydrous Na2SO4 and 
concentrated to a brown residue. Purification by flash chromatography (0-15% ethyl 
acetate/hexanes) afforded 4-2b (4.78 g, 81%) as a white crystalline solid. This compound has 
been previously characterized30. 1H NMR (400 MHz, CDCl3) δ 7.10-6.95 (m, 2H), 6.87 (d, J = 
7.5 Hz, 1H), 3.59 (td, J = 8.4, 2.9 Hz, 2H), 3.01 (t, J = 8.4 Hz, 2H). 
 
1-ethyl-6-iodoindoline (4-2c). 4-S2 (729 mg, 3.00 mmol) was dissolved in glacial acetic acid (15 
mL) and treated with sodium borohydride (681 mg, 18.0 mmol) in small portions at room 
temperature. After stirring for 1 hour, the reaction was treated with sodium cyanoborohydride 
(377 mg, 6.00 mmol). The reaction was concentrated in vacuo to a thick residue, which was then 
diluted with 25 mL of saturated aqueous NaHCO3. The resulting solution was extracted with 
ethyl acetate (25 mL, 3x). The combined organic layers were washed with saturated aqueous 







brown residue. Purification by flash chromatography (0-10% ethyl acetate/hexanes) afforded 4-2c 
(590 mg, 76%) as a light yellow oil. 1H NMR (400 MHz, CDCl3) δ 6.97 (dd, J = 7.6, 1.1 Hz, 1H), 
6.80 (d, J = 7.6 Hz, 1H), 6.78 (s, 1H), 3.38 (t, J = 8.2 Hz, 2H), 3.14 (q, J = 7.2 Hz, 2H), 2.93 (t, J 
= 8.2 Hz, 2H), 1.19 (t, J = 7.2 Hz, 3H). 13C NMR (300 MHz, CDCl3) δ 154.13, 130.53, 126.44, 
126.27, 116.06, 92.76, 52.52, 42.98, 28.49, 12.15. HRMS (FAB) Calcd for C10H12IN+ [M]+: 
273.0014; found 273.0011.  
 
1-azido-4-iodobutane. Prepared according to the published protocol31. 
 
1-(4-azidobutyl)-6-iodoindoline (4-2d). 4-2b (294 mg, 1.20 mmol) was dissolved in DMF and 
treated with 1-azido-4-iodobutane (405 mg, 1.80 mmol) and sodium carbonate (382 mg, 3.60 
mmol). The reaction was heated to 60 ˚C for 8 hours. After cooling to room temperature, the 
reaction was diluted with water (25 mL) and extracted with ethyl acetate (3 x 25 mL). The 
combined organic layers were washed with brine (30 mL) and dried over anhydrous Na2SO4, then 
concentrated to a light brown oil. Purification by flash chromatography (0-5% ethyl 
acetate/hexanes) provided 326 mg (80%) of 4-2d as a colorless oil. 1H NMR (400 MHz, CDCl3) δ 
6.98 (dd, J = 7.6, 1.5 Hz, 1H), 6.81 (d, J = 7.6 Hz, 1H), 6.76 (d, J = 1.4 Hz, 1H), 3.49 – 3.29 (m, 
4H), 3.08 (t, J = 6.8 Hz, 2H), 2.95 (t, J = 8.2 Hz, 2H), 1.77 – 1.65 (m, 4H). 13C NMR (75 MHz, 
CDCl3) δ 154.39, 130.26, 126.58, 126.37, 115.77, 92.81, 53.39, 51.70, 48.71, 28.57, 27.01, 25.02. 
HRMS (FAB) Calcd. For C12H15IN4+ [M+]: 342.0341; found 342.0328. 
 
ethyl 5-(6-iodoindolin-1-yl)pentanoate (4-2e). 4-2b (2.29 g, 9.34 mmol) was dissolved in DMF 
(15 mL) and treated with diisopropylethylamine (2.44 mL, 14.0 mmol), ethyl 5-bromovalerate 








˚C for 12 hours. After cooling to room temperature, the reaction was diluted with water (30 mL) 
and concentrated aqueous NH4Cl (10 mL), then extracted with ethyl acetate (3 x 30 mL). The 
combined organic layers were dried over anhydrous Na2SO4 and concentrated to a crude brown 
oil. Purification by flash chromatography (0-10% ethyl acetate/hexanes) provided 4-2e (3.10 g, 
89%) as a beige oil. 1H NMR (400 MHz, CDCl3) δ 6.95 (dd, J = 7.6, 1.5 Hz, 1H), 6.79 (d, J = 7.6 
Hz, 1H), 6.74 (d, J = 1.3 Hz, 1H), 4.17 (q, J = 7.1 Hz, 2H), 3.38 (t, J = 8.3 Hz, 2H), 3.06 (t, J = 
7.2 Hz, 2H), 2.93 (t, J = 8.3 Hz, 2H), 2.39 (t, J = 7.2 Hz, 2H), 1.79 – 1.70 (m, 2H), 1.69-1.60 (m, 
2H), 1.30 (t, J = 7.1 Hz, 3H). 13C NMR (300 MHz, CDCl3) δ 173.79, 154.36, 130.26, 126.48, 
126.27, 115.81, 92.74, 60.72, 53.32, 48.80, 34.42, 28.52, 27.08, 22.96, 14.68. HRMS (FAB) 
Calcd. For C15H20INO2+ [M+]: 373.0539; found 373.0553. 
 
 
1,1'-diethyl-[5,6'-biindolin]-6-ol (4-S9). An oven dried sealable tube was purged with argon then 
charged with 4-1c (163 mg, 1.00 mmol), palladium acetate (4 mg, 2.0 mol %), 2-(di-
tert0butylphosphino)biphenyl (8 mg, 3.0 mol %), finely ground potassium phosphate (355 mg, 
1.67 mmol), and a solution of 4-1c-triflate (246 mg, 0.833 mmol) in anhydrous toluene (3 mL). 
The reaction was sealed and heated to 100 ˚C for 16 hours. After cooling, the reaction was 
filtered through celite, concentrated, and the major product 4-S9 purified by flash 
chromatography and isolated as a colorless oil (138 mg, 54%). The structure was confirmed by 
1H NMR and mass spectrometry. The 1H NMR in CDCl3 shows an asymmetrical product with the 
expected multiplicities for the aromatic protons (3 singlets, 2 doublets). An additional singlet was 
present at 6.50 ppm (phenol –OH). The corresponding singlet is not present in the spectrum when 
obtained in MeOD. Mass spectrometry (ESI) showed a correct mass of 309.5 (M+1).  1H NMR 
(400 MHz, CDCl3) δ 7.15 (d, J = 7.3 Hz, 1H), 6.97 (s, 1H), 6.69 (d, J = 7.1 Hz, 1H), 6.50 (s, 1H), 
6.18 (s, 1H), 5.55 (s, 1H), 3.47-3.37 (m, 4H), 3.24 – 3.14 (m, 4H), 3.02 (t, J = 8.2 Hz, 2H), 2.95 
(t, J = 8.1 Hz, 2H), 1.27-1.18 (m, 6H). 1H NMR (400 MHz, MeOD) δ 7.05 (d, J = 7.5 Hz, 1H), 
6.93 (s, 1H), 6.78 (d, J = 7.5, 1H), 6.71 (s, 1H), 6.13 (s, 1H), 3.30 (td, J = 8.1, 1.8 Hz, 4H), 3.12 







3,3'-oxydianiline (4-3a). Following the general procedure, 3-aminophenol (4-1a, 1.32 g, 12.0 
mmol) and 3-iodoaniline (4-2a, 2.18 g, 10.0 mmol) were coupled to provide 4-3a (1.80 g, 90%) 
as a dense tan crystalline solid. This compound has been previously characterized21. 1H NMR 
(400 MHz, CDCl3) δ 7.08 (t, J = 8.0 Hz, 2H), 6.42 (m, 4H), 6.34 (s, 2H), 3.67 (br s, 4H). 
 
3-(1-ethyl-1,2,3,4-tetrahydroquinolin-7-yloxy)aniline (4-3b). Following the general procedure, 
phenol 4-1b (1.20 g, 12.0 mmol) and 3-iodoaniline (4-2a, 1.23 g, 10.0 mmol) were coupled to 
provide 4-3b (1.24 g, 82%) as a colorless oil. 1H NMR (400 MHz, CDCl3) δ 7.13 (t, J = 8.0 Hz, 
1H), 6.94 (d, J = 8.0 Hz, 1H), 6.49 (ddd, J = 8.2, 2.2, 0.9 Hz, 1H), 6.44-6.38 (m, 3H), 6.29 (dd, J 
= 8.0, 2.2 Hz, 1H), 3.70 (s, 2H), 3.39-3.29 (m, 4H), 2.80 (t, J = 6.4 Hz, 2H), 2.03 (dq, J = 9.0, 6.2 
Hz, 2H), 1.18 (t, J = 7.1 Hz, 3H). 13C NMR (300 MHz, CDCl3) δ 159.72, 156.50, 148.38, 146.53, 
130.54, 130.12, 118.25, 109.77, 108.63, 106.63, 105.21, 102.69, 48.64, 45.84, 28.05, 22.80, 
11.18. HRMS (FAB+) Calcd. For C17H20N2O+ [M+]: 268.1576; found 268.1583. 
 
1-ethyl-6-(indolin-6-yloxy)indoline (4-3c). Following the general procedure, phenol 4-1c (196 
mg, 1.20 mmol) and aryl iodide 4-2b (245 mg, 1.00 mmol) were coupled to provide 4-3c (251 
mg, 90%) as a colorless oil. 1H NMR (400 MHz, CDCl3) δ 7.05 (d, J = 7.9 Hz, 1H), 7.00 (d, J = 
7.9 Hz, 1H), 6.40 (dd, J = 7.9, 2.2 Hz, 1H), 6.36 (d, J = 2.1 Hz, 1H), 6.31 (dd, J = 7.8, 2.2 Hz, 
1H), 6.23 (d, J = 2.1 Hz, 1H), 4.32 (br s, 1H), 3.61 (t, J = 8.3 Hz, 2H), 3.41 (t, J = 8.3 Hz, 2H), 
3.12 (q, J = 7.2 Hz, 2H), 3.03 (t, J = 8.2 Hz, 2H), 2.96 (t, J = 8.0 Hz, 2H), 1.20 (t, J = 7.2 Hz, 
3H). 13C NMR (300 MHz, CDCl3) δ 158.29, 157.99, 154.12, 153.15, 125.23, 124.91, 109.08, 
108.04, 104.17, 101.00, 99.64, 96.18, 53.19, 48.36, 43.37, 29.53, 28.32, 12.20. HRMS (FAB) 









6,6'-oxybis(1-ethylindoline) (4-3d). Following the general procedure, phenol 4-1c (412 mg, 2.53 
mmol) and aryl iodide 4-2c (575 mg, 2.10 mmol) were coupled to provide 4-3d (520 mg, 80%) as 
a clear colorless oil. 1H NMR (400 MHz, CDCl3) δ 6.98 (d, J = 7.8 Hz, 1H), 6.29 (d, J = 7.8 Hz, 
1H), 6.22 (s, 1H), 3.40 (t, J = 8.2 Hz, 2H), 3.11 (q, J = 7.2 Hz, 2H), 2.95 (t, J = 8.2 Hz, 2), 1.18 (t, 
J = 7.2 Hz, 3H). 13C NMR (75 MHz, CDCl3) δ 158.26, 154.02, 125.10, 124.85, 107.64, 99.27, 
53.17, 43.33, 28.31, 12.19. HRMS (FAB) Calcd. For C20H24N2O+ [M+]: 308.1889; found 
308.1897. 
 
1-(4-azidobutyl)-6-(1-ethylindolin-6-yloxy)indoline (4-3e). Following the general procedure, 
the phenol 4-1c (166 mg, 1.02 mmol) and the aryl iodide 4-2d (290 mg, 0.848 mmol) were 
coupled to provide 4-3e (245 mg, 77%) as a colorless oil. 1H NMR (400 MHz, CDCl3) δ 7.01 (d, 
J = 3.5 Hz, 1H), 6.99 (d, J = 3.5 Hz, 1H), 6.32 (d, J = 2.3 Hz, 1H), 6.30 (t, J = 2.4 Hz, 1H), 6.24 
(d, J = 2.1 Hz, 1H), 6.22 (d, J = 2.1 Hz, 1H), 3.43 (t, J = 8.2 Hz, 4H), 3.39 – 3.33 (m, 2H), 3.14 
(q, J = 7.2 Hz, 2H), 3.10-3.05 (m, 2H), 2.98 (td, J = 8.1, 2.5 Hz, 4H), 1.78 – 1.67 (m, 4H), 1.21 (t, 
J = 7.2 Hz, 3H). 13C NMR (300 MHz, CDCl3) δ 158.36, 158.18, 154.32, 154.05, 125.21, 124.92, 
124.87, 124.72, 107.67, 107.54, 99.32, 98.86, 54.00, 53.17, 51.74, 48.98, 43.33, 28.36, 28.32, 










ethyl 5-(6-(1-ethylindolin-6-yloxy)indolin-1-yl)pentanoate (4-3f). Following the general 
procedure, the phenol 4-1c (1.60 g, 9.77 mmol) and the aryl iodide 4-2e (3.04, 8.14 mmol) were 
coupled to provide 4-3f (2.67 g, 80%) as a colorless oil. 1H NMR (400 MHz, CDCl3) δ 6.98 (d, J 
= 7.8 Hz, 1H), 6.29 (d, J = 7.8 Hz, 1H), 6.22 (s, 1H), 3.40 (t, J = 8.2 Hz, 2H), 3.11 (q, J = 7.2 Hz, 
2H), 2.95 (t, J = 8.2 Hz, 2), 1.18 (t, J = 7.2 Hz, 3H). 13C NMR (75 MHz, CDCl3) δ 173.85, 
158.28, 158.20, 154.34, 125.14, 124.83, 124.77, 107.69, 107.44, 99.33, 98.93, 60.66, 53.94, 
53.15, 49.08, 43.35, 34.48, 28.32, 28.29, 27.16, 23.01, 14.65, 12.15. HRMS (FAB) Calcd. For 
C25H32N2O3+ [M+]: 408.2413; found 408.2408. 
 
7,7'-oxybis(2,2,4-trimethyl-1,2-dihydroquinoline) (4-S3). 4-3a (400 mg, 2.00 mmol) was 
dissolved in 2,2-dimethoxypropane (5 mL) and treated with p-toluenesulfonic acid monohydrate 
(190 mg, 1.00 mmol) and stirred at room temperature for 5 days. The reaction was quenched by 
the addition of 4% aq. NaHCO3 (30 mL) and extracted with ethyl acetate (3 x 25 mL). The 
combined organic layers were washed with brine, dried over anhydrous Na2SO4 and concentrated 
to a crude residue. Purified by flash chromatography to provide 340 mg of 4-S3 as a white 
crystalline solid (47%). 1H NMR (400 MHz, CDCl3) δ 7.03 (d, J = 8.2 Hz, 1H), 6.35 (dd, J = 8.2, 
1.6 Hz, 1H), 6.13 (d, J = 1.6 Hz, 1H), 5.26 (s, 1H), 3.63 (br s, 1H), 2.01 (s, 3H), 1.28 (s, 6H). 13C 
NMR (300 MHz, CDCl3) δ 158.10, 145.01, 128.38, 127.32, 125.10, 117.36, 108.00, 103.55, 
52.39, 31.59, 19.07. HRMS (FAB+) Calcd. For C24H29N2O+ [M+1]: 361.2274; found 361.2280. 
 
diethyl 5,5'-(7,7'-oxybis(2,2,4-trimethylquinoline-7,1(2H)-diyl))dipentanoate (4-S4). A 
solution of 4-S3 (270 mg, 0.75 mmol) in anhydrous acetonitrile (4 mL) was treated with sodium 
iodide (112 mg, 0.75 mmol), sodium carbonate (476 mg, 4.50 mmol), and ethyl 5-bromovalerate 










additional ethyl 2-bromovalerate (0.30 mL, 1.9 mmol) and sodium carbonate (238 mg, 2.25 
mmol). After an additional 24 hours of heating, TLC of the reaction indicated a ~3:1 mixture of 
the desired bis-alkylated product to the mono-alkylated product. The reaction was then quenched 
by the addition of water (30 mL) and extracted with ethyl acetate (3 x 25 mL). The combined 
organic layers were washed with brine and dried over anhydrous Na2SO4 and concentrated to a 
crude residue. Purified by flash chromatography to provide 230 mg of 4-S4 as a colorless oil 
(50%). 1H NMR (400 MHz, CDCl3) δ 6.98 (d, J = 8.3 Hz, 2H), 6.25 (dd, J = 8.3, 2.1 Hz, 2H), 
6.15 (d, J = 2.2 Hz, 2H), 5.17 (d, J = 1.2 Hz, 2H), 4.14 (q, J = 7.1 Hz, 4H), 3.17 (t, J = 7.0 Hz, 
4H), 2.32 (t, J = 6.9 Hz, 4H), 1.97 (d, J = 1.1 Hz, 6H), 1.69 – 1.57 (m, 8H), 1.32 (s, 12H), 1.27 (t, 
J = 7.1 Hz, 6H). 13C NMR (300 MHz, CDCl3) δ 173.75, 158.44, 145.65, 128.10, 127.83, 124.81, 
118.69, 105.63, 102.00, 60.65, 57.26, 44.25, 34.46, 28.88, 28.29, 22.96, 19.13, 14.64. HRMS 
(FAB+) Calcd. For C38H53N2O5+ [M+1]: 617.3949; found 617.3947. 
 
7-(1-ethyl-1,2,3,4-tetrahydroquinolin-7-yloxy)-2,2,4-trimethyl-1,2-dihydroquinoline (4-S5). 
A solution of 4-3b (1.20 g, 4.47 mmol) in acetone (80 mL) was treated with p-toluenesulfonic 
acid monohydrate (213 mg, 1.12 mmol) and stirred at room temperature for 48 hours. The 
reaction was then concentrated to a residue under reduced pressure, brough up 4% aq. NaHCO3 
(30 mL) and extracted with ethyl acetate (3 x 25 mL). The combined organics were washed with 
brine and dried over anhydrous Na2SO4 and concentrated to a crude residue. Purified by flash 
chromatography to provide 1.17 g of 4-S5 as a white foamy solid (75%). 1H NMR (400 MHz, 
CDCl3) δ 7.03 (d, J = 8.4 Hz, 1H), 6.91 (d, J = 8.0 Hz, 1H), 6.38 (d, J = 2.3 Hz, 1H), 6.35 (dd, J = 
8.4, 2.4 Hz, 1H), 6.27 (dd, J = 8.0, 2.3 Hz, 1H), 6.14 (d, J = 2.4 Hz, 1H), 3.71 (s, 1H), 3.37-3.27 
(m, 4H), 2.77 (t, J = 6.4 Hz, 2H), 2.06 – 1.99 (m, 5H), 1.31 (s, 6H), 1.16 (t, J = 7.1 Hz, 3H). 13C 
NMR (300 MHz, CDCl3) δ 159.07, 156.45, 146.44, 145.01, 130.03, 128.60, 126.92, 125.01, 
118.14, 116.89, 107.08, 106.71, 102.71, 102.65, 52.36, 48.61, 45.81, 31.52, 28.02, 22.78, 19.07, 








yl)pentanoate (4-S6). According to the protocol used to synthesize 4-S4, 4-S5 (1.05 g, 3.00 
mmol) was subjected to alkylation and purified by flash chromatography to yield 845 mg of 4-S6 
as a colorless oil (59%). 1H NMR (400 MHz, CDCl3) δ 6.97 (d, J = 8.3 Hz, 1H), 6.88 (d, J = 8.0 
Hz, 1H), 6.36 (d, J = 2.3 Hz, 1H), 6.25 (dd, J = 4.3, 2.3 Hz, 1H), 6.23 (dd, J = 4.6, 2.3 Hz, 1H), 
6.11 (d, J = 2.2 Hz, 1H), 5.15 (d, J = 1.3 Hz, 1H), 4.16 (q, J = 7.1 Hz, 2H), 3.35 – 3.25 (m, 4H), 
3.15 (t, J = 7.2 Hz, 2H), 2.74 (t, J = 6.3 Hz, 2H), 2.31 (t, J = 7.1 Hz, 2H), 2.03 – 1.93 (m, 2H), 
1.97 (s, 3H) 1.67-1.55 (m, 4H), 1.32 (s, 6H), 1.29 (t, J = 7.1 Hz, 3H), 1.13 (t, J = 7.1 Hz, 3H). 13C 
NMR (300 MHz, CDCl3) δ 173.80, 164.92, 159.31, 156.47, 146.37, 145.54, 129.94, 127.84, 
124.81, 118.14, 118.02, 106.52, 104.81, 102.60, 101.17, 60.66, 57.25, 48.58, 45.78, 44.24, 34.47, 
28.90, 28.28, 27.95, 22.94, 22.75, 19.13, 14.65, 11.13. HRMS (FAB+) Calcd. For C30H41N2O3+ 
[M+1]: 477.3112; found 477.3129. 
 
ethyl-5-(7-(1-ethyl-1,2,3,4-tetrahydroquinolin-7-yloxy)-2,2,4-trimethyl-3,4-dihydroquinolin-
1(2H)-yl)pentanoate (4-S7). A round bottom flask charged with a magnetic stirbar, 4-S6 (185 
mg, 0.39 mmol) and ethyl acetate (6 mL) was evacuated under vacuum and backfilled with argon 
gas. This process was repeated three times. The vessel was then charged with 10% palladium on 
carbon (41 mg, 0.039 mmol), evacuated with vacuum, and backfilled with hydrogen gas. This 
process was repeated five times, then the reaction left to stir overnight under an atmosphere of 
hydrogen gas (balloon). The next morning, the reaction was filtered through a pad of celite and 
concentrated under reduced pressure to provide 180 mg of 4-S7 as a colorless oil (97%). 1H NMR 







8.3 Hz, 1H), 6.28 (d, J = 8.0, 1H), 6.21 (s, 1H), 4.20 (q, J = 7.1 Hz, 2H), 3.40 – 3.25 (m, 5H), 
3.08 - 2.97 (m, 1H), 2.95 – 2.84 (m, 1H), 2.77 (t, J = 6.2 Hz, 2H), 2.35 (m, 2H), 2.05 – 1.97 (m, 
2H), 1.77 (dd, J = 12.9, 4.5 Hz, 1H), 1.70 - 1.54 (m, 5H), 1.43 – 1.28 (m, 9H), 1.23 (s, 3H), 1.17 
(t, J = 7.0 Hz, 3H 13C NMR (300 MHz, CDCl3) δ 173.91, 157.88, 156.64, 146.37, 146.30, 129.98, 
126.73, 122.43, 117.89, 106.58, 104.62, 102.75, 101.60, 60.72, 54.84, 48.62, 47.52, 45.82, 45.31, 
34.54, 30.08, 29.01, 28.00, 27.28, 25.50, 22.94, 22.81, 20.56, 14.74, 11.16. HRMS (FAB+) 
Calcd. For C30H42N2O3+ [M+]: 478.3195; found 478.3210. 
 
 (1-(5-ethoxy-5-oxopentyl)-7-(1-ethyl-1,2,3,4-tetrahydroquinolin-7-yloxy)-2,2-dimethyl-1,2-
dihydroquinolin-4-yl)methanesulfonate (4-S8) sodium salt. To a solution of fuming sulfuric 
acid (20% SO3, 1.2 mL) in sulfuric acid (4 mL) cooled in a brine ice bath was added 4-S6 (954 
mg, 2.00 mmol). The mixture was stirred on ice for 30 minutes then allowed to warm to room 
temperature and stir for 12 hours at room temperature. The reaction was then poured into a beaker 
of ice (50 grams) and the resulting solution, cooled in an ice bath, was neutralized to pH 7 with 
10% sodium hydroxide. The precipitated sodium sulfate solids were filtered, and the resulting 
aqueous filtrate was concentrated under reduced pressure to white solids. This material was 
boilded gently in 30 mL of ethanol, filtered, and the solids washed with additional hot ethanol. 
The filtrate was concentrated under reduced pressure and purified by flash chromatography to 
provide 825 mg of 4-S8 as a light pink oil (72%). 1H NMR (400 MHz, MeOD) δ 7.28 (d, J = 8.4 
Hz, 1H), 6.83 (d, J = 8.0 Hz, 1H), 6.27 (d, J = 1.8 Hz, 1H), 6.18 (ddd, J = 14.3, 8.2, 1.9 Hz, 2H), 
5.98 (d, J = 1.7 Hz, 1H), 5.50 (s, 1H), 4.11 (t, J = 7.2 Hz, 2H), 3.88 (s, 2H), 3.25 (m, 4H), 3.10 
(m, 2H), 2.68 (t, J = 6.2 Hz, 2H), 2.24 (t, J = 6.6 Hz, 2H), 1.96 – 1.87 (m, 2H), 1.78 – 1.64 (m, 
2H), 1.64 – 1.56 (m, 2H), 1.33 (s, 6H), 1.25 (t, J = 7.1 Hz, 3H), 1.08 (t, J = 7.0 Hz, 3H). 13C NMR 
(300 MHz, MeOD) δ 176.67, 174.15, 159.61, 156.29, 146.28, 145.58, 132.49, 129.71, 125.84, 
124.63, 118.30, 116.59, 106.86, 104.70, 102.72, 100.70, 67.60, 61.55, 60.52, 57.03, 53.82, 48.28, 
45.34, 43.91, 33.89, 33.62, 32.04, 28.77, 27.89, 27.67, 27.37, 22.56, 22.46, 21.54, 13.74, 10.10. 








Diazene 4-4a. Following the general procedure, 4-S4 (205 mg, 0.332 mmol) was reacted to give 
167 mg of 4-4a as a deep purple residue (66%). 
 
Diazenes 4-4b and 4-5b. Following the general procedure, 4-S6 (185 mg, 0.388 mmol) was 
reacted to give 155 mg of a mixture of 4-4b and 4-5b as a deep purple residue (69%). 
 
Diazenes 4-4c and 4-5c. Following the general procedure, 4-S7 (180 mg, 0.376 mmol) was 
































Diazene 4-4d. Following the general procedure, 4-3d (230 mg, 0.756 mmol) was reacted to give 
270 mg of 4-4d as a deep red/bronze solid (79%). 1H NMR (400 MHz, CDCl3) δ 8.24 (d, J = 9.1 
Hz, 2H), 7.79-7.71 (m, 3H), 7.00 (d, J = 7.6 Hz, 1H), 6.34 (d, J = 7.9 Hz, 1H), 6.30 (s, 1H), 6.06 
(s, 1H), 3.67 (t, J = 8.2 Hz, 2H), 3.42 (t, J = 8.2 Hz, 2H), 3.27 (t, J = 7.1 Hz, 2H), 3.13 (t, J = 7.2 
Hz, 2H), 3.08 (t, J = 8.1 Hz, 2H), 2.97 (t, J = 8.2 Hz, 2H), 1.26-1.14 (m, 6H). 13C NMR (300 
MHz, CDCl3) δ 160.66, 158.73, 158.04, 157.61, 154.21, 146.99, 135.85, 127.05, 125.56, 124.98, 
122.91, 113.32, 107.55, 99.21, 96.07, 53.18, 51.95, 43.28, 41.59, 28.31, 26.97, 12.11. HRMS 
(FAB+) Calcd. For C26H27N5O3+ [M+]: 457.2114; found 457.2131. 
 
Diazenes 4-4e and 4-5e. Following the general procedure, 4-3e (240 mg, 0.636 mmol) was 
reacted to give 237 mg of a mixture of 4-4e and 4-5e as a deep purple film (71%). 
 
Diazenes 4-4f and 4-5f. Following the general procedure, 4-3f (1.42 g, 3.47 mmol) was reacted 






























Diazenes 4-4g and 4-5g. A round bottom flask charged with a magnetic stir-bar, 4-S8 (150 mg, 
0.26 mmol) and methanol (10 mL) was evacuated under vacuum and backfilled with argon gas. 
This process was repeated three times. The vessel was then charged with 10% palladium on 
carbon (30 mg, 0.026 mmol), evacuated with vacuum, and backfilled with hydrogen gas. This 
process was repeated five times, then the reaction left to stir overnight under an atmosphere of 
hydrogen gas (balloon). The next morning, the reaction was filtered through a pad of celite and 
concentrated under reduced pressure to tan oil. The resulting oil was then brought up in methanol 
(2 mL) and cooled in an ice bath for 10 minutes. The solution was then treated with 2N aqueous 
HCl (5 mL, pre-cooled in ice bath) followed by the slow addition of p-nitrobenzenediazonium 
tetrafluoroborate (62 mg, 0.26 mmol). After stirring on ice for 1.5 hours, the reaction was diluted 
with water (20 mL) and extracted directly without neutralization (DCM, 3 x 25 mL). The 
combined organic layers were dried over Na2SO4 and concentrated in vacuo to a deep red-purple 
residue. Flash chromatography (5-30% dichloromethane/methanol) provided the regioisomeric 
mixture of the diazenes 4-4g and 4-5g (115 mg, 63%).  
 
 
Oxazine 4-6a. Following the general procedure, 4-4a (91 mg, 0.119 mmol) was cyclized to 
provide 70 mg of 4-6a as a purple film (74%). 1H NMR (400 MHz, MeOD) δ 7.70 (d, J = 8.1 Hz, 
2H), 7.42 (s, 2H), 7.19 (d, J = 8.0 Hz, 2H), 6.74 (s, 2H), 5.85 (s, 2H), 4.18 (q, J = 7.1 Hz, 4H), 



















= 7.1 Hz, 6H). 13C NMR (300 MHz, MeOD) δ 173.92, 153.45, 149.98, 142.77, 140.44, 135.13, 
134.47, 128.71, 126.69, 125.96, 125.78, 124.72, 96.03, 61.76, 60.58, 33.42, 28.35, 27.41, 22.16, 
20.36, 17.64, 13.66. HRMS (FAB) Calcd. for C38H50N3O5+ [M+]: 628.3745; found 628.3775. 
 
Oxazine 4-6b. Following the general procedure, the mixture of regioisomeric diazenes 4-4b and 
4-5b (140 mg, 0.241 mmol) was cyclized to provide 135 mg of 4-6b as a deep blue film (85%). 
1H NMR (400 MHz, MeOD) δ 7.70 (d, J = 8.0 Hz, 2H), 7.43 (s, 1H), 7.40 (s, 1H), 7.19 (d, J = 8.0 
Hz, 2H), 6.90 (s, 1H), 6.68 (s, 1H), 5.82 (s, 1H), 4.18 (q, J = 7.1 Hz, 2H), 3.80 – 3.64 (m, 6H), 
2.94 (t, J = 5.9 Hz, 2H), 2.48 (br s, 2H), 2.35 (s, 3H), 2.11 (s, 3H), 2.09 – 2.02 (m, 2H), 1.82 (br s, 
4H), 1.58 (s, 6H), 1.37 (t, J = 7.0 Hz, 3H), 1.28 (t, J = 7.1 Hz, 3H). 13C NMR (300 MHz, MeOD) 
δ 173.95, 154.47, 153.30, 149.94, 148.86, 142.75, 140.48, 135.05, 134.19, 130.69, 129.82, 
128.72, 126.26, 125.96, 125.76, 124.74, 95.80, 95.31, 61.59, 60.58, 50.26, 46.16, 33.39, 28.40, 
27.41, 27.35, 22.14, 20.93, 20.35, 17.64, 13.65, 10.79. HRMS (FAB) Calcd. For C30H38N3O3+ 
[M+]: 488.2908; found 488.2897. 
 
Oxazine 4-6c. Following the general procedure, the mixture of regioisomeric diazenes 4-4c and 
4-5c (150 mg, 0.257 mmol) was cyclized to provide 148 mg of 4-6d as a deep blue film (87%). 
1H NMR (400 MHz, MeOD) δ 7.68 (d, J = 8.1 Hz, 2H), 7.50 (s, 1H), 7.41 (s, 1H), 7.15 (d, J = 8.0 
Hz, 2H), 6.88 (s, 1H), 6.66 (s, 1H), 4.17 (q, J = 7.1 Hz, 2H), 3.70 (t, J = 5.6 Hz, 4H), 3.57 – 3.44 
(m, 1H), 2.98 (d, J = 6.5 Hz, 1H), 2.95 – 2.90 (m, 2H), 2.47 (br s, 2H), 2.31 (s, 3H), 2.10 – 1.97 
(m, 3H), 1.79 (br s, 4H), 1.53 (s, 3H), 1.45 (s, 6H), 1.36 (t, J = 6.9 Hz, 3H), 1.28 (t, J = 7.1 Hz, 













135.02, 134.20, 133.45, 130.84, 129.89, 128.68, 128.13, 125.98, 96.56, 95.30, 60.56, 59.25, 
50.34, 46.62, 44.47, 33.44, 28.40, 27.75, 27.40, 27.16, 25.26, 22.27, 20.90, 20.44, 18.49, 13.73, 
10.90. HRMS (FAB) Calcd. For C32H38N3O3+ [M+]: 490.3064; found 490.3079. 
 
 
Oxazine 4-6d. Following the general procedure, diazene 4-4d (108 mg, 0.236 mmol) was 
cyclized to provide 105 mg of 4-6d as a deep blue film (90%). 1H NMR (400 MHz, MeOD) δ 
7.71 (d, J = 8.2 Hz, 2H), 7.40 (s, 2H), 7.22 (d, J = 8.0 Hz, 2H), 6.68 (s, 2H), 4.03 (t, J = 7.2 Hz, 
4H), 3.66 (q, J = 7.3 Hz, 4H), 3.29 (t J = 7.2 Hz, 4H), 2.36 (s, 3H), 1.35 (t, J = 7.3 Hz, 6H). 13C 
NMR (300 MHz, MeOD) δ 159.56, 150.80, 142.51, 140.64, 137.96, 134.66, 128.75, 125.96, 




Oxazine 4-6e. Following the general procedure, the mixture of regioisomeric diazenes 4-4e and 
4-5e (157 mg, 0.298 mmol) was cyclized to provide 130 mg of 4-6e as a dark blue film (78%). 1H 
NMR (400 MHz, MeOD) δ 7.51 – 7.41 (m, 2H), 6.74 (s, 1H), 6.72 (s, 1H), 4.05 (q, J = 6.6 Hz, 
4H), 3.75-3.62 (m, 4H), 3.43 (t, J = 6.6 Hz, 2H), 3.31 (m, 4H), 1.92 – 1.80 (m, 2H), 1.77-1.66 (m, 
2H), 1.36 (t, J = 7.3 Hz, 3H). 13C NMR (300 MHz, CDCl3) δ 159.96, 159.73, 150.99, 150.79, 
138.22, 137.65, 135.03, 134.58, 126.07, 90.55, 90.43, 53.25, 52.78, 51.08, 46.74, 41.94, 26.26, 












Oxazine 4-6f. Following the general procedure, the mixture of regioisomeric diazenes 4-4d and 
4-5d (1.05 g, 1.88 mmol) were cyclized to provide 1.04 g of 4-7f as a metallic red amorphous 
solid (94%). 1H NMR (400 MHz, MeOD) δ 7.69 (d, J = 8.0 Hz, 2H), 7.24 (s, 2H), 7.16 (d, J = 8.0 
Hz, 2H), 6.60 (s, 1H), 6.56 (s, 1H), 4.14 (q, J = 7.1 Hz, 2H), 3.97 (t, J = 6.3 Hz, 4H), 3.63 – 3.51 
(m, 4H), 3.21 (br s, 4H), 2.42 (t, J = 6.9 Hz, 2H), 2.31 (s, 3H), 1.81 – 1.65 (m, 4H), 1.31 (t, J = 
7.2 Hz, 3H), 1.26 (t, J = 7.1 Hz, 3H). 13C NMR (300 MHz, MeOD) δ 173.95, 159.77, 159.43, 
150.48, 150.37, 143.03, 140.38, 138.04, 137.62, 134.61, 134.32, 128.73, 125.98, 90.66, 90.52, 
60.54, 53.29, 52.80, 47.00, 42.04, 33.48, 26.50, 26.18, 26.14, 22.28, 20.41, 13.67, 11.35. HRMS 
(FAB) Calcd. for C25H30N3O3+ [M+]: 420.2282; found 420.2291. 
 
Oxazine 4-6g. Following the general procedure, the mixture of regioisomeric diazenes 4-4g and 
4-5g (102 mg, 0.144 mmol) were cyclized to provide 68 mg of 4-7g as a deep blue residue (83%). 
1H NMR (400 MHz, MeOD) δ 7.69 (s, 1H), 7.41 (s, 1H), 6.92 (s, 1H), 6.64 (s, 1H), 4.18 (q, J = 
7.1 Hz, 2H), 3.74 (m, 5H), 3.60 (dd, J = 14.0, 4.0 Hz, 1H), 3.53 – 3.39 (m, 2H), 3.04-2.91 (m, 
3H), 2.59 (dd, J = 13.6, 4.3 Hz, 1H), 2.47 (m, 2H), 2.12 – 2.02 (m, 2H), 1.86 – 1.68 (m, 5H), 1.54 
(s, 3H), 1.46 (s, 3H), 1.38 (t, J = 7.0 Hz, 3H), 1.28 (t, J = 7.1 Hz, 3H). 13C NMR (300 MHz, 
MeOD) δ 173.92, 155.10, 154.26, 149.14, 147.89, 142.73, 140.50, 135.47, 133.15, 131.29, 
131.07, 130.16, 128.95, 128.72, 125.96, 96.65, 95.36, 60.57, 59.00, 55.06, 50.45, 46.60, 41.84, 
33.42, 30.25, 28.26, 27.77, 27.37, 25.08, 22.27, 20.89, 20.33, 13.65, 10.89. HRMS (FAB+) 














Xanthene 4-7a. Following the general procedure, diaryl ether 4-3d (154 mg, 0.500 mmol) was 
reacted with benzoyl chloride (0.46 mL, 4.0 mmol) to provide 120 mg of 4-7a as a deep purple 
residue (56%) and 55 mg of recovered 4-3d (36%). 1H NMR (400 MHz, MeOD) δ 7.70-7.65 (m, 
3H), 7.45-7.40 (m, 2H), 6.96 (t, J = 1.7 Hz, 2H), 6.72 (s, 2H), 3.92 (t, J = 7.8 Hz, 4H), 3.60 (q, J 
= 7.2 Hz, 4H), 3.15 – 3.08 (m, 4H), 1.33 (t, J = 7.3 Hz, 6H). 13C NMR (300 MHz, MeOD) δ 
159.69, 159.47, 154.79, 134.33, 133.47, 129.89, 129.43, 129.00, 123.22, 114.41, 90.55, 51.93, 
41.27, 26.08, 10.92. HRMS (FAB) Calcd. for C27H27N2O+ [M+]: 395.2118; found 395.2122. 
 
Xanthene 4-7c. Following the general procedure, diaryl ether 4-3d (154 mg, 0.500 mmol) was 
reacted with p-(Me2N)-benzoyl chloride (460 mg, 2.5 mmol) to provide 182 mg of 4-7c as a deep 
red residue (77%). 1H NMR (400 MHz, MeOD) δ 7.30 (d, J = 8.8 Hz, 2H), 7.19 (s, 2H), 7.02 (d, 
J = 8.8 Hz, 2H), 6.64 (s, 2H), 3.89 (t, J = 7.8 Hz, 4H), 3.57 (q, J = 7.2 Hz, 4H), 3.17 – 3.08 (m, 
10H), 1.32 (t, J = 7.2 Hz, 6H). 13C NMR (300 MHz, CDCl3) δ 159.55, 159.12, 151.82, 133.76, 
131.33, 123.76, 121.12, 120.45, 114.34, 112.31, 90.50, 51.82, 41.21, 39.67, 26.16, 10.91. HRMS 









Xanthene 4-7d. Following the general procedure, diaryl ether 4-3d (154 mg, 0.500 mmol) was 
reacted with p-fluorobenzoyl chloride (0.47 mL, 4.0 mmol) to provide 106 mg of 4-7d as a deep 
purple residue (48%) and 63 mg of recovered 4-3d (41%). 1H NMR (400 MHz, MeOD) δ 7.50 – 
7.39 (m, 4H), 6.96 (s, 2H), 6.71 (s, 2H), 3.92 (t, J = 7.8 Hz, 4H), 3.61 (q, J = 7.2 Hz, 4H), 3.19 – 
3.08 (m, 4H), 1.33 (t, J = 7.2 Hz, 6H). 13C NMR (300 MHz, CDCl3) δ 159.65, 159.48, 153.65, 
134.46, 131.84, 131.73, 129.45, 123.07, 116.24, 115.94, 114.50, 90.59, 51.95, 41.29, 26.10, 
10.92. HRMS (FAB) Calcd. for C27H26N2FO+ [M+]: 413.2024; found 413.2017. 
 
Xanthene 4-7e. Following the general procedure, diaryl ether 4-3d (154 mg, 0.500 mmol) was 
reacted with 2,3,4,5,6-pentafluorobenzoyl chloride (0.57 mL, 4.0 mmol) to provide 138 mg of 4-
7e as a green/blue solid (53%) and 61 mg of recovered 4-3d (40%). 1H NMR (400 MHz, MeOD) 
δ 7.06 (s, 2H), 6.77 (s, 2H), 3.97 (t, J = 7.6 Hz, 4H), 3.64 (q, J = 7.2 Hz, 4H), 3.27 – 3.10 (m, 
4H), 1.35 (t, J = 7.3 Hz, 6H). 13C NMR (300 MHz, MeOD) δ 159.87, 159.45, 145.99, 142.80, 
140.39, 137.53, 135.81, 121.90, 114.53, 107.73, 90.91, 52.21, 41.46, 26.09, 10.97. HRMS (FAB) 












Xanthene 4-7f. Following the general procedure, diaryl ether 4-3d (154 mg, 0.500 mmol) was 
reacted with 1-methyl-1H-imidazole-2-carbonyl chloride (361 mg, 2.5 mmol) to provide 78 mg of 
4-7e as a deep blue-purple solid (36%) and 68 mg of recovered 4-3d (44%). 1H NMR (400 MHz, 
MeOD) δ 7.95 (d, J = 1.9 Hz, 1H), 7.92 (d, J = 1.9 Hz, 1H), 6.85 – 6.81 (m, 4H), 4.01 (t, J = 7.5 
Hz, 4H), 3.80 (s, 3H), 3.67 (q, J = 7.3 Hz, 4H), 3.26 – 3.18 (m, 4H), 1.35 (t, J = 7.3 Hz, 6H). 13C 
NMR (300 MHz, CDCl3) δ 159.98, 159.36, 138.08, 136.83, 130.75, 125.95, 122.11, 120.92, 
114.93, 91.53, 52.45, 41.63, 34.80, 26.12, 11.04. HRMS (FAB) Calcd. for C27H27N4O+ [M+]: 
399.2179; found 399.2197. 
 
Xanthene 4-7b. Diaryl ether 4-3f (1.15 g, 2.81 mmol) in anhydrous dichloromethane (30 mL) 
was treated dropwise via a pressure equalizing addition funnel with a solution of trifluoroacetic 
anhydride (0.87 mL, 6.2 mmol) in 20 mL of DCM over the course of approximately 2 hours. 
After addition was complete, the reaction was left to stir at room temperature overnight. The next 
day, the deep blue reaction mixture was quenched by the addition of 4% aqueous NaHCO3, then 
extracted with dichloromethane (3 x 30 mL). The combined organic layers were dried over 
Na2SO4 and then concentrated under reduced pressure. The crude product was purified by flash 
chromatography (0-10% methanol/dichloromethane) to provide 1.40 g of 4-7b as a green/blue 
solid (83%). 1H NMR (400 MHz, MeOD) δ 7.72 (s, 2H), 6.76 (s, 1H), 6.74 (s, 1H), 4.15 (q, J = 
7.1 Hz, 2H), 4.01 (td, J = 7.4, 3.7 Hz, 4H), 3.69 – 3.58 (m, 4H), 3.32-3.25 (m, 4H), 2.44 (t, J = 
7.0 Hz, 2H), 1.86 – 1.68 (m, 4H), 1.35 (t, J = 7.3 Hz, 3H), 1.26 (t, J = 7.1 Hz, 3H). 13C NMR (300 












111.85, 111.67, 91.49, 91.33, 60.53, 52.87, 52.36, 46.61, 41.61, 33.43, 26.42, 22.23, 13.52, 11.09. 
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5.0 Chapter Outlook 
 Emerging technologies in optical imaging are providing methods for visualizing 
biomolecules at unprecedented resolution. As advances are made in the microscopy 
arena, the properties of fluorescent probes must evolve to meet the demands of new 
technologies. Recent developments in the field of super-resolution imaging have enabled 
sub-diffraction localization of individual molecules inside of living cells. These 
technologies require fluorophores with special properties such as photoswitching and 
photoactivatability. In addition, the resolution of the image depends on the total number 
of photons that can be detected per molecules, and therefore benefits from fluorophores 
with high photon outputs. Here, we report the design and synthesis of a photoactivatable 
azido-acyl oxazine fluorophore for live cell imaging that can be applied to meet these 
needs. Photoactivation is achieved cleanly and rapidly with 365 nm light, producing a 
single fluorescent oxazine photoproduct. We demonstrate protein specific labeling in 
living cells using trimethoprim conjugates, confirming the utility of azido-acyl oxazines 
for live cell imaging applications. Notably, the photoactivatable oxazine fluorophores 
outperform their standard oxazine counterparts, establishing photocaging as a feasible 
approach for overcoming challenges of cell-permeability and non-specific staining. The 
photoactivatable oxazine developed here provides a powerful new reagent for biological 






5.1  Introduction 
With the continuing development of fluorescence-based tools for studying 
molecular processes within living cells comes the demand for brighter, multifunctional 
fluorescent probes1. Great strides have been made over the past several decades in 
devising chemical tools for protein specific labeling2–7 and intracellular molecular 
sensing8 using fluorescent reporters. Likewise, there has been significant progress in the 
development of single molecule super-resolution imaging technologies9,10 for localizing 
biomolecules in cells with unprecedented precision.  For live-cell imaging, these methods 
require probes with high overall brightness, high photostability, preferably with 
absorbance and emission of red or near-IR light, cellular permeability, and good cellular 
properties (i.e. devoid of non-specific staining)1. Several other advantageous properties, 
such as fluorogenicity11 and photoactivatability12, are also exploited in various 
applications. Thus, while the microscopy toolkit expands to meet new challenges in the 
imaging arena, so too should our repertoire of small molecule fluorophores in order to 
maximize the potential of emerging technologies. 
Oxazines comprise a class of live-cell fluorescent imaging reagents exemplified 
by the popular commercial dye Atto 655. Their remarkable photostability, notably higher 
in comparison to the cyanine fluorophores, and emission in the red/far-red region of the 
visible spectrum, notably redder than the rhodamine dye class, make these fluorophores 
well-suited to live-cell and single molecule-based techniques. Oxazines also undergo 
photoswitching13, which has been exploited for super-resolution dSTORM imaging14. 
Like many other classes of fluorophores, one drawback for oxazines is their unreliable 
behavior within the context of living cells, either due to low permeability or aggregation 
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leading to high background staining. Also, to date, the derivatization of oxazine scaffolds 
has not been extensively explored, potentially due to synthetic challenges. Therefore, the 
oxazine class of molecules would benefit from new synthetic methods for their assembly 
that enable the diversification of the scaffold with new chemical features, either to 
improve cellular behavior or to install useful functionality. 
 
Figure 5-1. Strategies for caging fluorescent dyes. Approaches include trapping molecules in 
non-fluorescent states with enzymatically cleavable or photocleavable capping groups. Some pro-
fluorescent molecules are intrinsically photoactivatable. The latter category most closely 




Previously, other fluorophore scaffolds have been derivatized to overcome 
challenges of solubility15, cell-permeability16, and brightness17, and to introduce 
functionality such as photoactivatability18,19. Representative examples include fluorescein 
diacetate, which is cell permeable and cleaved by intracellular esterases20 to generate 
fluorescent product, and the photoactivatable fluorophores NVOC2-Rhodamine21 and 
azido-DCDHF22 (Fig. 5-1). While NVOC is commonly used as a photocleavable group, it 
incorporates unwanted bulk and hydrophobicity into the probe. Also, in the case of 
NVOC2-Rhodamine, full uncaging of the fluorophore requires two photocleavage events. 
Azido-DCDHF contains a smaller photoactivation motif that minimally perturbs its 
overall structure and requires just a single uncaging event; however, the photoreaction 
gives rise to a mixture of products. 
Here, we report the design and synthesis of new oxazine derivatives and 
demonstrate their feasibility for use in live-cell imaging. First, we have addressed the 
synthetic chemistry challenges by employing recent advances in transition metal catalysis 
to synthesize acyl oxazine intermediates, providing an avenue for facile functionalization 
of the oxazine scaffold. Second, we prepared azido-acyl oxazines and demonstrated that 
they undergo rapid and clean photoconversion to the oxazine fluorophores through 
cleavage of the acyl moiety accompanied by the concomitant release of molecular 
nitrogen. Lastly, using the TMP chemical tagging technology, we show that azido-acyl 
oxazines are useful reagents for live mammalian cell imaging, especially when compared 





5.2  Results 
5.2.1  Chemical synthesis of azido-acyl oxazines  
In order to apply the approaches displayed in Figure 5-1 to the oxazine class of 
fluorophores, we chose to build upon the report that acyl oxazines undergo UV-induced 
cleavage of the N-acyl bond to generate oxazine dyes23. However, because acyl oxazines 
uncage relatively slowly, the extent of UV exposure required for efficient photoactivation 
is incompatible with living cells. Moreover, competitive Photo-Fries rearrangement 
products are obtained in addition to the desired oxazines. Inspired by azido-DCDHF, we 
set out to synthesize azido-acyl oxazines (Fig. 5-1, PA-oxazine 1a) in an attempt to 
enhance photoactivation. We anticipated the release of molecular nitrogen would provide 
a strong thermodynamic driving force for irreversibility of acyl bond cleavage, favoring 
the forward reaction and resulting in fewer radical recombination byproducts.  
Previously, acyl oxazines have been prepared from their parent oxazine 
fluorophores by in situ reduction of the oxazine to its leuco form in the presence of an 
acylating agent (Fig. 5-1, Prior Works). However, this procedure is limited in its 
compatibility with other functionality, and is circuitous from a synthetic standpoint. To 
circumvent these challenges, we sought to take advantage of our recently reported diaryl 
ether scaffold24 to prepare acyl oxazines directly without passing through the oxazine 
dye. Given the electronically activated nature of the diaryl ether system, we reasoned that 
bromination followed by coupling with primary amides or carbamates would furnish acyl 






Figure 5-2. Synthesis of azido-acyl oxazines via acyl oxazine intermediates. N,N’-DMED = 
N,N’-dimethylelthylenedi-amine. 
 
Diaryl ether 5-5 was prepared according to our previously reported strategy, 
utilizing a key copper(I) promoted reaction between aminophenol 5-3 and iodoindoline 5-
4. Bromination of 5-5 was achieved using N-bromosuccinimide, proceeding exclusively 
with the desired regioselectivity to afford 5-6 in high yield (Fig. 5-2). Then, a second key 
copper(I) promoted reaction25 was implemented to construct the oxazine core, where the 
initial coupling between the amide or carbamate and 5-6 is followed by a second 
intramolecular coupling resulting in a cyclized acyl oxazine product. Importantly, this 






















5-7a, 5-1a: R = Me
5-7b, 5-1b: R = OtBu
5-7c: R = OBn
5-7d: R = OMe











































reaction occurs in the presence of non-protected primary anilines, which are orthogonal 
under the conditions employed. Coupling/cyclization products bearing various acyl 
substituents were prepared in good to excellent yields, and several of these derivatives 
became colorful upon exposure to UV light. Of note, acyl oxazines can be deprotected 
under the appropriate conditions to yield leuco dyes, which upon exposure to air 
spontaneously oxidize to furnish the fluorescent oxazines. From acyl oxazines, synthesis 
of the target azido-acyl oxazines was achieved by diazotransfer from imidazole sulfonyl 
azide. Thus, this approach provides a general route to the construction of the oxazine core 
allowing for functionalization of the scaffold before deprotection of the fluorophore’s 
sensitive conjugated cationic system.  
 
5.2.2  Photochemical characterization of azido-acyl oxazines 
As anticipated, azido-acyl oxazines were extremely sensitive to UV light and 
readily converted to fluorescent photoproducts after brief exposures (Fig. 5-3a). In the 
UV-Vis absorbance and fluorescence traces of a representative compound, 5-1b, 
following increasing exposure to UV light, an absorbance band steadily arises in the 
visible region with a lmax of 612 nm, as does a fluorescence band with lmax centered at 642 
nm. Closer inspection of the UV region within Figure 5-3b displays several isosbestic 
points for the photochemical process (Fig. 5-4), indicative of a clean reaction devoid of 





Figure 5-3. The azido-acyl oxazine uncaging photoreaction. (a) Photoactivation of azido-acyl 
oxazines and acyl oxazines. (b) Absorbance and fluorescence spectra (excitation = 594 nm) of 5-
1b as a function of total exposure to 254 nm light. (c) Comparison of photoactivation rates for the 
azido-acyl oxazines 5-1a and 5-1b vs. the corresponding acyl oxazines 5-7a and 5-7b. 
 
The absorbance and fluorescence traces of the photoproducts overlay nearly 
identically with those of the independently synthesized oxazine 5-2, which is the 
expected product of the photoreaction (Fig. 5-5). Additionally, HPLC analysis of the 
crude photoreaction indicated formation of just a single major product, identified as the 
anticipated oxazine by co-elution with the independently synthesized authentic marker 5-
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2 (Fig. 5-6). Together, these results demonstrate that the photoreaction proceeds cleanly 
to a single product, and that the product is the oxazine fluorophore 5-2 generated by 
cleavage of the acyl group and release of molecular nitrogen from the parent compound. 
In comparison to the acyl oxazines 5-7a and 5-7b, the corresponding azido-acyl oxazine 
derivatives 5-1a and 5-1b undergo more rapid uncaging to the fluorophore in response to 
UV light, with rate accelerations of 20-30 fold (Fig. 5-3c). 
 
Figure 5-4. UV absorbance spectra of the photoreaction. The spectra were obtained for 
compound 5-1b after varying durations of exposure to 254 nm light. Focus on the UV-region.  
 
Figure 5-5. UV-vis spectra of the photoproduct. Overlay of (a) absorbance and (a) fluorescence 









Figure 5-6. Reverse-phase HPLC analysis of the azido-acyl oxazine photoreaction. Co-injection 
of the authentic oxazine 5-2 and the photoreaction (lower panel) shows a single peak, indicating 






5.2.3  Live-cell imaging with photoactivatable azido-acyl oxazines  
To assess whether the photoactivatable oxazines were viable reagents for live cell 
imaging, we first tested the azido-acetyl oxazine derivative 5-1a for permeability and 
photoactivatability in living cells. HeLa cells incubated with 2 µM of 5-1a were 
irradiated with 365 nm light for 1s, resulting in a dramatic increase in the fluorescence 
signal (Fig. 5-7). This demonstrated that the photoactivatable oxazine is cell permeable 
and capable of undergoing photoactivation within the cellular environment. Given these 
promising results, we then tested the trimethoprim (TMP) conjugate of the 
photoactivatable oxazine for labeling E. coli dihydrofolate reductase (eDHFR) in 
HEK293T cells (Fig. 5-8). TMP binds to eDHFR with nanomolar affinity, allowing 
specific labeling of a protein of interest (POI) when it is fused to eDHFR by staining with 
TMP-fluorophore conjugates (Fig. 5-8A).  
 
Figure 5-7. Photoactivation and fluorescence imaging of azido-acyl oxazines in live mammalian 






Figure 5-8. Protein-specific labeling in live cells with TMP-oxazine conjugates. (A) eDHFR is 
fused to a protein of interest (POI) and labeled with trimethoprim based probes. (B) Structures of 
the photoactivatable TMP-1a and the oxazine fluorophore TMP-2. (C) Labeling of a nuclear 
localized H2B-eDHFR fusion and (D) a plasma membrane (PM) localized eDHFR in HEK cells, 
co-tranfected with H2B-GFP. Scale bar = 50 µm. Photoactivation conducted with 365nm light. 
 
We prepared the TMP conjugate of the photoactivatable acetyl-azido oxazine 
(TMP-1a) as well as the native oxazine fluorophore (TMP-2) as a point of comparison 
(Fig. 5-8B). Labeling of nuclear localized H2B-eDHFR with TMP-1a followed by a 
brief exposure to 365 nm light resulted in bright fluorescent labeling of the target protein 
(Fig. 5-8C). Interestingly, when TMP-2 was imaged, very weak staining was observed, 
likely on account of poor cell permeability. We also observed clean labeling of a plasma 
membrane (PM) localized eDHFR with the photoactivatable TMP-1a, whereas TMP-2 
showed only weak staining of the intracellular DHFR (Fig. 5-8D). Of note, we have 
observed similarly poor cellular behavior with other oxazine analogs (data not shown). 
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These results indicate that the caged azido-acetyl oxazine is a superior reagent for live 
cell applications when compared to its corresponding oxazine fluorophore.  
 
5.3  Discussion  
In conclusion, we present a new synthetic route to the synthesis and derivatization 
of oxazine dyes and demonstrate the utility of this approach through the design and 
synthesis of a photoactivatable motif for oxazine fluorophores. We demonstrate that these 
reagents undergo rapid and clean photoconversion to a single major fluorescent product, 
and further apply these reagents for live cell imaging. Importantly, caged oxazines were 
found to be useful alternatives to native oxazine dyes on account of their improved 
cellular behavior. This new class of reagents expands our toolkit for probing the 
dynamics of individual molecules and unraveling the molecular mechanisms of biology 
in living cells. 
 
5.4  Experimental Methods 
General procedure 5.4.1 for the Copper(I) promoted coupling of phenols and aryl 
iodides.  
According to the published protocol by Maiti and Buchwald26, an oven dried, sealable 
glass vessel was charged with a magenetic stirbar, the phenol (2.40 mmol), potassium 
phosphate (4.00 mmol, 849 mg), copper(I) iodide (0.20 mmol, 38 mg), 2-picolinic acid 
(0.40 mmol, 49 mg), and the aryl iodide, if a solid (2.00 mmol). The vessel was then 
fitted with a rubber septum, evacuated under vacuum and backfilled with argon. This 
process was repeated 3 times. The vessel was then charged with DMSO (4.0 mL), or if 
the aryl iodide is a liquid, the vessel was charged with the aryl iodide as a solution in 
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DMSO. The rubber septum was removed and the reaction vessel was immediately sealed 
tightly with a Teflon screw cap. The reaction was then heated to 85 ˚C for 16-24 hours. 
After cooling to room temperature, the reaction was diluted with 10 mL of water and 
extracted with ethyl acetate (25 mL, 4x). The combined organic layers were washed with 
brine and dried over Na2SO4, then concentrated in vacuo to a crude residue. Purification 
by flash chromatography (hexanes/ethyl acetate) afforded the diaryl ethers as colorless 
oils, which were stored at -20 ˚C under inert atmosphere. 
General procedure 5.4.2 for the Copper(I) promoted coupling and cyclization of di-
arylbromides with amides and carbamates. 
According to the published protocol by Klapars et al.25, an oven dried, sealable glass 
vessel was charged with a magenetic stirbar, the di-bromoaryl ether (1.00 mmol), the 
amide or carbamate (1.20-1.50 mmol), potassium carbonate (3.00 mmol, 415 mg), 
copper(I) iodide (0.10 mmol, 19 mg), and N,N’-DMED (0.20 mmol, 17.6 mg). The 
vessel was then fitted with a rubber septum, evacuated under vacuum and backfilled with 
argon. This process was repeated 3 times. The vessel was then charged with toluene (1.2 
mL). The rubber septum was removed and the reaction vessel was immediately sealed 
tightly with a Teflon screw cap. The reaction was then heated to 110 ˚C for 24 hours. 
After cooling to room temperature, the reaction was diluted with 10 mL of water and 
extracted with ethyl acetate (25 mL, 4x). The combined organic layers were washed with 
brine and dried over Na2SO4, then concentrated in vacuo to a crude residue. Purification 
by flash chromatography (hexanes/ethyl acetate) afforded the cyclized acyl-leuco 
oxazines as colorless amorphous solids, which were stored protected from light at -20 ˚C 
under inert atmosphere. 
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General procedure 5.4.3 for converting acyl-oxazine to azido-acyl oxazines. 
Imidazole sulfonyl azide · HCl (172 mg, 0.821 mmol) was dissolved in anhydrous 
dichloromethane (6 mL) and treated with triethylamine (0.32 mL, 2.30 mmol). To this 
mixture, the aniline (0.657 mmol) was added followed by copper (II) sulfate pentahydrate 
(~1 mg, 1.0 mol %). The reaction was stirred at room temperature for 6 hours and 
monitored for consumption of starting material. If the reaction did not reach completion, 
it was supplemented with additional triethylamine and imidazole sulfonyl azide · HCl. 
Upon completion, the reaction was filtered through celite, then diluted with 10 mL of 
water and extracted with dichloromethane (25 mL, 4x). The combined organic layers 
were washed with brine and dried over Na2SO4, then concentrated in vacuo to a crude 
residue. Purification by flash chromatography (hexanes/ethyl acetate) afforded the azido-
acyl oxazines as colorless amorphous solids, which were stored protected from light at -
20 ˚C under inert atmosphere. 
Cell culture, transfection and labeling. HEK293T cells were cultured in DMEM with 
glutamine (Bibco), supplemented with 10% v/v fetal bovine serum and 1% v/v Pen/Strep. 
Cells were maintained under 5% CO2 at 37 ˚C. For transfection, labeling, and 
fluorescence imaging, cells were plated in 8-well chambered #1 borosilicate coverglass 
(ThermoFisher) and grown for 24 h before being transfected. Transfection of plasmids 
(0.4 ug DNA per well) expressing H2B-GFP and eDHFR fusion proteins of interest was 
achieved with Fugene HD (Roche). 24 h following transfection, 300 uL of fresh media 
containing 0.3 uL of the fluorophore stock solution (1 mM in DMF) was added to the 
well (1 uM final concentration of fluorophore). Cells were incubated with the staining 
solution for 10 min at 37 ˚C then washed with fresh media twice before imaging. 
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Confocal images were obtained on a Zeiss LSM700 confocal and processed with ZEN 
software. Photoactivation of the azido-acyl oxazines was achieved by illumination with 
365 nm excitation.  
 
 
5-(1-ethylindolin-6-yloxy)-2-methylaniline (5-5). Following general procedure 5.4.1, 3-amino-
4-methyl phenol (1.13 g, 9.18 mmol) and 1-ethyl-6-iodoindoline 4-2c (2.09 g, 7.65 mmol) were 
coupled to provide 5-5 (1.66 g, 81%) as a colorless oil. 1H NMR (400 MHz, CDCl3) δ 7.00 (dd, J 
= 7.9, 1.4 Hz, 2H), 6.41 (dd, J = 8.1, 2.4 Hz, 1H), 6.38 (d, J = 2.4 Hz, 1H), 6.30 (dd, J = 7.8, 2.1 
Hz, 1H), 6.22 (d, J = 2.1 Hz, 1H), 3.62 (br s, 2H), 3.41 (t, J = 8.2 Hz, 2H), 3.12 (q, J = 7.2 Hz, 
2H), 2.96 (t, J = 8.2 Hz, 2H), 2.16 (s, 3H), 1.20 (t, J = 7.2 Hz, 3H). 13C NMR (300 MHz, CDCl3) 
δ 157.82, 157.57, 154.15, 145.96, 131.44, 125.42, 124.89, 117.02, 108.94, 107.99, 105.44, 99.58, 
53.16, 43.28, 28.32, 17.06, 12.22. HRMS (FAB+) Calcd. For C17H20N2O+ [M+]: 268.1576; found 
268.1580. 
 
ethyl 4-(6-(3-amino-4-methylphenoxy)indolin-1-yl)butanoate (5-S2). Following general 
procedure 5.4.1, 3-amino-4-methyl phenol (880 mg, 7.15 mmol) and 5-S1 (2.14 g, 5.96 mmol) 
were coupled to provide 5-S2 (1.69 g, 80%) as a colorless oil. 1H NMR (400 MHz, CDCl3) δ 6.98 
(dd, J = 7.8 Hz, 3.1 Hz, 2H), 6.39 (dd, J = 7.8, 2.3 Hz, 1H), 6.38 (s, 1H), 6.28 (dd, J = 7.8, 2.1 
Hz, 1H), 6.19 (d, J = 2.1 Hz, 1H), 4.14 (q, J = 7.1 Hz, 2H), 3.57 (br s, 2H), 3.42 (t, J = 8.3 Hz, 
2H), 3.08 (t, J = 7.1 Hz, 2H), 2.96 (t, J = 8.2 Hz, 2H), 2.41 (t, J = 7.4 Hz, 2H), 2.15 (s, 3H), 1.94 






157.46, 154.29, 145.90, 131.44, 125.00, 124.91, 117.10, 108.99, 107.96, 105.49, 99.27, 60.79, 
53.99, 48.76, 32.20, 28.34, 23.22, 17.05, 14.61. HRMS (FAB+) Calcd. For C21H26N2O3+ [M+]: 
354.1943; found 354.1946. 
 
4-bromo-5-(5-bromo-1-ethylindolin-6-yloxy)-2-methylaniline (5-6). Compound 5-5 (1.58 g, 
5.91 mmol) was dissolved in dichloromethane (20 mL) and cooled to 0˚C in an ice bath. The 
solution was then treated with N-bromosuccinimide (2.16 g, 12.1 mmol) in small portions over a 
period of 10 minutes. After stirring at 0˚C for 30 minutes, the reaction showed completion by 
TLC and was treated with 25 mL of sat. aq. NaHCO3. The organic layer was separated from the 
aqueous, and the aqueous layer extracted twice with 25 mL of dichloromethane. The combined 
organic layers were washed with brine and dried over Na2SO4, then concentrated in vacuo to a 
red-brown oil. Purified by flash chromatography to yield 1.91 g of 5-6 as a beige solid (89%). 1H 
NMR (400 MHz, CDCl3) δ 7.26 (s, 1H), 7.23 (s, 1H), 6.14 (s, 1H), 6.08 (s, 1H), 3.59 (br s, 2H), 
3.41 (t, J = 8.3 Hz, 2H), 3.05 (q, J = 7.2 Hz, 2H), 2.97 (t, J = 8.3 Hz, 2H), 2.13 (s, 3H), 1.14 (t, J 
= 7.2 Hz, 3H). 13C NMR (75 MHz, CDCl3) δ 153.39, 153.15, 152.91, 145.25, 134.71, 128.70, 
128.15, 119.04, 105.20, 101.03, 100.91, 100.50, 52.84, 43.12, 28.11, 16.88, 12.00. HRMS 
(FAB+) Calcd. For C17H18Br2N2O+ [M+]: 423.9786; found 423.9781. 
 
ethyl 4-(6-(5-amino-2-bromo-4-methylphenoxy)-5-bromoindolin-1-yl)butanoate (5-S3). 
Compound 5-S2 (1.58 g, 5.91 mmol) was dissolved in dichloromethane (20 mL) and cooled to 








in small portions over a period of 10 minutes. After stirring at 0˚C for 30 minutes, the reaction 
showed completion by TLC and was treated with 25 mL of sat. aq. NaHCO3. The organic layer 
was separated from the aqueous, and the aqueous layer extracted twice with 25 mL of 
dichloromethane. The combined organic layers were washed with brine and dried over Na2SO4, 
then concentrated in vacuo to a red-brown oil. Purified by flash chromatography to yield 1.98 g of 




7a). Following general procedure 5.4.2, 5-6 (319 mg, 0.75 mmol) and acetamide (53 mg, 0.90 
mmol) were coupled to provide 5-7a (218 mg, 90%) as a colorless amorphous solid. 1H NMR 
(400 MHz, CDCl3) δ 7.13 (s, 2H), 6.44 (s, 1H), 6.21 (s, 1H), 3.64 (br s, 2H), 3.38 (t, J = 8.2 Hz, 
2H), 3.12 (q, J = 7.2 Hz, 2H), 2.95 (t, J = 8.2 Hz, 2H), 2.29 (s, 3H), 2.16 (s, 3H), 0.91 (t, J = 7.2 
Hz, 3H). 13C NMR (300 MHz, CDCl3) δ 170.13, 151.69, 151.49, 150.86, 143.48, 126.63, 124.94, 
121.44, 121.13, 119.88, 117.15, 103.06, 96.20, 53.01, 43.40, 28.38, 23.27, 17.37, 12.10. HRMS 











carboxylate (5-7b). Following general procedure 5.4.2, 5-6 (319 mg, 0.75 mmol) and t-butyl 
carbamate (106 mg, 0.90 mmol) were coupled to provide 5-7b (204 mg, 71%) as a colorless 
amorphous solid. 1H NMR (400 MHz, CDCl3) δ 7.20 (s, 2H), 6.37 (s, 1H), 6.16 (s, 1H), 3.57 (s, 
2H), 3.35 (t, J = 7.8 Hz, 2H), 3.11 (q, J = 7.1 Hz, 2H), 2.93 (t, J = 7.6 Hz, 2H), 2.14 (s, 3H), 1.55 
(s, 9H), 1.19 (t, J = 7.2 Hz, 3H). 13C NMR (75 MHz, CDCl3) δ 153.29, 150.82, 150.77, 149.98, 
142.72, 126.79, 124.72, 121.23, 120.67, 119.25, 116.98, 102.83, 96.03, 81.71, 53.11, 43.58, 




(5-7c). Following general procedure 5.4.2, 5-6 (319 mg, 0.75 mmol) and benzyl carbamate (136 
mg, 0.90 mmol) were coupled to provide 5-7c (199 mg, 64%) as a colorless amorphous solid. 1H 
NMR (400 MHz, CDCl3) δ 7.47 – 7.33 (m, 5H), 7.25 (d, J = 4.3 Hz, 2H), 6.39 (s, 1H), 6.20 (s, 
1H), 5.30 (s, 2H), 3.60 (br s, 2H), 3.37 (t, J = 8.2 Hz, 2H), 3.12 (q, J = 7.2 Hz, 2H), 2.94 (t, J = 
8.2 Hz, 2H), 2.13 (s, 3H), 1.21 (t, J = 7.2 Hz, 3H). 13C NMR (75 MHz, CDCl3) δ 154.31, 151.17, 
150.91, 150.06, 143.24, 136.70, 128.90, 128.52, 128.43, 128.22, 126.62, 124.94, 120.12, 118.80, 
117.17, 102.89, 96.05, 68.17, 53.06, 43.50, 28.42, 17.30, 12.20. HRMS (FAB+) Calcd. For 











(5-7d). Following general procedure 5.4.2, 5-6 (319 mg, 0.75 mmol) and methyl carbamate (68 
mg, 0.90 mmol) were coupled to provide 5-7d (168 mg, 66%) as a colorless amorphous solid. 1H 
NMR (400 MHz, CDCl3) δ 7.20 (d, J = 5.7 Hz, 2H), 6.39 (s, 1H), 6.17 (s, 1H), 3.83 (s, 3H), 3.60 
(br s, 2H), 3.37 (t, J = 8.1 Hz, 2H), 3.11 (q, J = 7.2 Hz, 2H), 2.95 (t, J = 8.1 Hz, 2H), 2.15 (s, 3H), 
1.19 (t, J = 7.2 Hz, 3H). 13C NMR (75 MHz, CDCl3) δ 155.07, 151.16, 150.92, 150.11, 143.14, 
126.48, 124.95, 120.97, 120.30, 118.82, 117.22, 102.88, 96.03, 53.54, 53.05, 43.47, 28.43, 17.37, 




7e). Following general procedure 5.4.2, 5-6 (319 mg, 0.75 mmol) and formamide (51 mg, 1.13 
mmol) were coupled to provide 5-7e (137 mg, 59%) as a colorless amorphous solid. 1H NMR 
(400 MHz, CDCl3) δ 8.52 (s, 1H), 7.64 (d, J = 5.3 Hz, 1H), 6.80 (d, J = 6.5 Hz, 1H), 6.38 (d, J = 
5.7 Hz, 1H), 6.16 (d, J = 6.4 Hz, 1H), 3.54 (br s, 2H), 3.36 (t, J = 7.8 Hz, 2H), 3.11 (q, J = 7.2 Hz, 
2H), 2.93 (t, J = 7.8 Hz, 2H), 2.13 (s, 3H), 1.17 (t, J = 7.2 Hz, 3H). 13C NMR (75 MHz, CDCl3) δ 













96.00, 52.90, 43.33, 28.38, 17.30, 12.02. HRMS (FAB+) Calcd. For C18H19N3O2+ [M+]: 




yl)butanoate (5-S4). Following general procedure 5.4.2, 5-S3 (512 mg, 1.00 mmol) and 
acetamide (71 mg, 1.20 mmol) were coupled to provide 5-S4 (310 mg, 76%) as a colorless 
amorphous solid. 1H NMR (400 MHz, CDCl3) δ 7.08 (m, 2H), 6.39 (s, 1H), 6.17 (s, 1H), 4.13 (q, 
J = 7.1 Hz, 2H), 3.69 (s, 2H), 3.35 (t, J = 8.3 Hz, 2H), 3.05 (t, J = 7.0 Hz, 2H), 2.92 (t, J = 8.2 Hz, 
2H), 2.39 (t, J = 7.3 Hz, 2H), 2.25 (s, 3H), 2.11 (s, 3H), 1.91 (p, J = 7.2 Hz, 2H), 1.25 (t, J = 7.1 
Hz, 3H). 13C NMR (75 MHz, CDCl3) δ 173.68, 170.10, 151.68, 151.65, 150.78, 143.72, 126.51, 
124.48, 121.19, 121.16, 119.88, 117.09, 102.97, 95.89, 60.79, 53.88, 48.81, 32.06, 28.41, 23.24, 
















mg, 52%) and recovered as a colorless amorphous solid. 1H NMR (400 MHz, CDCl3) δ 7.32 (s, 
1H), 7.06 (s, 1H), 6.88 (s, 1H), 6.22 (s, 1H), 3.41 (t, 2H), 3.15 (q, J = 7.2 Hz, 2H), 2.97 (t, J = 8.2 
Hz, 2H), 2.30 (s, 3H), 2.20 (s, 3H), 1.21 (t, J = 7.2 Hz, 3H). 13C NMR (75 MHz, CDCl3) δ 
170.00, 151.77, 151.48, 150.55, 136.63, 127.52, 127.01, 125.50, 124.47, 120.97, 119.11, 106.52, 
96.08, 52.91, 43.26, 28.33, 23.29, 17.21, 12.07. HRMS (FAB+) Calcd. For C19H19N5O2+ [M+]: 
349.1539; found 349.1539. 
 
tert-butyl 8-azido-1-ethyl-7-methyl-2,3-dihydropyrrolo[3,2-b]phenoxazine-5(1H)-
carboxylate (5-1b). Following general procedure 5.4.3, 5-7b (208 mg, 0.545 mmol) was 
converted to 5-1b (146 mg, 66%) and recovered as a colorless amorphous solid. 1H NMR (400 
MHz, CDCl3) δ 7.32 (s, 1H), 7.19 (s, 1H), 6.80 (s, 1H), 6.16 (s, 1H), 3.38 (t, J = 8.2 Hz, 2H), 3.13 
(q, J = 7.2 Hz, 2H), 2.94 (t, J = 8.2 Hz, 2H), 2.18 (s, 3H), 1.54 (s, 9H), 1.20 (t, J = 7.2 Hz, 3H). 
13C NMR (75 MHz, CDCl3) δ 173.72, 152.82, 151.23, 150.44, 135.74, 127.47, 126.35, 124.79, 
124.06, 121.22, 118.47, 106.21, 95.59, 82.37, 53.91, 43.87, 28.60, 28.45, 17.15, 12.64. HRMS 
(FAB+) Calcd. For C22H25N5O3+ [M+]: 407.1957; found 407.1963. 
 
ethyl 4-(5-acetyl-8-azido-7-methyl-2,3-dihydropyrrolo[3,2-b]phenoxazin-1(5H)-yl)butanoate 
(5-S5). Following general procedure 5.4.3, 5-S4 (305 mg, 0.745 mmol) was converted to 5-S5 










CDCl3) δ 7.29 (s, 1H), 7.04 (s, 1H), 6.85 (s, 1H), 6.20 (s, 1H), 4.16 (q, J = 7.1 Hz, 2H), 3.42 (t, J 
= 8.3 Hz, 2H), 3.10 (t, J = 7.1 Hz, 2H), 2.97 (t, J = 8.3 Hz, 2H), 2.42 (t, J = 7.2 Hz, 2H), 2.29 (s, 
3H), 2.19 (s, 3H), 1.94 (p, J = 7.2 Hz, 2H), 1.27 (t, J = 7.1 Hz, 3H). 13C NMR (75 MHz, CDCl3) δ 
173.66, 169.98, 151.98, 151.47, 150.50, 136.61, 127.49, 126.94, 125.10, 124.44, 121.00, 119.09, 
106.50, 95.84, 60.86, 53.80, 48.65, 32.01, 28.39, 23.30, 22.99, 17.25, 14.64. HRMS (FAB+) 
Calcd. For C23H25N5O4+ [M+]: 435.1907; found 435.1896. 
  
4-(8-imino-7-methyl-2,3-dihydropyrrolo[3,2-b]phenoxazin-1(8H)-yl)butanoic acid · HCl salt 
(5-S6). Compound 5-S5 (25 g, 0.0574 mmol) was heated to 60 ˚C for 16 hours in a mixture of 
THF (3 mL) and 0.5N HCl (12 mL). The aqueous layer was extracted with 25 mL of a 4:1 
mixture of ethyl acetate/hexanes, and then extracted with dichloromethane (3x 25 mL). The 
dichloromethane layers were concentrated under reduced pressure to yield 5-S6 as a deep blue 
residue  (15 mg, 71%). 1H NMR (400 MHz, MeOD) δ 7.49 (s, 1H), 7.37 (s, 1H), 6.76 (s, 1H), 
6.69 (s, 1H), 4.11 (t, J = 6.0 Hz, 2H), 3.72 (t, J = 6.0 Hz, 2H), 3.31 (m, 2H), 2.49 (t, J = 6.8 Hz, 
2H), 2.30 (s, 3H), 2.07 (p, J = 7.2 Hz, 2H). 13C NMR (75 MHz, CDCl3) δ 175.27, 161.27, 158.18, 
151.52, 147.62, 139.25, 136.91, 132.64, 132.05, 127.20, 126.70, 96.93, 91.14, 54.00, 46.86, 











TMP-1a. Compound 5-S5 (25 mg, 0.0574 mmol) was subjected to hydrolysis conditions as 
above (THF/0.5N HCl) for 5 hours at 60 ˚C, then purified by flash chromatography 
(DCM/MeOH) to yield 8 mg of the carboxylic acid (35%). Then, TMP-(PEG)3-NH2 (1.2 mg, 1.7 
umol), the carboxylic acid of 5-S5 (1.0 mg, 2.3 umol), HCTU (4.5 mg, 11 umol), triethylamine 
(1.0 uL, 7.2 umol) and dimethylformamide (0.2 mL) were combined in an amber vial, which was 
then purged with argon and sealed. Stirred at room temperature for 75 minutes, then purified 
directly by reverse phase HPLC to yield 0.8 mg of TMP-1a (48%). 1H NMR (400 MHz, MeOD) 
δ 7.39 (s, 1H), 7.24 (s, 1H), 7.14 (s, 1H), 6.97 (s, 1H), 6.58 (s, 2H), 6.30 (s, 1H), 3.93 (t, J = 6.1 
Hz, 2H), 3.82 (s, 6H), 3.67 (s, 2H), 3.63 - 3.59 (m, 4H), 3.59-3.52 (m, 4H), 3.52 - 3.46 (m, 4H), 
3.43 (t, J = 8.4 Hz, 2H), 3.27 (t, J = 6.8 Hz, 4H), 3.11 (t, J = 6.9 Hz, 2H), 2.96 (t, J = 8.3 Hz, 2H), 
2.29 (s, 3H), 2.29 (p, J = 8.1 Hz, 4H), 2.20 (s, 3H), 1.94 (p, J = 7.6 Hz, 2H), 1.86 – 1.69 (m, 8H). 
























TMP-2. TMP-(PEG)3-NH2 (1.2 mg, 1.7 umol), S09 (1.0 mg, 2.2 umol), HCTU (4.5 mg, 11 
umol), triethylamine (1.0 uL, 7.2 umol) and dimethylformamide were combined in an amber vial, 
which was then purged with argon and sealed. Stirred at room temperature for 75 minutes, then 
purified directly by reverse phase HPLC to yield 1.2 mg of TMP-2 (69%). 1H NMR (400 MHz, 
MeOD) δ 7.62 (s, 1H), 7.49 (s, 1H), 7.25 (s, 1H), 6.85 (s, 1H), 6.82 (s, 1H), 6.57 (s, 2H), 4.12 (t, 
J = 6.9 Hz, 2H), 3.93 (t, J = 6.1 Hz, 2H), 3.81 (s, 6H), 3.73 (t, J = 7.1 Hz, 2H), 3.67 (s, 2H), 3.65 
- 3.60 (m, 4H), 3.60 - 3.55 (m, 4H), 3.53 - 3.47 (m, 4H), 3.36 (m, 2H), 3.26 (dt, J = 9.4, 6.9 Hz, 
4H), 2.34 (s, 3H), 2.34 (t, J = 6.8 Hz, 2H). 2.27 (t, J = 7.3 Hz, 2H), 2.10 (p, J = 7.2 Hz, 2H), 1.87 
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A1.  Identification and characterization of -1 PRF motifs from NGS data.  
A pipeline was established for processing and analyzing NGS data described in 
Chapter 3.2.1 from the point of generation to final motif identification Step 1 of the 
pipeline processes the raw sequencing fastq file and generates a file with every unique 
sequence and its read count. The HiSeq run yielded roughly 56 million sequencing reads 
after processing, from which >3 million unique sequences were recovered. Abundances 
(or read counts) of these sequences ranged from 1 read to >800,000 reads. 50% of the 
total sequencing reads are accounted for by the top 6,752 most abundant unique 
sequences (Fig. A.1-1). We set out to identify -1 PRF motifs from this dataset with a 
specific focus on RNA pseudoknots (PKs), which are known to promote -1 PRF. 
 
 
Figure A1-1. Distribution of sequencing reads based on ranked sequence abundance. 
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To assign a PK structure to each sequence, we chose to assess compatibility with 
PK configurations without accounting for energetic contributions. Because this approach 
is tailored to our restricted scaffold, it is computationally more efficient than absolute 
prediction. Notably, this approach often leads to PK assignments that are in agreement 
with pseudoknot prediction algorithms (such as pKiss). We created a hairpin-type (H-
type) PK feature space using the starting library’s sequence constraints and our imposed 
structural constraints. Every H-type PK can be defined by the lengths of its segments: (a) 
stem 1; (b) loop 1; (c) stem 2; (d) loop 2; and (e) loop 3. To establish the PK position 
within the library scaffold, we also define the length of the segment of unpaired 
nucleotides preceding (5’ to) the PK, the length of the segment downstream of (3’ to) the 
PK (Fig. A.1-2), and fix the total length to 44 nucleotides.  
 
Figure A1-2. Construction of the pseudoknot (PK) feature space.  
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 Using the library scaffold’s constraints and our imposed constraints, a total of 
2,068 PK features were generated. The top 20,000 most abundant sequences from the 
NGS, as well as every theoretical starting library sequence, was evaluated for its 
compatibility with the PK feature space (step 2 of the pipeline). A sequence was deemed 
compatible with a given PK feature if it supported the base pairs present within the PK 
feature (allowable base pairs include the standard Watson-Crick A-U, U-A, G-C, and C-
G, along with the wobble G·U and U·G pairs). Of the PK features supported by a given 
sequence, the feature with the most base pairs is chosen as the assigned PK feature for 
that sequence. In the case of a tie, both PK features are assigned to the sequence. From 
the theoretical starting library, 1,507 PK features were selected by at least 1 sequence. 
 In step 3 of the pipeline, we determined the enrichment of each PK feature by 
calculating its pre-selection probability and comparing it to its post-selection probability 
(Fig. A1-3). Explicitly, pre-selection probability was defined as the total number of 
sequences from the theoretical starting library that were assigned to the PK feature 
divided by the total starting sequences (2.68 x 108).  Post-selection probability was 
defined as the total number of sequencing reads that fit to the PK feature (number of 
unique sequences in that feature multiplied by the mean read-count of sequences within 
that PK feature) divided by the total sequencing reads (approximately 5.6 x 107). The 
enrichment factor (EF) is then defined as the ratio of the post-selection probability to the 
pre-selection probability (Equation A1-1).  
EF =
post − selection probability( )
pre− selection probability( )
=
(#PK reads / total reads)
(#PK initial / total initial)
       (Equation A1-1) 
Each PK feature was ranked according to its EF, and PK features that showed low 
occupancy (low total read mass) were removed. Then, PK features ranked within the top 
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10% of EFs were nominated for primary sequencing clustering analysis. Primary 
sequence clustering was performed using a greedy algorithm, resulting in families of 
sequences that comprise the motifs. Clusters containing less than 5 sequences were 
discarded or ignored. From this analysis, 97 clusters were nominated as final -1 PRF 
motifs.  
 
Figure A1-3. PK feature enrichment. The PK feature probability was calculated from the 
theoretical starting library (assuming equal distribution of sequences) by dividing the 
number of sequences within a PK feature by the starting library size (approx. 2.68 x 108). 
Post selection probability was computed by dividing the number of sequencing reads 
contained within the PK feature by the total sequencing reads (approx. 6 x 107).  
 
The analysis pipeline generates a summary spreadsheet report for all nominated 
motifs, including an ID number, the number of sequences supporting the motif, the mean 
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and standard deviation of abundance level for sequences in the motif, the assigned PK 
secondary structure, the mode sequence, the neighborhood occupancy about the mode, 
and the normalized neighborhood entropy about the mode. Additionally, for each motif, 
the analysis pipeline generates a fasta file containing the motif’s sequences and a 
sequence logo1 displaying information content (Fig. A1-4). An additional variant analysis 
can be performed as step 4 in the pipeline to analyze the sequence neighborhood of a 
particular sequence of interest. This output provides a plot of single nucleotide variants 
(Fig. A1-5) for any sequence of interest, as well as a heat map of abundance for variants 
with two nucleotide (pairwise) differences (Fig. A1-6). Notably, the pairwise output may 
highlight positions where mutual information is present. 
 
 
Figure A1-4. Sequence logo for -1 PRF motif. Thick bars indicate positions of 





Figure A1-5. Single nucleotide variants of target sequence FS-1. 
 
 
Figure A1-6. Pairwise variants of the target sequence FS-1.  
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A2.  Thermodynamic calculations for -1 PRF ON-switches.  
To design and optimize the ligand responsive ON-switches described in chapter 
3.2.2, thermodynamic calculations were performed using RNA secondary structure 
prediction algorithms. Calculations were performed using NUPACK2 with Turner 
parameters3 and the temperature set to 30 ˚C. By default, NUPACK does not predict 
pseudoknots and therefore will predict the lowest energy non-pseudoknotted secondary 
structure for the RNA. pKiss was used to predict FS-2 pseudoknot energy at 30 ˚C. Table 
A2-1 summarizes the results of the calculations. RNA segments used for calculations 
spanned from the start of the FS-2 pseudoknot to the unstructured mid-insulator region.  
Ligand binding energy contributions were estimated based on the Kd of the ligand 
aptamer interaction and the concentration of the ligand that was used. We estimated 
thermodynamic contributions of RNA folding and ligand binding for 4 hypothetical 
scenarios: (1) ΔG of the system in the OFF state not bound to ligand; (2) ΔG of the 
system in the ON state not bound to ligand; (3) ΔG of the system in the OFF state when 
bound to ligand; and (4) ΔG of the system in the ON state when bound to ligand (Fig. A-
2.1). The ON state is defined by a folded FS-2 pseudoknot structure. The following 
energies were calculated as contributors to each of the scenarios: 
(1) ΔG of the system in the OFF state not bound to ligand, Σ of: 
- Ensemble ΔG of the unfolded pseudoknot 
- Ensemble ΔG of the switching hairpin 
- Ensemble ΔG of the aptamer region 
(Note: Σ of ΔG’s can be estimated by the ensemble ΔG of the entire sequence) 
 
(2) ΔG of the system in the ON state not bound to ligand, Σ of: 
- ΔG of the folded pseudoknot  





(3) ΔG of the system in the OFF state when bound to ligand, Σ of: 
- Ensemble ΔG of sequence 5’ to the aptamer 
- ΔG of the folded aptamer 
- ΔG of ligand binding 
 
(4) ΔG of the system in the ON state when bound to ligand, Σ of: 
- ΔG of the folded pseudoknot 
- ΔG of the folded aptamer 
- ΔG of ligand binding 
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Figure A2-1. Description of thermodynamic calculations for evaluation of -1 PRF ON-
switches.  
 
The relative calculated energies of the ON and OFF states were used to guide 
decision for constructing switches, with the desirable property that the OFF state is 
preferred in the absence of ligand and the ON state is preferred in the presence of ligand 
(i.e. minimize ΔΔG ON – OFF in the absence of ligand, and maximize ΔΔG ON – OFF in 
the presence of ligand). When ligand is absent from the system, only scenarios (1) and (2) 
are considered. However, in the presence of ligand, energies of all 4 scenarios must be 
considered (ON unbound and ligand bound, OFF unbound and ligand bound). Therefore, 
!
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for calculating ΔΔG between the ON and OFF states in the presence of ligand, the 
Helmholtz free energy was used (-kT ln Q) for the ON and OFF states using the two 
contributing scenarios (unbound and ligand bound). 
 
Table A2-1. Summary of thermodynamic calculations for -1 PRF ON-switches. 
!
Sequence 
























Theo-ON-1 -32.44 -33.58 -33.16 -36.75 +1.14 +3.43 
Theo-ON-2 -34.14 -33.75 -34.86 -36.75 -0.39 +1.73 
Theo-ON-3 -35.87 -33.65 -36.59 -36.75 -2.22 +0.00 
Theo-ON-4 -35.69 -35.04 -37.35 -38.58 -0.65 +1.19 
Theo-ON-5 -36.69 -35.95 -36.77 -39.99 -0.74 +2.84 
Theo-ON-6 -36.45 -39.00 -38.18 -43.27 +2.55 +5.05 
Neo-ON-1 -25.70 -28.65 -25.71 -32.64 +2.95 +6.51 
Neo-ON-2 -27.46 -28.62 -27.55 -32.64 +1.19 +4.73 
Neo-ON-3 -31.15 -29.82 -31.02 -32.64 -1.33 +1.14 
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